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Investigation of miRNAs enrichment and degradation in bovine granulosa cells during 
follicular development 
 
The granulosa cells in the mammalian ovarian follicle respond to gonadotropin signalling and 
are involved in the processes of folliculogenesis and oocyte maturation. Although, several 
studies have been done on spatio temporal expression of genes during follicular development, 
little is known about the post-transcriptional regulation of those genes. This study unravelled the 
basic knowledge on bovine miRNA prevalence and expression pattern during the early luteal 
phase of the bovine estrous cycle. For this, miRNAs enriched total RNA isolated from granulosa 
cells of subordinate follicles (SF) and dominant follicles (DF) obtained from heifers slaughtered 
at day 3 and day 7 of the estrous cycle and were subjected for miRNAs deep sequencing. The 
data analysis revealed that 291 and 318 mature miRNAs were detected in granulosa cells of SF 
and DF, respectively at day 3 of estrous cycle, while 314 and 316 were detected in granulosa 
cells of SF and DF, respectively, at day 7 of estrous cycle. A total of 244 detected miRNAs were 
common to all follicle groups, of which 15 miRNAs including bta-miR-10b, bta-miR-26a, let-7 
families, bta-miR-92a, bta-miR-191, bta-miR-125a, bta-miR-148 and bta-miR-30a-5p, were 
highly abundant (≥3000 reads) in both SF and DF at both days of the estrous cycle. At day 3 of 
the estrous cycle, 16 miRNAs including bta-miR-449a, bta-miR-449c, bta-miR-212, bta-miR-
21-3p, bta-miR-183 and bta-mir-34c were differentially expressed (DE) in granulosa cell of 
subordinate follicle groups. Similarly, at day 7 of the estrous cycle, a total of 108 miRNAs 
including bta-mir-409a, bta-miR-2446, and bta-mir-383 were altered in granulosa cells of SF 
compared to DF. Nine miRNAs including bta-miR-21-3p, bta-miR-708, and bta-miR-335 were 
commonly DE between SF and DF at day 3 and day 7 of the estrous cycle. In addition to known 
miRNAs, a total of 21 novel miRNAs were identified and detected in granulosa cells of SF 
and/or DF at day 3 and day 7 of the estrous cycle. The majority of the DE miRNAs were found 
to be involved in regulation of programmed cell death and regulation of cell proliferation. In 
addition, the DE miRNAs were found to be involved in Wnt signaling, TGF-beta signaling, 
oocyte meiosis, MAPK signaling, focal adhesion, axon guidance and gap junction. Therefore, 
our findings suggest that temporal variation in the abundance of mature miRNAs during bovine 
follicular development in SF and DF of granulosa cells, which may be associated with 
recruitment, selection and development of bovine follicles. 
 
 
 
 
   
 
Untersuchung der miRNA Anreicherung und Abbau in bovine Granulosazellen während 
der Follikelreifung 
 
Die Granulosazellen aus ovarialen Säugertierfollikeln reagieren auf Gonadotropin-Signale und 
sind an den Prozessen der Follikulogenese und Eizellenreifung beteiligt. Obwohl bereits 
mehrere Studien über die spatio-temporale Genexpression während der follikulären 
Entwicklung erfolgten, ist bisher wenig über die post-transkriptionelle Regulierung dieser Gene 
bekannt. Daher befasst sich diese Studie mit der Untersuchung von der bovine miRNA 
Prävalenz und ihrer Expressionsmuster während der frühen Lutealphase des bovinen 
Östruszyklus. Dafür wurde miRNA angereicherte Gesamt-RNA aus Granulosazellen von 
untergeordneten Follikeln (SF) und dominanten Follikeln (DF) am Tag 3 und Tag 7 des 
Östruszyklus von geschlachteten Färsen isoliert und mittels Deep Sequenzierung analysiert. 
Durch die Datenanalyse konnten jeweils 291 und 317 miRNAs in Granulosazellen von SF und 
DF am Tag 3 des Östruszyklus ermittelt werden. Für Tag 7 des Östruszyklus gewonnene 
Granulosazellen konnten 314 und 316 miRNAs identifizierten werden. In allen Follikelgruppen 
wurden insgesamt 244 miRNAs detektiert, wobei 15 miRNAs einschließlich bta-miR-10b, bta-
miR-26a, let-7 families, bta-miR-92a, bta-miR-191, bta-miR-125a, bta-miR-148 und bta-miR-
30a-5p in beiden SF und DF und auch an beiden Tagen des Östruszyklus hoch reguliert (≥3000 
reads) waren. Am Tag 3 des Östruszyklus waren 16 miRNAs einschließlich bta-miR-449a, bta-
miR-449c, bta-miR-212, bta-miR-21-3p, bta-miR-183 und bta-mir-34c unterschiedlich in 
Granulosazellen der untergeordneten Follikelgruppe exprimiert (DE). Genauso zeigten am Tag 
7 des Östruszyklus insgesamt 108 miRNAs einschließlich bta-mir-409a, bta-miR-2446, und bta-
mir-383 in SF Granulosazellen im Vergleich zu DF eine unterschiedliche Expression. Neun 
miRNAs, u.a. bta-miR-21-3p, bta-miR-708 und bta-miR-335 waren sowohl am Tag 3 als auch 
am Tag 7 DE zwischen SF und DF des Östruszyklus. Insgesamt wurden 21 neue miRNAs 
zusätzlich zu den bekannten miRNAs in den Granulosazellen von SF und/oder DF am Tag 3 
und 7 des Östruszyklus identifiziert und detektiert. Die Mehrheit der DE miRNAs sind an der 
Regulierung des programmierten Zelltods und der Regulierung der Zellproliferation beteiligt. 
Gleichwohl waren diese DE miRNAs auch an den Signalwegen Wnt, TGF-beta, Meiose der 
Eizelle, MAPK, fokal Adhäsion, Axon Guidance und Gap Junction involviert. Deshalb lassen 
unsere Ergebnisse darauf schließen, dass temporale Variationen in der Anreicherung von 
miRNAs während der bovinen Follikelentwicklung in SF und DF aus Granulosazellen, welche 
mit der Rekrutierung, Selektion und Entwicklung boviner Follikel assoziiert werden, 
vorkommen können. 
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1 Introduction 
One or multiple oocytes ovulate per reproductive cycle in mammalian species. The 
commencement of follicular growth is alike across species, with numerous follicles 
growing to the antral stage. From the pool of these antral follicles, a cluster of follicles 
(cohort) are recruited which continue growth toward ovulation. In mono-ovulatory 
species (e.g., cattle, horses, humans), single follicle is selected from the cohort and 
continues its growth and attains the ovulatory capacity, whereas, the fate of other 
follicles is atresia (Ginther et al. 2000b, Ginther et al. 2001, Hodgen 1982, Zeleznik 
2001). Two major functions of the mammalian ovary are the production of germ cells 
(oocytes), which allow continuation of the species, and hormone production, primarily 
steroids (mainly estrogens and progestins) and peptide growth factors, which are critical 
for ovarian function, regulate the hypothalamic-pituitary-ovarian axis, and development 
of secondary sex characteristics (Edson et al. 2009). Within ovary follicular granulosa 
cells border and foster oocytes, and yield sex steroid hormones. It is understood that 
during growth, the ovarian surface epithelial cells enter into the ovary and develop into 
granulosa cells when correlating with oogonia to form follicles (Hummitzsch et al. 
2013). 
In the reproductive lifespan of mammals, a continuously gentle stream of primordial 
follicles is released from dormancy and move in the growing follicle pool. As soon as 
growth is initiated, the follicle boards on a complex path of development during which 
the oocyte progresses through a series of highly orchestrated phases of development 
which are essential for its fruitful ovulation and fertilization. This process begins as 
soon as the pool of primordial follicles is established in the ovary and continues until the 
pool is devastated and folliculogenesis ends (Hutt and Albertini 2007). 
 
Follicular development is the outcome of multifarious hormonal and biochemical 
interactions that could be triggered or deactivated within the follicular environment in a 
spatiotemporal fashion. Mammalian ovaries consist of follicles as elementary functional 
units, and each follicle comprises of an oocyte enclosed by one or multiple layers of 
somatic granulosa cells and theca cells (Tu et al. 2014). The layer and number of 
granulosa cells may differ reliant on the size and phase of follicular development. For 
instance, in primordial follicle, the small, non-growing functionally immature oocyte is 
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surrounded by a single layer of squamous granulosa cells (Aerts and Bols 2010, 
Buccione et al. 1990). Generally in domesticated animal species the stock of primordial 
follicles begins during fetal life. The transition from non-growing to growing follicles is 
a steady process, which originates shortly after the formation of the primordial follicles 
and continues throughout reproductive life (Fortune et al. 1998). The primordial 
follicles then advance to the primary follicles by commencing follicle growth and 
transforming the single layer of granulosa from flattened to a cuboidal morphology and 
there by undergoes proliferation and differentiation of granulosa cells which results in 
an increase in the number of granulosa cells and accompanied by enlargement of the 
oocyte volume which may gradually become Graafian follicle (Aerts and Bols 2010). 
This involuntary and compound transit of the primordial follicle into large sized antral 
follicles is primarily initiated by morphological conversion and functional 
differentiation of the granulosa cells. Therefore, when the follicles start to develop from 
state of resting pool, the oocytes continue to grow and the granulosa cells proliferate 
until the stage of preantral follicle (Thomas and Vanderhyden 2006). The pre-antral 
phase of folliculogenesis is characterized by zona pellucida formation, granulosa cell 
proliferation, the recruitment of thecal cells to the follicular basal lamina and a vivid 
increase in oocyte volume (Pedersen 1969).  In consequence, during these acute periods, 
oocyte development is governed by paracrine interactions between the oocyte and the 
granulosa cells by which the oocyte controls the growth and development of granulosa 
cells and vice-versa (Buccione et al. 1990). Therefore for symbiotic survival of both cell 
types, the granulosa and oocyte undergo a bidirectional communication by establishing 
a gap junction mediated syncytium (Aerts and Bols 2010, Buccione et al. 1990). The 
bidirectional crosstalk between the oocyte and the somatic cell type (granulosa and 
theca cells) affects the hormonal production and the expression of genes associated with 
follicular development (Palma et al. 2012). Hence, the growth, development and notable 
functional differentiation of the granulosa cells are one of the significant events that are 
required for follicle maturation (Yada et al. 1999). The granulosa cells are indeed 
specialised in production of estradiol hormone, inhibin and activin (Hatzirodos et al. 
2014a). Therefore, the fate of follicular growth and development is believed to be 
mainly determined by the growth and development of the granulosa cells (Clement et al. 
1997). 
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In bovine, follicular development is characterized by recruitment of a group of follicles 
in 2 or 3 follicular waves though high rate of growth is initiated only in one of the 
follicles which later on succeeded to be dominant over the others and becomes 
ovulatory (Ahmad et al. 1997). However, the dominant follicle could not be ovulated 
when the follicular development is happening through the luteal phase of estrous cycle. 
Here the main query is to recognize the mechanism how the follicular atmosphere 
assists one follicle to develop dominant and thereby shadow the development of other 
follicles and they become atretic. This may lead to the hypothesis that the follicular 
microenvironment could have distinctive molecular signals which would affect 
differently the bidirectional crosstalk between the oocytes and the companion somatic 
cells in the subordinate and dominant follicles.  This may perhaps clue to the hypothesis 
that the follicular atmosphere could have distinctive molecular indications which would 
mark contrarily the bidirectional crosstalk between the oocytes and the surrounding 
somatic cells in the subordinate and dominant follicles. 
 
Two key developments during the last decade have dramatically increased knowledge of 
the molecular control of follicular development. First is the advent and application of 
genomic technologies to study ovarian function leading to the identification of hundreds 
of new genes putatively involved in ovarian processes in different species. Second a 
major development has been the discovery and characterization of animal microRNAs 
(miRNAs); 19-22 nucleotides non-coding RNAs which function as key regulators of 
gene expression post-transcriptionally. miRNAs works by interact with the 3´-UTR of 
the target mRNA. For instance, it has been reported that, a total of 13162 genes were 
detected in germinal vesicle (GV) oocytes and their companion CCs, of those 1516 and 
2727 are exclusively expressed in oocytes and CCs, respectively, while 8919 are 
expressed in both. Moreover, a total of 265 transcripts are differentially expressed 
between oocytes cultured with (OO+CCs) and without (OO-CCs) CCs, of which 217 
and 48 are over expressed in the former and the later groups, respectively. The presence 
or absence of oocyte and CC factors during bovine oocyte maturation can have a 
profound effect on transcript abundance of each cell types, thereby showing the 
prevailing molecular cross-talk between oocytes and their corresponding CCs (Regassa 
et al. 2011). Using a heterologous approach Tesfaye and co-scientists revealed a set of 
59 differentially expressed miRNAs, of which 31 and 28 miRNAs were found to be 
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preferentially expressed in immature and matured oocytes, respectively (Tesfaye et al. 
2009). In another study, a total of 47 and 51 miRNAs were highly abundant in immature 
and matured oocytes, respectively, compared with their surrounding cumulus cells. 
Furthermore, expression analysis of six miRNAs enriched in oocyte miR-205, miR-150, 
miR-122, miR-96, miR-146a and miR-146b-5p at different maturation times showed a 
dramatic decrease in abundance from 0 h to 22 h of maturation (Abd El Naby et al. 
2013). These results confirmed the presence of distinct sets of miRNAs in oocytes or 
cumulus cells and the presence of their dynamic degradation during bovine oocyte 
maturation which indicating the important potential role of miRNAs during the dynamic 
stage of follicular development. The significance and involvement of miRNAs in the 
ovarian function, and follicular development has also been described by several authors 
(Donadeu et al. 2012, Hossain et al. 2009, Toloubeydokhti et al. 2008, Tripurani et al. 
2010), but their existence, richness and sequential expression in the subordinate and 
dominant follicles during the bovine luteal phase of the estrous cycle needs to be 
revealed. 
  
Several signaling molecules including the TGF-beta superfamily members, follicle 
stimulating hormone receptor, luteinizing hormone receptor, cytochrome 450s 
(CYP11A1, CYP17A1, CYP19A1), GDF9, IGF-1, IGF-II, IGFBP2 and several  of 
genes have been found to be altered in granulosa and/or theca cells depending on the 
size and stage of follicular development (Bao and Garverick 1998a, Hayashi et al. 2010, 
Sisco et al. 2003, Spicer et al. 2011, Vitt et al. 2000a). Abnormal expression of those 
developmentally related genes and gene products in the oocytes and supporting cells 
could then lead  to cellular communication dysfunction and dysregulation of normal 
follicle recruitment and development (Toloubeydokhti et al. 2008). However, the 
posttranscriptional regulatory mechanism of genes and gene products associated with 
follicular recruitment, selection and dominance during the luteal phase of the estrous 
cycle is still poorly understood. 
  
In the recent years, the fast progress of next generation sequencing (NGS) technologies 
haas enormously boosted the profiling of miRNA expression levels as well as 
identification of novel miRNA genes. High-throughput miRNA profile analysis from 
different ovarian somatic cell types appears rare among the publications so far. Based 
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on that, we formulate an aim of the current study was to fill the gap in information 
regarding the miRNA profile in bovine follicular granulosa cells from subordinate and 
dominant follicles at different time points of estrous cycle. The study was performed 
using next-generation sequencing to determine annotated as well as novel miRNAs. We 
aimed to examine the degree of difference between granulosa cells from subordinate 
and dominant follicles obtained at day 3 and day 7 of estrous cycle and  regarding their 
miRNA profile, then to predict the potential targets of differential expressed miRNAs in 
either cell type or at each time points. Therefore, the objectives of this study were to 
understand the availability and abundance of miRNAs in bovine granulosa cells derived 
from subordinate and dominant follicles during bovine follicular development across the 
estrous cycle. 
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2 Literature review 
 
2.1 Ovary and folliculogenesis 
 
The two key functions of the ovary are gametogenesis (the production of female 
gametes) and steroidgenesis (the production of steroid hormones), which play dynamic 
roles to control the reproductive tract for fertilization and the establishment of 
pregnancy (Knight and Glister 2006). After the formation of zygote by the unification of 
an oocyte and a spermatozoon, all cells up to the eight-cell stage of embryogenesis 
appear to have analogous totipotency, because of the fact of same morphological 
appearance for all these cells. However, with the formation of a 16-cell morula, the cells 
begin the process of differentiation with cells being allocated to either the inside or 
outside of the embryo. This process is inflated further at the blastocyst stage by defining 
the lineages: trophectoderm (future placenta), epiblast (future embryo), and primitive 
endoderm (future yolk sac). Cells with in the epibalst eventually form the precursors of 
the primordial germ cells (PGCs), claimed to be the initial cells of the ovary by the 
result of implantation and further differentiation. By the arrival of PGS in to the 
indifferent gonad, eventually the formation of ovary occurs and allow the PGCs to 
differentiate in to oocytes, which enter meiosis and subsequently arrest; this 
differentiation stage and entry into meiosis propose that the last of the oocyte “stem 
cells” (i.e., the PGCs) likely disappear at this stage of fetal life. The meiotically arrested 
oocytes eventually become surrounded by pre-granulosa cells and form individual 
primordial follicles, the resting pool of oocytes that have the potential to be recruited 
into the growing follicle pool in the postpubertal mammal. The meiotically arrested 
oocytes ultimately become enclosed by pre-granulosa cells and form distinct primordial 
follicles, while the resting pool of oocytes that have the potential to be recruited into the 
growing follicle pool in the post pubertal mammal, to be fertilized, and to contribute to 
the next generation (Edson et al. 2009). 
 
Folliculogenesis is the outcome of a follicle which is recruited, matured and sequentially 
ovulated following the growth and differentiation of the oocyte and its surrounding 
somatic cells (Gougeon 1996, Knight and Glister 2001). The major steps in ovarian 
folliculogenesis (Figure 2.1) include the formation of the inactive pool of primordial 
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follicles, the recruitment and selection of primordial follicles for growth and 
development resulting in the development of follicles through the primary, secondary, 
antral, and preovulatory stages and ovulation, which ends up with the establishment of a 
corpus luteum (CL) from remaining somatic cells of the follicle (Edson et al. 2009). The 
cataloging of the follicle is based on the size of oocyte, the morphology of granulosa 
cells and the number of granulosa cell layers surrounding the oocyte (Braw-Tal and 
Yossefi 1997, Lussier et al. 1987). It is recognized that folliculogenesis in bovine 
species occur in the course of fetal development. Once oocytes attainments to diplotene 
stage of prophase I, it’s surrounded by a single layer of squamous pre-granulosa cells 
inactive on a basement membrane and forming the non-growing or primordial follicle 
(Picton et al. 1998). The bulky population of non-growing primordial follicles serves as 
the pool of developing follicles and oocytes until the end of a female’s reproductive life. 
Primordial follicles are transformed into primary follicles by changing the flattened 
granulosa cells to cuboidal form by allowing the oocyte to attain its extensive growth 
phase. (Eppig 2001, van Wezel and Rodgers 1996). Expansion to the secondary follicle 
stage also known as preantral follicle or growing follicle is characterized by the 
presence of a second layer of granulosa cells, increased oocyte diameter (Driancourt et 
al. 1991), zona pellucida and cortical granule formation, development of gap junction 
between oocyte and granulosa cell which may serve both to maintain meiotic arrest and 
oocyte growth (Braw-Tal and Yossefi 1997, Fair et al. 1997b), first measurable signs of 
oocyte RNA synthesis (Fair et al. 1997a) and gonadotrophin responsiveness where the 
follicular stimulating hormone (FSH) receptor mRNA expression has been detected in 
follicles with one to two layers of granulosa cells in cattle (Bao and Garverick 1998, 
Fair 2003, Xu et al. 1995). Development beyond the early antral follicle stage is clearly 
dependent upon gonadotrophins, antral follicles are sometimes called tertiary follicles 
and well developed antral follicles are often stated to as Graafian follicle (Eppig 2001). 
The transition to antral follicle is characterized by formation of antrum which is fluid 
filled cavity surrounded by multiple layer of granulosa cells, this fluid contain important 
regulatory substance to be delivered to oocyte (Braw-Tal and Yossefi 1997, Eppig 2001, 
Lussier et al. 1987). After antrum formation, granulosa cells are divided into two 
distinct subtypes, the cumulus granulosa surrounding and in intimate metabolic contact 
with the oocyte forming a structure called cumulus oocyte complex (COC) and the 
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mural granulosa lining the follicle wall and adjacent to the basal lamina, the mural 
granulosa cells nearest the antrum are called periantral granulosa cells (Eppig 2001). 
 
 
Figure 2.1: Schematic presentation of the major stages of mammalian folliculogeneis. 
 
These stages are divided into two separate groups. (i) Intraovarian regulation of 
folliculogenesis (primordial, primary, and secondary stages). (ii) Gonadotropin-
dependent regulation of folliculogenesis (antral, preovulatory, and ovulation of the 
follicle) (Edson et al. 2009). 
 
Ideally a fully grown follicle known as graafian follicle is a three-dimensional structure 
with an antrum in the center and surrounded by a diverse set of cell types. The main 
discrete histologic components in graafian follicle comprise (Figure 2.2) of theca 
interna, mural granulosa cells, cumulus granulosa cells, oocyte  antrum filled with 
follicular fluid (Aerts and Bols 2010). 
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Figure 2.2: Morphology of a graffian follicle (Aerts and Bols 2010). 
 
In mammals, follicular growth and development is commenced and organized by a 
multifarious interaction between physiological, molecular, and genetic elements. During 
the course of follicular development many cellular changes occur that regulate cell 
differentiation and are prerequisite for the provision of oocyte competency. These 
changes are intervened in a self-motivated approach by autocrine, paracrine and 
endocrine factors including growth factors and hormones acting to control cell 
signalling, cell-cell adhesion, and cell-extracellular matrix interactions (Albertini et al. 
2001). Follicular growth is furthermost clearly apparent by the growth of the pre-antral 
follicles comprising primordial, primary and secondary stage follicles. This growth is 
categorized by the expansion of the follicular basal lamina which is associated by a 
proliferation in oocyte size and the number of granulosa cells. Once this process is 
initiated, the thecal cells are also signalled to begin differentiation in preparation for 
oocyte release and possible fertilization (Albertini et al. 2001). A better thoughtful of 
the many factors contributing to follicular maturation is vital to understanding ovarian 
function.  
 
2.2 Regulation of folliculogenesis by paracrine and hormonal factors 
 
The growth, development and maturation of ovarian follicles across the life span of an 
animal are indispensable courses for efficient reproduction. Germ cell numbers are 
established during fetal development. Soon afterwards, primordial follicles form and 
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initiate to change through primordial, primary and preantral stages of development. 
Folliculogenesis can be categorized into 2 main phases: 1) the gonadotrophin-
independent phase and 2) the gonadotrophin dependant phase. The first phase is allied 
with primordial to preantral follicles and involves growth and differentiation of the 
oocyte and granulosa cells; pituitary gonadotrophins are not necessary for this growth 
phase, although they may impact growth. The second phase is associated with antral to 
ovulatory follicles and hinge largely on the manifestation of circulating levels of follicle 
stimulating hormone (FSH) and luteinising hormone (LH). This stage marks follicle 
receptiveness to FSH and LH, comprises the growth and development of granulosa cells 
and the recruitment of theca cells. The factors that rule oocyte and primordial follicle 
development during the gonadotrophin-independent phase stay unclear however 
increasing evidence has advised that growth factors such as TGF-β1 and activins play 
main roles during these processes (Knight 1996, Rosairo et al. 2008, Webb et al. 2004, 
Woodruff and Mather 1995). 
  
2.2.1 Gonadotropin-independent phase 
 
Paracrine signalling between the oocyte and its surrounding companion cells is 
indispensable to the processes of oogenesis and folliculogenesis in mammals. The key 
paracrine factors which regulate preantral follicle growth include kit ligand (KL), anti-
müllerian hormone (AMH), growth differentiation factor-9 (GDF-9) and activins. 
 
2.2.1.1 Kit Ligand and c-Kit in the ovary  
 
Recently, the role and importance of growth factors in ovarian folliculogenesis has been 
broadly studied in various species. Particularly kit ligand (KL), which was one of the 
first growth factors identified in the ovarian follicle, plays a  crucial role in mammalian 
oogenesis and folliculogenesis (Thomas and Vanderhyden 2006). Since its identification 
in 1990, in vivo and in vitro studies have shown that the functions of this system (Figure 
2.3) in the mammalian ovary include the establishment of primordial germ cells (PGCs), 
activation of primordial follicles, oocyte survival and growth, proliferation of granulosa 
cells, theca cell recruitment and maintenance of meiotic competence (Hutt et al. 2006, 
Thomas et al. 2008). 
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Figure 2.3: Several functions of the KL/c-Kit system in the ovary: 1) Establishment of 
primordial germ cells; 2) Activation of primordial follicles; 3) Oocyte survival 
and growth; 4) Proliferation of granulosa cells and recruitment of theca cells. 
PGCs: primordial germ cells; TC : theca cells; GC: granulosa cells; O: oocyte 
(Celestino J.J 2009).  
 
Kit Ligand also named as stem cell factor, steel factor, or mast cell growth factor 
(MCGF), is a locally produced factor that has numerous characters in ovarian function 
from embryogenesis onward (Driancourt et al. 2000, Yoshida et al. 1997). In follicles, 
the expression of the mRNA for KL has been studied in the granulosa cells of several 
species  like rat by (Ismail et al. 1996), ovine by (Tisdall et al. 1999), mouse by (Doneda 
et al. 2002), human by (Hoyer et al. 2005) and caprine by (Silva et al. 2006).  
 
KL affects target cells through binding to its receptor c-Kit, a member of the tyrosine 
kinase receptor family. During postnatal ovarian development, c-Kit mRNA and protein 
are present in oocytes of all stages of follicular development. In addition, c-Kit is 
expressed in interstitial and thecal cells of antral follicles in rodent (Motro and Bernstein 
1993),  ovine  (Clark et al. 1996) and caprine (Silva et al. 2006). KL as the first 
granulosa cell-derived growth factor can directly stimulate theca cell growth and 
androstenedione production in the absence of gonadotropins (Parrott and Skinner 1997). 
 
Further in vivo and in vitro studies support the knowledge that KIT-KITL signaling is 
essential for early follicular growth. For example, when newborn mice are injected with 
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ACK2 (an antibody to KIT, which blocks its interaction with KITL), follicular growth is 
blocked resulting in an ovary populated with only primordial stage follicles. On the 
other hand, when neonatal rat ovaries were treated in whole organ culture with 
recombinant KITL, there is an acceleration of the primordial to primary follicle 
transition, resulting in an increased number of growing follicles (Parrott and Skinner 
1999). Jointly, these studies indicate the KL is crucial for the transition from primordial 
to primary follicles and the initiation of follicle development (Edson et al. 2009). 
  
2.2.1.2 Anti-Mullerian Hormone 
 
Anti-Müllerian hormone (AMH), also known as Müllerian inhibiting substance (MIS), 
is a glycoprotein hormone belongs to the transforming growth factor-β family of growth 
and differentiation factors and involved in regulation of folliculogenesis. AMH is note 
worthy for its properties during sex differentiation. Initially, AMH was identified 
because of its role in male sex differentiation. AMH is synthesized in the sertoli cells of 
the fetal testis and induces degeneration of the Müllerian ducts, the anlagen of the 
female internal reproductive structure, which in the female differentiate into the 
oviducts, the uterus and the upper part of vagina (Josso et al. 1993, Lee and Donahoe 
1993). 
  
 At the time of sex differentiation, no ovarian AMH activity was  expressed in the 
ovary, but few days later after birth AMH mRNA expression has been noticed in the 
ovarian granulosa cells of rodent,  agreeing with the initiation of primary follicle growth 
(Beppu et al. 2000, Lawson et al. 1999).  
 
Some studies of immunohistochemistry and mRNA in situ hybridization  in sheep 
(Bezard et al. 1987) and rodents (Baarends et al. 1995) have exposed the definite 
expression of AMH in granulosa cells of initially growing, preantral and small antral 
follicles, while the signs for AMH expression were lost in non-atretic big antral follicles 
as well as in all atretic follicles. Similarly prior to 36 weeks of gestation no AMH 
expression in the fetal and neonatal tissues of human was detected (Rajpert-De Meyts et 
al. 1999). There are also some evidences by (Durlinger et al. 1999) that AMH knockout 
(AMHKO) mice specify that AMH displays an inhibitory effect on initial follicle 
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recruitment. Instantly after birth, a normal‐sized primordial follicle reservoir has been 
fashioned in AMHKO animals, but depletion of the primordial follicle pool was 
enhanced, subsequent in premature termination of the estrus cycle. Additionally, ovarian 
follicles of AMH null mice treated in vivo with exogenous FSH look to be more delicate 
to FSH compared with follicles from wild type mice, causing in an enlarged number of 
follicles reaching the ovulatory stage compared with wild type mice  (Durlinger et al. 
1999, Durlinger et al. 2001) by  the  involvement of AMH in mouse primordial follicle 
selection and growing follicle cyclic recruitment. The in vitro explanations are 
obviously reliable with the concept of AMH as a negative feedback signal of the 
number of growing follicles that are present in the ovary (Figure 2.4). 
 
 
Figure 2.4: Action of AMH in the postnatal mouse ovary. AMH produced by the small 
growing (primary and preantral) follicles in the postnatal ovary has two sites of 
action in the postnatal ovary. It inhibits recruitment (1), while it also inhibits the 
stimulatory effect of FSH on the growth of preantral and small antral follicles (2) 
(Visser and Themmen 2005). 
  
2.2.1.3 Growth differentiation factor 9 
  
 Growth differentiation factor 9 (GDF-9) also known as GDF-9B, is another major 
factor belonging to the TGF-β family has  been shown  to be selectively expressed by 
oocytes throughout ovulation commencing from initial -stage follicles – primary 
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follicles in rodents and primordial follicles in cattle  and sheep (Bodensteiner et al. 
1999, Elvin et al. 2000, Jaatinen et al. 1999, McGrath et al. 1995).  
 
GDF-9 has also shown their vital role in mice granulosa cell development, as somatic 
cells fail to develop beyond the primary stage with a null mutation in the GDF-9 gene 
thus by causing infertility and viewing its obligation during early ovarian 
folliculogenesis (Dong et al. 1996), their by designating that oocyte-derived GDF-9 is 
necessary for endorsing  follicle  progression. This conclusion is strengthened by the 
result that GDF-9 treatment in vivo (Vitt et al. 2000) or in vitro (Nilsson and Skinner 
2002)  boosts the development of initial to late-stage primary follicles in the rat. 
 
Mice with null mutations in the GDF -9 gene have also shown reduced proliferation and 
failings in differentiation in granulosa cells, as well as nonappearance of theca layer 
development (Dong et al. 1996, Elvin et al. 1999) .  
 
Additionallly, lesser granulosa cells experience apoptosis, and KL, as well as the 
peptide inhibin, are melodramatically increased in GDF-9 null mice granulosa cells 
compared to controls, signifying that GDF-9  inhibits granulosa cell assembly of these 
growth factors (Elvin et al. 1999).  
 
2.2.1.4 Activins 
 
Activins are growth and differentiation factors belong TGF-β superfamily, govern and 
arrange multiple physiological processes and are indispensable for the development, 
growth and functional dependability of most tissues, including the pituitary. Activins 
produced by pituitary cells roles in union with central, peripheral, and other local factors 
to affect the function of gonadotropes and to accomplish normal reproductive axis 
(reviewed in (Welt et al. 2002). Activins, comprising of dimers of two inhibin-β 
subunits (βA and/or βB subunits) linked by disulfide bonds. Activins, generally formed 
by granulosa cells in the ovary, are requisite for the ovarian development and for 
reproductive functions, as mice with genetic deletions of activin constituents are 
infertile (Pangas et al. 2007). Mammalian ovaries express both types of activin receptors 
(ALK4 and ActRIIA/B) and in the rat, both βA and βB subunits are highly expressed in 
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granulosa cells of developing follicles, while theca cells express tiny or no β subunit 
mRNAs (Drummond et al. 1996, Drummond et al. 2002, Meunier et al. 1988, Roberts et 
al. 1993). In divergence, the oocyte does not perform to express either subunit exhibits 
both type I and type II receptors (Sidis et al. 1998). During folliculogenesis, the 
differentiation status of granulosa cells determines the response to activins (Findlay 
1993). Activin is produced by granulosa cells of primary to tertiary follicles of the ovary 
(Rabinovici et al. 1992, Zhao et al. 2001). Activin has been found to promote the release 
of FSH from the anterior pituitary (Katayama et al. 1990). In the ovary, it displays an 
atmosphere in endorsing aromatase activity, antral cavity formation and granulosa cell 
proliferation (Findlay 1993, Mizunuma et al. 1999, Zhao et al. 2001). Furthermore, 
activin is provoked by follistatin and by inhibin binding to its receptors (Lewis et al. 
2000). 
 
 
Figure 2.5: Members of the TGF-β superfamily feature prominently amongst the 
growing list of extracellular ligands implicated in the bi-directional 
communication between theca and granulosa cells, and granulosa cells and 
oocyte. Both autocrine (thick grey arrows) and paracrine (thick black arrows) 
signalling events are likely, depending on the expression of appropriate 
combinations of type-I and type-II receptors on the cell surface (Knight and 
Glister 2006). 
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2.2.2 Gonadotropin-dependent phase 
 
During each estrous cycle in cattle the advance stages of antral follicle development are 
characterized by two or three follicular waves. These follicular waves seem to be 
essential and have been predicted prior to puberty and through other stages of anestrus. 
A cluster of follicles are recruited in each wave of growth in cattle and continue to grow 
to approximately 6 to 8 mm in diameter. In mono-ovulatory species, such as cattle the 
fate of mostly follicles is atresia only one follicle from the cohort of identical follicles  
is selected for continued growth and becomes dominant (Adams 1999, Ireland et al. 
2000). Antral follicle is under gonadotropic control when it attains growth atleast 2 mm 
in diameter (Campbell et al. 1995) as verified by treatment of  hypogonadotropic cattle 
with bovine follicular fluid and estradiol (Figure 2.6). 
  
 
Figure 2.6: Schematic depiction of the pattern of secretion of follicle-stimulating 
hormone (FSH; blue line), luteinizing hormone (LH; green lines), and 
progesterone (P4; orange line); and the pattern of growth of ovarian follicles 
during the estrous cycle in cattle. Healthy growing follicles are shaded in yellow, 
atretic follicles are shaded red. A surge in LH and FSH concentrations occurs at 
the onset of estrus and induces ovulation. The pattern of secretion of LH pulses 
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during an 8-h window early in the luteal phase (greater frequency, lesser 
amplitude), the mid-luteal phase (lesser frequency, lesser amplitude) and the 
follicular phase (high frequency, building to the surge) is indicated in the inserts 
in the top panel (Campbell et al. 2003).  
 
2.2.3 Gonadotropin regulation of follicular maturation during the estrous cycle 
  
Cattle are polyestrous animals. Estrous cycle is the period from one estrus to the next 
estrus. For the cow and heifer, this period averages 21 days, with a typical range of 18 
to 24 days in length. The estrous cycle is regulated by the hormones of the 
hypothalamus (gonadotropin-releasing hormone; GnRH), the anterior pituitary (follicle-
stimulating hormone; FSH and luteinizing hormone; LH), the ovaries (progesterone; P4, 
estradiol; E2 and inhibins) and the uterus (prostaglandin F2α; PGF). By mechanisms of 
positive and negative feedback these hormones govern the estrous cycle of cattle (Roche 
1996). 
 
The gonadotropin dependent regulation of folliculogenesis is initiated by gonadotropin-
releasing hormone (GnRH), which is a 10 amino acid peptide hormone secreted from 
neurons in the hypothalamus (Reece 2004). Isolation and chemical characterization of 
gonadotropin-releasing hormone were first discovered in 1971 from the hypothalamus 
of pigs. Later the translation from basic discovery to clinical usefulness with numerous 
signs was swift in human medicine (Conn and Crowley 1991). Synthesis occurs in 
neurons found in the ventral portion of the hypothalamus, specifically in the arcuate 
nucleus, as well as in the preoptic nucleus of the anterior portion of the hypothalamus. 
Many neurotransmitters and neuropeptides are involved in the regulation of GnRH 
secretion (Hadley 1999). After its release, GnRH is transported from the hypothalamus 
to the pituitary gland via the hypophyseal portal blood system and  binds to its G-protein 
coupled receptor on the cell surface of the gonadotroph cells (Kakar et al. 1993, 
Moenter et al. 1992).  
 
This binding release intracellular calcium which activates intermediaries in the mitogen 
activated protein kinase (MAPK) signaling pathway concluding in the release of FSH 
and LH from storage sections in the cytoplasm. The release of these gonadotropins is 
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differentially regulated by GnRH and is hooked on the area of the hypothalamus that is 
stimulated by neural depolarization to release GnRH. Upon stimulation of the arcuate 
nucleus, the hypothalamus mediates tonic or basal secretion of LH. When the preoptic 
nucleus is stimulated, there is a surge release of both FSH and LH. Finally, if there is a 
surge release of GnRH prior to ovulation, this mediates a secretory surge of LH, with 
less FSH  (Reece 2004). 
 
In the course of follicular development, selected follicles experience an irreversible 
progression of oocyte growth, granulosa cell proliferation, and theca cell differentiation. 
These resulting follicles become immensely responsive to gonadotropins secreted from 
the anterior pituitary gland with the consequence of high levels of FSH signal and thus 
by endorsing the development to the pre-ovulatory stage. This period is characterized by 
an increased capacity to synthesize estradiol, formation of the large fluid filled antrum, 
and the expression of the LH receptor. These phenotypic changes permit for an 
increased level of circulating estradiol. When estradiol attains the peak, it acts on the 
hypothalamic-pituitary axis leading to an increased release of LH, known as the LH 
surge (Couse et al. 2005). Rupturing of follicle and ovulation occurs by the expression 
of LH receptor in healthy pre-ovulatory follicles. After the occurrence of this, the 
granulosa cells then experience terminal differentiation forming the corpus luteum. 
During the course of follicular development the gonadotropin dependent mechanisms 
occur over the signalling cascades prompting from FSH and LH expression. In demands 
for these endocrine hormones to complete their obligatory functions, the genes encoding 
their receptors must also be expressed (Couse et al. 2005). 
 
2.2.4 Gonadotropin regulation of final maturation of the preovulatory follicle and 
selection 
 
The gonadotropins follicle stimulating hormone (FSH) and luteinizing hormone (LH) 
are protein hormones (Figure 2.7) secreted by the pituitary gland, comprising of a 
common α-subunit and a hormone-specific   β-subunit. Transcriptional regulation of 
gonadotropin subunits involves basal gene expression as well. Further, synthesis and 
secretion of FSH and LH are both positively and negatively regulated by steroids and 
gonadal peptides reviewed by (Brown and McNeilly 1999).  
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For each wave of growth comprise emergence, selection and dominance followed by 
either atresia or ovulation of the DF. Both FSH and LH have a noticeable role in ovarian 
follicle development. Given that follicles are involved in the positive and negative 
feedback mechanisms of the hypothalamic–pituitary–gonadal (HPG) axis (estradiol and 
inhibins), these hormones have a leading role in the regulation of the estrous cycle of 
cattle. The commencement of gonadotropin dependent follicle development is 
characterized by the emergence of a follicle cohort normally consisting of 5–20 follicles 
≥5mm and is associated with a transient increase in FSH concentration (Adams et al. 
1992, Sunderland et al. 1994).  This results the beginning of dependency of follicle 
growth on FSH (Adams et al. 1992) with FSH receptors (FSH-R) localized within the 
granulosa cells of the follicles by day 3 of the follicle wave (Camp et al. 1991, Evans 
and Fortune 1997). This permits FSH to perform its required down stream signalling 
effects including endorsing cellular growth and proliferation (Richards 1994, Richards 
et al. 1998).Transient increase in FSH concentrations further encourages an increase in 
aromatase enzyme activity (P450arom; CYP19), in the granulosa cells of ovarian 
follicles, which transforms androgen to estrogen (Hillier 1994). The diameter of the 
dominant follicle increases by its selection from the cohort of follicles and is accepted 
as the largest healthy follicle in the cohort (Gougeon and Lefevre 1983). Follicular fluid, 
estradiol and inhibin concentartions are elevated by the increase of dominant follicles 
diameter (Hillier 1994). 
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Figure 2.7: Schematic presentation of the hypothalamic–pituitary–gonadal axis showing 
positive and negative regulators of gonadotrophin hormone gene expression. 
Gonadotrophin-releasing hormone (GnRH) synthesized in and released from the 
hypothalamus binds to GnRH receptor (GnRHr), a seven transmembrane G-
protein-coupled receptor located on the surface of the gonadotroph. The binding 
of GnRH to the GnRHr triggers the synthesis, and ultimately the secretion, of 
LH and FSH into the vascular system. A stylized steroid receptor (SR) is also 
indicated on the gonadotroph cell, this represents androgen, oestrogen and 
progesterone receptor. Testosterone (T), oestrogen (E) and progesterone (P) 
negatively regulate gonadotrophin synthesis directly at the pituitary and via 
downregulation of hypothalamic GnRH secretion. The gonadal peptides, inhibin 
and activin, have opposing roles in regulating gonadotrophin synthesis and seem 
to regulate production of FSH. Activin transactivates its own receptor (activin 
receptor; ActR) but it is yet to be determined whether inhibin signals through the 
same or an unidentified receptor (Brown and McNeilly 1999). 
 
Suppression of FSH happens by the appearance of dominance, when the dominat 
follicle attains the diameter of 9mm, there by stopping further follicle wave emergence 
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till the dominant follicle either experiences atresia or ovulated. The upsurge in estradiol 
concentrations in performance with inhibin are the main endocrine signals that suppress 
FSH concentrations from the anterior pituitary gland via negative feedback reducing 
FSH to basal concentrations (Ginther et al. 2000b, Ginther et al. 2000a, Sunderland et 
al. 1994). The selected dominant follicles shows progressively response to LH (Ginther 
et al. 2000a) and continues growth in the aspect of decreasing FSH concentrations. 
Regardless of the stage of the estrous cycle through which follicles developed, the shift 
from FSH (Adams et al. 1992) to LH dependency (Kulick et al. 1999) is spread through 
the presence of LH receptors (LH-R) on the granulosa cells (Xu et al. 1995). LH-R is 
confined to the theca and granulosa cells of healthy follicles, at different stages of 
follicle development (Camp et al. 1991). 
  
As the follicle accomplishes the growth, the theca cell LH-R increases and LH-R is 
attained by the granulosa cells of the follicle undergoing selection to become the 
dominant follicle (Bao et al. 1997, Braw-Tal and Roth 2005, Xu et al. 1995). In 
addition, evidence suggests transient increases in circulating LH concentrations that 
occur at or around the time of follicle selection (Ginther et al. 2003), permits the 
dominant follicle to continue E2 production and grows in the face of declining FSH 
concentrations (Ireland and Roche 1983). During the early luteal phase of the follicular 
development slighter amplitude and greater frequency (20–30 pulses/24 h) LH pulses 
occur, while  in the mid-luteal period LH pulses are of larger amplitude and lesser 
frequency (6–8 pulses/24 h) both of which are of inadequate amplitude and frequency 
for final maturation and successive ovulation of the dominant follicle (Rahe et al. 1980). 
  
Dominant follicles are produced during the luteal phase of the estrous cycle go through 
atresia, E2 and inhibin production decreases, and removes this negative feedback block 
to the hypothalamus/pituitary, FSH secretion can raise and a new follicle wave emerges. 
The production of high concentrations of estradiol is a defining characteristic of the 
dominant follicle (Ireland and Roche 1982, Ireland and Roche 1983) and prior to visible 
differences in follicle diameter; the supposed dominant follicle has larger follicular fluid 
concentrations of estradiol compared with other follicles in its cohort (Fortune 1994, 
Mihm et al. 2000, Sunderland et al. 1994). The synthesis of estradiol is reliant on the 
production of androgens in the theca cells and subsequent aromatization of these 
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androgens to estrogens in the granulosa cells known as the two cell/two gondatropin 
model. (Fortune and Quirk 1988). Production of estradiol from growing follicles is 
dependent on sufficient LH pulse frequency (Crowe et al. 2001a, Crowe et al. 2001b). 
The binding of LH to its receptors in the theca cells drives the conversion of cholesterol 
to testosterone through a series of catalytic reactions. Testosterone, once produced in the 
theca cells, diffuses out into the granulosa cells where it is converted to estrogens by the 
aromatase enzyme (Dorrington et al. 1975). At the follicular phase of the estrous cycle, 
when the progesterone concentrations are at basal level, the vast concentration of 
estradiol produced by the pre-ovulatory dominant follicles induces a GnRH surge from 
the hypothalamus. The subsequent LH surge is of adequate amplitude and frequency to 
stimulate final maturation and ovulation of the dominant follicle (Sunderland et al. 
1994).  
 
2.3 Genetic regulation of folliculogenesis 
 
Recently two developmental keys have preciously increased understanding on the 
molecular control of follicular and luteal development. One is the arrival and 
submission of genomic technologies to study ovarian function leading to the 
identification of hundreds of novel genes   putatively elaborate in ovarian processes in 
different species (Agca et al. 2006, Bogan et al. 2009, Espey and Richards 2002, Evans 
et al. 2004, Hamel et al. 2008). The second foremost development has been the 
discovery and classification of animal microRNAs (Ambros 2004). 
 
During the course of follicular development, a compact, coordinated transcriptional 
activity is involved. Dynamic progresses have been made in understanding 
transcriptional gene regulation during follicular and luteal development (Liu et al. 2009, 
Patel et al. 2009, Pisarska et al. 2011, Wu and Wiltbank 2002). Follicular development 
entails the appropriate expression of multiple genes at different follicular developmental 
stages. Several studies in oocyte biology on natural altered in sheep (Fabre et al. 2006) 
and on mutant mouse models revealed that the expression of diverse oocyte-specific 
genes is crucial during early folliculogenesis in a stage specific expression pattern (Choi 
and Rajkovic 2006). Genes such as Figla, Nobox, Pten, Foxo3A and nerve growth factor 
are convoluted in the development of primordial follicles, whereas genes such as βFGF, 
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GDF-9 and BMP 4 are involved in the transformation from primordial to primary 
follicles. Some other  genes like BMP15 are not uttered in the oocyte until the primary 
follicle stage and are involved in the transition from primary to secondary follicles, as 
presented in sheep reviewed by (Monget et al. 2012).  Studies on large scale expression 
have been directed in multiple species. Two studies in specific identified the explicit 
transcriptome of human oocytes in the quiescent state. These studies tinted enhanced 
functions such as transcription, RNA post transcriptional modifications and molecular 
mechanisms in human oocytes (Bonnet et al. 2011, Grondahl et al. 2013, Markholt et al. 
2012). 
 
However, little is known about the post-transcriptional mechanisms involvement. 
Assuming the dynamic nature of the mammalian ovary, miRNAs are predicted to play 
crucial roles in the regulation of ovarian function. Spatial and temporal information on 
miRNA expression patterns would assist the identification of the regulatory miRNA 
networks. 
 
2.4 MicroRNAs 
 
MicroRNAs (miRNAs) represent a thrilling discovery in the field of biology in recent 
years. MicroRNAs (miRNAs) control gene expression in animals, plants, and 
unicellular eukaryotes by endorsing degradation or inhibiting translation of target 
mRNAs. miRNA expression is often tissue specific and developmentally regulated both 
at transcriptional and posttranscriptional level (Siomi and Siomi 2010). MicroRNAs 
(miRNAs) short , non-coding RNAs,19-25 nucleotides in length, are key regulators of 
gene expression that have significant roles in a wide range of biological processes, 
including cell division, cell proliferation and differentiation, apoptosis and metabolism 
while  some robust evidence suggests the involvement of miRNAs pathogenesis in 
human diseases such as  cancer  and metabolic disorders (Bartel 2009, Carthew and 
Sontheimer 2009, Krol et al. 2010). Functionally significant small non-coding RNAs 
(lin-4) was firstly identified in nematodes in 1993 (Lee et al. 1993, Wightman et al. 
1993) and was consider as worm specific. Later on in 2001, the researchers took keen 
interest and by recognizing the function of this family of RNA that includes miRNA and 
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identified that their worth was not limited to lower-order organisms (Lau et al. 2001, 
Lee and Ambros 2001). 
 
2.5 Function of microRNAs 
 
To accomplish the regulatory functions, miRNAs are incorporated into 
ribonucleoprotein (RNP) complexes known as miRNA-induced silencing complexes 
(miRISCs) or micro-ribonucleoprotein (mi-RNPs). RISC and miRNP complexes are 
also linked functionally. The mammalian let-7 and other miRNPs can function as RISC 
nucleases, capable to cleave RNAs that bear sequences perfectly complementary to 
miRNAs. Argonaute family proteins are the major machineries of these complexes. 
AGO1 to AGO4 are the four AGO proteins in mammals (Hutvagner and Zamore 2002, 
Liu et al. 2004, Meister et al. 2004, Pillai et al. 2004). MiRNAs guide the Argonaute 
(AGO) proteins to the target mRNAs by their perfect or near-perfect complementary 
sequence to the 3’UTR of the mRNA, resulting in silencing of the gene expression 
reviewed by (Bushati and Cohen 2007). 
   
In plant, miRNAs varying from animal miRNAs on the basis of their biogenesis and 
method of target regulation. Mostly plant miRNAs bind to their mRNA targets with 
perfect or nearly perfect complementary sequence, and trigger the endonucleolytic 
mRNA cleavage through the RNAi-like mechanism (Vaucheret 2006). While In 
animals, miRNAs usually bind base pair with their target genes imperfectly. The seed 
region (position 2 to 8) of miRNAs is most important for target recognition and 
silencing (Doench et al. 2003, Lewis et al. 2005). It has been suggested that adjacent 
and perfect base pairing in the 5’ proximal seed region of the miRNAs and the 3’UTR 
of its target mRNAs is strictly required for the interaction (Eulalio et al. 2008, 
Filipowicz et al. 2008). Some research show that both the 3’UTR and 5’UTR (Doench 
et al. 2003, Zeng et al. 2002) and even the mRNA-coding regions (Forman et al. 2008). 
A search for conserved sequences in coding regions reveals that the let-7 microRNA 
targets Dicer within its coding sequence) may comprise the potential binding sites of 
miRNAs. Usually, the number of miRNA binding site imitates the degree of translation 
repression. It is normally believed that miRNAs regulate gene expression by 
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translational repression or cause deadenylation and degradation of mRNA (Eulalio et al. 
2008, Filipowicz et al. 2008, Nilsen 2007). 
 
miRNA target prediction is a lively arena with increasing thoughtfulness on advance of 
new analysis tools (Peterson et al. 2014). Computational prediction and validation of 
miRNA targets are essential for revealing the comprehensive functions of miRNAs in 
gene regulation. Computational prediction of miRNA targets is much more puzzling in 
animals than in plants, because animal miRNAs mostly shows imperfect base-pairing 
with their target sites, which stance a trail for the precise computational identification of 
animal miRNA targets (Brennecke et al. 2005, Lai 2004, Lewis et al. 2005). By 
divergence, plants miRNAs bind their targets by entirely or nearly entirely 
complementarity, so target identification is forthright (Jones-Rhoades and Bartel 2004).  
 
First computational miRNA target prediction programs concentrated on the fruit fly 
(Enright et al. 2003, Rajewsky and Socci 2004, Stark et al. 2003) and mammalian 
(Kiriakidou et al. 2004, Lewis et al. 2003) genome was independently developed by 
several research groups. Significant advances have been made in computational target 
prediction (Sethupathy et al. 2006) and many diverse algorithms have been developed 
for the prediction of miRNA targets such as TargetScan (Grimson et al. 2007) , PicTar 
(Krek et al. 2005), miRanda (Enright et al. 2003), PITA (Kertesz et al. 2007), DIANA-
microT (Kiriakidou et al. 2004), RNAhybrid (Rehmsmeier et al. 2004), microInspector 
(Rusinov et al. 2005), MovingTargets (Burgler and Macdonald 2005), rna22 (Miranda 
et al. 2006), NBmiRTar (Yousef et al. 2007) and Nucleus (Rajewsky and Socci 2004). 
These mentioned algorithms make predictions mainly based on various significant 
features of miRNA-target nucleotide sequence interaction. Although different 
algorithms utilize different sets of features, a few important features including seed 
match, free energy, sequence conservation and site accessibility are the four common 
features for miRNA target prediction tools and are briefly described as: 
 
2.5.1 Seed Match 
 
The first 2–8 position nucleotides starting at the 5′ end and totaling toward the 3′ end is 
termed as seed sequence of a miRNA (Lewis et al. 2003). Mostly for tools, a seed match 
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is a Watson-Crick (WC) match between a miRNA and its target in the seed sequence. A 
WC match between a miRNA and mRNA nucleotide occurs when adenosine (A) pairs 
with uracil (U) and guanine (G) pairs with cytosine (C). A perfect seed match between 
the miRNA and the mRNA target has no gaps in alignment within the WC matching. 
6mer, 7mer-m8, 7mer-A1 and 8mer are the main types of seed matches which could be 
considered depending on the algorithm (Brennecke et al. 2005, Krek et al. 2005, Lewis 
et al. 2003, Lewis et al. 2005).  
 
2.5.2 Conservation 
 
Conservation mentions to the upkeep of a sequence across species. Conservation 
analysis may emphasis on regions in the 3′ UTR, the 5′ UTR and the miRNA seed 
region, or any combination of the three. Generally, there is higher conservation in the 
miRNA seed region than in the non-seed region (Lewis et al. 2003). In a small fraction 
of miRNA:mRNA target interactions, there is conserved pairing at the 3′ end of the 
miRNA which can pay compensation for seed mismatches, and these sites are called 3′ 
compensatory sites (Friedman et al. 2009). In the milieu of predicting miRNA targets in 
3′ UTRs, conservation analysis may provide evidence that a predicted miRNA target is 
functional because it is being selected for and furthermore there is accumulative interest 
in conservation analysis of the genomic regions flanking the miRNA gene and miRNA 
target genes. As examples, conservation analysis has been functional to the promoter 
regions of miRNAs and their target genes (Fujiwara and Yada 2013), and to the co-
localization of independently transcribed miRNAs and flanking protein coding genes 
(Ohler et al. 2004). 
  
2.5.3 Free Energy 
 
To measure the stability of a biological system the term free energy or Gibs free energy 
can be used. Free energy states to the minimum free energy and shows how strong the 
binding of a miRNA:mRNA is. Free energy is usually considered as a negative real 
value for which kcal/mol unit is used. True binding could be considered by the stable 
binding structure in the result of low free energy (Yue et al. 2009). 
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2.5.4 Site Accessibility 
 
Site accessibility is a degree of the comfort with which a miRNA can pinpoint and 
hybridize with an mRNA target. In the result of transcription, mRNA adopts a 
secondary structure which can hinder with a miRNA's ability to bind to a target site 
(Mahen et al. 2010). Two step development is involved in the hybridization of 
miRNA:mRNA, firstly miRNA binds to a short reachable region of the mRNA and 
secondly miRNA  completes binding to a target when the mRNA secondary structure 
unfolds (Long et al. 2007). Consequently, the possibility that mRNA is the target of a 
miRNA, the projected quantity of energy to make a site accessible to a miRNA can be 
estimated. 
  
Inorder to avoid some limitations in the existing algorithms a new tool named as 
miREcords for animal miRNA:mRNA interactions, was established consisting of two 
components the validated target component and the predicted target component. The 
predicted targets component of miRecords is an integration of predicted miRNA targets 
formed by 11 conventional miRNA target prediction databases. As the maximum 
complete integration of predicted miRNA targets, it is predictable to provide significant 
help to researchers exploring new miRNA targets (Xiao et al. 2009).  
 
Studies conducted on the miRNA target predictions and microyrray put forward that an 
individual miRNA could regulate multiple genes post-transcriptionally (Lim et al. 
2005). Furthermore, an messenger RNA can be regulated by a set of miRNAs, in a 
cooperative manner, in which the translational repression of an individual target gene 
may only be operative by interaction of different miRNAs (Krek et al. 2005). 
 
A large set of diverse miRNAs are communicated in different types of cells and tissues, 
thus by making a multifarious regulatory network between miRNAs and their target 
genes to regulate the functions of the specific cells and tissues. Indeed, miRNAs play 
their role in various biological processes including cell proliferation, development, 
apoptosis, organogenesis, tumorigenesis, haematopoiesis (Ambros 2004, Baehrecke 
2003, Hwang and Mendell 2007). The following sections give a brief review of the 
literature on function of miRNAs in reproduction. 
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2.6 MiRNAs in cell cycle regulation 
 
Gametogenesis and development comprises proliferation of the germ cells and their 
accompanying somatic cells. miRNAs are involved in the regulation of various 
biological processes, such as cell proliferation (Dong et al. 2010), apoptosis (Chan et al. 
2005) and differentiation (Goljanek-Whysall et al. 2012). Du and coworkers (Du et al. 
2014) reported that miR-545 inhibited cell proliferation in vitro and in vivo and  also 
invented  that miR-545 caused cell cycle arrest at the G0/G1 phase and induced cell 
apoptosis in lung cancer cells by targeting cyclin D1 and CDK4 genes. Results showed 
that miR-503 blocked the proliferation of hepatocellular carcinoma (HCC) cells by 
introduction of G1 phase arrest through Rb-E2F signaling pathways. (Xiao et al. 2013). 
Recent study verified that miR-107 is downregulated in breast cancer samples related 
with normal tissue and may perform a crucial role in breast cancer progression. 
Abundance of miR-107 expression causes cellular growth inhibition, migration and G1 
phase arrest by targeting CDK8 (Li et al. 2014). 
 
First time the role of miRNAs in apoptosis was stated in 2003 when miR-14 and bantam 
were exposed to regulate cell death in Drosophilia (Brennecke et al. 2003, Xu et al. 
2003). Bantam, formerly recognized as a gene that causes overgrowth of wing and eye 
tissue (Hipfner et al. 2002), was validated to be a miRNA and was exposed to endorse 
proliferation and prevent apoptosis by targeting the proapoptotic gene hid1(Brennecke 
et al. 2003). On the other hand miR-14, recognized in a presentation for genes that 
modify cell death in the eye of Drosophila, was revealed to inhibit apoptosis by 
regulating the effector caspase Drice (Xu et al. 2003). 
 
Another study identified targets and biological processes generated by the transfection 
of human cells with miRNAs. Cellular growth and cell cycle progression was negatively 
regulated by mir-16 family miRNAs, thus by showing that over-expression of mir-16 
family miRNAs induced G0/G1 capture in cultured human tumour cells, and that 
domination of many identified targets of mir-16 family miRNAs induced G0/G1 
accumulation. CDK6, one of the identified targets and was a cell cycle kinase could be 
triggered by binding to D-type cyclins during early G1 phase (Linsley et al. 2007). 
Cyclin-dependent kinase inhibitor p21/CDKN1A being a direct target of miR-106b and 
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it shut up shows a major role in miR-106b-triggered cell cycle phenotypes (Ivanovska et 
al. 2008). 
  
2.7 MiRNAs in development 
 
MicroRNA expression may contribute to developmental robustness because of the fact 
that microRNAs are the main post-transcriptional regulators of developmental gene 
expression and its importance to alter the expression of several target genes (Karp et al. 
2011). Role of miRNAs in the regulation of development are evidenced by the study 
that some of the miRNAs in the embryonic stem cells appear in the cell specific pattern 
by inhibiting as ES cells differentiate into embryoid bodies and are down regulated in 
adult mouse organs (Houbaviy et al. 2003). Another study showed that miRNAs can 
play key role in a spatial temporal expression pattern in zebra fish embryonic 
development. The results showed that the majority of the miRNAs what were used in 
the study were down regulated in early development while highly expressed during 
segmentation and later stages (Wienholds et al. 2005). Similarly, mutation in the gene 
dicer1 in mice caused the depleted stem cells in embryos thus by causing death early in 
development (Bernstein et al. 2003). With the advancement of development, a diverse 
set of miRNAs were involved   from oocyte stage to tadpole stage in Xenopus laevis, 
thus showing the stage-specific temporal expression of miRNAs during development 
(Watanabe et al. 2005). 
 
2.8 MiRNAs in female reproduction 
 
For fruitful reproduction, appropriate development and function of the female 
reproductive tract are necessary stages. Directives of the distinguished functions of the 
organs that constitute the female reproductive tract are well documented to happen at 
various levels including transcription, translation, and posttranslational modifications. 
Posttranscriptional gene regulation mediated by miRNA has ascended as a central 
mechanism governing normal tissue development and function. MicroRNA in 
mammalian cells are vital post-transcriptional regulators and function by modulating 
translation or degradation of their target mRNA (Nothnick 2012). In order to explore the 
role of miRNAs in reproductive tissues, widespread miRNA expression profiling has 
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been measured indicating the presence of large numbers of miRNA within reproductive 
tissues and cells. Thousands of miRNA have now been recognized in a variety of 
organisms. (Fiedler et al. 2008, Hassan et al. 2010, Lin et al. 2013, Nagaraja et al. 2008, 
Tesfaye et al. 2009, Yao et al. 2009). In this part the discussion is being made on the 
role of miRNAs in folliculogenesis. 
 
2.9 MiRNAs in ovary 
 
Recently it has begun to discover the regulatory role of small RNA molecules in ovarian 
cells, recognizing their impact on gonadal development, proliferation, apoptosis, 
steroidogenesis, ovulation and corpus luteum progression. This emergent area of 
research has pushed and reformed our understanding on how ovarian function is 
regulated. MiRNAs are expressed during different stages of ovarian advancement and 
are expected to play significant roles during gonadal development and folliculogenesis.  
Here, we discuss the current intimation and role of miRNA involvement in ovarian 
development and function. 
 
Folliculogenesis is the outcome of series of complex and synchronized processes, which 
comprise morphological and functional alterations in different types of follicular cells 
and their communications. Sequential recruitment of growing follicles, atresia, 
ovulation, and luteal tissue development and regression are dynamically regulated 
events that recapped on a cyclical basis within the ovary. These processes are under 
control of closely harmonized endocrine and paracrine factors to grow a number of 
ovulatory follicles that are species and breed dependent (Hunter et al. 2004). These 
actions comprise intense changes in cellular growth, angiogenesis, steroidogenesis, cell 
cycle status, and apoptosis and are tightly regulated at the endocrine and tissue level. 
These steady state cyclic alterations are organized by tightly regulated expression and 
interaction of a assembly of genes in different compartments of the ovary (oocyte, mural 
granulosa, cumulus granulosa cells and theca cells) to enable oocyte development 
(Bonnet et al. 2008). Defects in regulatory control can lead to ovarian failure such as 
premature ovarian failure (POF) due to disruption of folliculogenesis, block of 
ovulation, and corpus luteum (CL) insufficiency (Carletti and Christenson 2009). 
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It is apparent that germ cells of the ovary and the supporting granulosa cells of the 
follicles, tickle a discourse that is important for granulosa cells growth and 
differentiation and oocyte growth, maturation and ovulation. Inside the ovary, granulosa 
cells are considered as an important location for the production of estrogen which is 
utilized for local use as well as providing endocrine signaling to other tissues (Nelson 
and Bulun 2001). 
  
The luteinizing hormone (LH) surge prompts multiple firmly connected ovarian 
processes, including steroidegenesis, maturation of oocyte and ovulation (Jamnongjit et 
al. 2005). Like wise many roles of miRNA in folliculogenesis, current studies have 
provided demonstration for the important function of Dicer, which is an RNase III 
enzyme accountable for miRNA processing obligatory for oogenesis regulation. The 
importance of small RNA in the ovary is cleared by the proof of Dicer1 conditional 
knockout (cKO) mouse ovarian tissue , in which Dicer1 is removed specifically in 
follicular granulosa cells which  led to an enlarged primordial follicle pool bestowed , 
enhanced early follicle recruitment and extra degenerate follicles in the cKO ovaries. 
This study showed that dicer 1 plays a crucial role in follicular cell development 
through the differential regulation of mRNA expression (Lei et al. 2010). 
  
In a study by deleting Dicer in growing oocytes in mouse showed incomplete meiosis, 
which illustrates that oocytes lacking Dicer arrest in meiosis I with numerous disarrayed 
spindles and chromosomal congression defects. Additionally, they proposed that 
miRNAs might be elaborate in the degradation of many maternal transcripts essential to 
completion of meiotic maturation (Murchison et al. 2007).  Matching result attained 
from mouse injected with Dicer siRNA showed significant reduction in maturation rate, 
increased uncharacteristic chromosomal and spindle organization, and reduced 
transcripts of Dicer miRNAs, spindle formation proteins and spindle check points genes, 
thus, specified that Dicer and miRNA appear to have an important role during oogenesis 
and meiosis accomplishment (Liu et al. 2010). 
  
In a study of differentially expressed plasma microRNAs in premature ovarian failure 
patients they found regulatory effects on proliferation and apoptosis of granulosa cells 
by effecting different signaling pathways including the AKT signaling pathway, steroid 
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hormone receptor signaling pathways. They concluded that mir-23a may show an 
important role in regulating apoptosis via decreasing the levels of X-linked inhibitor of 
apoptosis protein (XIAP) and increasing caspase-3 cleavage (Yang et al. 2012).  
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3 Material and methods 
 
3.1 Materials 
 
In this section, materials used in this study such as chemicals, kits, all other biological 
materials, reagents, media, equipment, software and their sources are mentioned. 
 
3.1.1 Chemicals, kits, biological and other materials 
 
Chemicals, kits, biological and other materials Manufacturer/Supplier 
10x PCR buffer                                       Genaxxon bioscience GmbH, 
Germany 
5x First-Strand buffer Invitrogen Life Technologies, 
Karlsruhe, Germany 
Acetic acid Roth, Karlsruhe, Germany 
Agarose                                                         Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
AllPrep® DNA/RNA Micro Kit 
 
QIAGEN, Hilden, Germany 
Ammonium acetate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Calcium chloride dihydrate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Chloroform Roth , Karlsruhe, Germany 
Citric acid Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Diethylpyrocarbonate (DEPC)  Roth, Karlsruhe, Germany 
dNTPs Roth , Karlsruhe, Germany 
Dithiothreitol (DTT) Invitrogen Life Technologies, 
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Karlsruhe, Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
Ethylenediaminetetra acetic acid (EDTA) Roth , Karlsruhe, Germany 
ExoSAP-IT USB, Ohio, USA 
Gentamycin sulphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hemi-calcium lactate Promega, WI, USA 
Hyaluronidase Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hydrochloric acid Roth, Karlsruhe, Germany 
Hydroxylamine Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Igepal Roth, Karlsruhe, Germany 
Ionomycin Sigma-Aldrich, Chemie GmbH, 
Munich, Germany 
Isopropyl -D-thiogalactoside (IPTG) Roth, Karlsruhe, Germany 
L-Glutamine Sigma-Aldrich, Germany 
Magnesium chloride Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
MicroRNA LNA
TM
 PCR primer set Exiqon, Vedbaek, Denmark 
MiRNeasy® mini kit QIAGEN, Hilden, Germany 
Nuclease free water Exiqon, Vedbaek, Denmark 
Oligonucleotide primers MWG Biotech, Eberberg, Germany 
QIAquick PCR Purification Kit QIAGEN, Hilden, Germany 
Random primer Promega, WI, USA 
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Ribo-nuclease inhibitor (RNasin) Promega, WI, USA 
RNA later Sigma-Aldrich, MI, USA 
Ribo-nuclease inhibitor (Rnasin) Promega, WI, USA 
RNA 6000 Nano LabChip® kit Agilent Technologies Inc, CA, USA 
Roti PAGE gradient (4-20%) 
Carl Roth GmbH, Karlsruhe, 
Germany 
Rotiphorese Gel 30 (37, 5:1) 
Carl Roth GmbH, Karlsruhe, 
Germany 
RQ1 Rnase-free Dnase Promega, WI, USA 
Sample Loading Solution (SLS) Beckman Coulter, Krefeld, 
Germany 
Sodium acetate Roth , Karlsruhe, Germany 
Sodium bicarbonate Sigma-Aldrich chemie, Steinheim, 
Germany 
Sodium chloride Roth , Karlsruhe, Germany 
Superscript II reverse transcriptase Invitrogen,  CA, USA 
SuperSignal West Pico Chemiluminescent Substrate Thermo Scientific, Rockford, 
U.S.A. 
Taq DNA polymerase Sigma-Aldrich Inc, MO, USA 
Universal cDNA synthesis kit II Exiqon, Vedbaek, Denmark 
ExiLENT SYBR®GREEN master mix Exiqon, Vedbaek, Denmark 
 
3.1.2 Reagents and media preparation 
 
During this experiment, the following reagents and media formulation were used. All 
solutions used in this study were prepared with deionised and demineralised millipore 
water (ddH2O) and when necessary, the pH was adjusted with sodium hydroxide 
(NaOH) or hydrochloric acid (HCl). In addition, the solutions or buffers were 
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subsequently filtered through 0.2 μl filter and autoclaved at 120°C for 20 min when it 
was necessary. 
 
Name of the Buffer/media Constituents  Volume / amount 
Physiological saline solution Sodium chloride 9.0 g 
( NaCl 9%) added to water 1000.0 ml 
 Water up to 1000.0 ml 
70% Ethanol Ethanol (100%) 700 ml 
 Water 300 ml 
10x CMF (Calcium magnesium free  Sodium chloride (NaCl) 8 g 
PBS) Potasium chloride (KCl) 0.2 g 
 Sodium hydrogen phosphate 
(Na2HPO4) 
1.15 
 Potasium hydrogen 
phosphate (KH2PO4) 
0.2 g 
 Water up to 1000 ml 
10x PBS NaCl  8.77 g 
 Na2HPO4  1.50 g 
 NaH2PO4  2.04 g 
 Water up to 1000.0 ml 
1x PBS 10x PBS  100 ml 
 DEPC-treated water upto 1000 ml 
3% BSA in PBS BSA 30g 
 10x PBS : added to 1,000.0 ml 
3M Sodium acetate, pH 5.2 Sodium acetate  123.1 g 
 ddH2O added to 500 ml 
 ddH2O added to 1000 ml 
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O added to 25 ml 
DEPC-treated water (1000 ml) DEPC 1 ml 
 added to water  1000 ml 
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dNTP solution dATP (100 mM) 10 l 
 dGTP (100 mM) 10 l 
 dTTP (100 mM) 10 l 
 ddH2O added to 400 l 
EDTA 100 Mm (pH 2.0)  EDTA 37.224 g 
 Water up to  1000.0 ml 
4% paraformaldehyde  Paraformaldehyde  4.0 g 
 1X PBS 100.0 ml 
Lysis buffer Igepal (0.8%)  0.8 μl 
 40U RNasin  5.0 μl 
 DTT  5.0 μl 
 ddH2O added to 100.0 μl 
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3.1.3 Equipment 
 
Equipment Manufacturer 
Agilent 2100 Bioanalyzer Agilent Technologies , CA, USA 
Electrofusion machine CFA 400 Kruess, Munich, Germany 
Electrophoresis unit BioRad, Munich, Germany 
CEQ
TM
 8000 Genetc Analysis Beckman Coulter, Krefeld, Germany 
Illumina Hiseq 2000 GATC Bio Tech AG Konstanc, Germany 
Nanodrop 8000 spectrophotometer  Thermo Fisher Scientific, DE, USA 
Millipore apparatus Millipore Corporation, USA 
MyCycler Thermal Cycler  Bio-Rad Laboratories, CA, USA 
Stereomicroscope SMZ 645 Nikon, Japan 
StepOnePlus real-time PCR system Applied Bio Systems 
Ultra-low freezer (-80
o
C) Labotect GmbH, Göttingen, Germany 
Universal centrifuge 233MK Hermel, Wehingen, Germany 
UV Transilluminator (Uvi-tec)  Uni Equip, Martinsried, Germany 
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3.1.4 List of software programs and statistical packages   
 
Programs (softwares) 
 and statistical packages 
Source  
BLAST program  http://www.ncbi.nlm.nih.gov/Blast/  
Bos taurus genome   
ftp://ftp.ensembl.org/pub/release-
72/fasta/bos_taurus/dna/ 
Bowtie 1.3 
http://sourceforge.net/projects/bowtie-
bio/files/bowtie/old/0.11.3/ 
Cutadapt https://code.google.com/p/cutadapt/ 
DAVID Bioinformatic Resource 6.7 https://david.abcc.ncifcrf.gov/ 
EndNote X1 Thomson 
ENSEMBL genome browser  http://www.ensembl.org/ 
Entrez Gene http://www.ncbi.nlm.nih.gov/gene/ 
FASTQC version 0,10,0   http://www.bioinformatics.babraham.ac.uk/project
s/fastqc 
GraphPad prism v.5  GraphPad software, Inc. 
KEGG pathway http://www.genome.jp/kegg/pathway.html 
MiRBase v.19 http://www.mibase.org/ 
miRDB  
 
http://www.mirdb.org/ 
MicroRNA.org-Target and 
Expression 
http://www.microrna.org/ 
miRecords http://mirecords.biolead.org/ 
PicTar  http://www.pictar.org/ 
Primer Express® software v.2.0 Applied Biosystems, Foster City, CA, USA 
RT
2
 PCR Array Data Analysis Version 
3.5 
http://pcrdataanalysis.sabiosciences.com/pcr/array
analysis.php 
Primer 3 (version 4) http://frodo.wi.mit.edu/primer3/ 
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Prism for windows (ver.5.0) GraphPad software, Inc. 
Seqtk tools https://github.com/lh3/seqtk 
TargetScan 5.1 http://www.targetscan.org/ 
Weight to molar quantity  
(for nucleic acids) converter 
http://www.molbiol.ru/eng/scripts/01_07.html 
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3.2 Methods 
 
3.2.1 Experimental layout 
 
 
Figure 3.1 Brief overview of the present study 
SF= Subordinate follicles (DF) = Dominant follicles  
 
3.2.2 Animals and treatment 
 
Handling of experimental animals was in accordance with the 1972 rules and 
regulations of German law of animal protection and the experiment was licensed by the 
animal protection office of the University of Bonn. Healthy Simmental heifers (n =13) 
aged between 15 to 20 months and weighing between 380 and 500 kg were used in this 
study. All experimental heifers received chief characteristics and they were kept under 
the same farm and housing conditions. Prior to collection of experimental samples, all 
heifers used for the experiment were estrous synchronized as previously described (Gad 
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et al. 2011, Ghanem et al. 2011, Hoelker et al. 2012, Salilew-Wondim et al. 2010). 
Briefly, the heifers received intra muscular administration of 500 mg of the 
prostaglandin F2α (PGF2α) analogue cloprostenol (Estrumate; Munich, Germany) twice 
within 11 days interval. Two days after each of the PGF2α treatments, animals received 
0.02 mg GnRH-analogue buserelin (Receptal) (Intervet, Boxmeer, the Netherlands). 
Common signs of estrus were monitored by visual observation and careful rectal 
palpation 3 days after the last PGF2α injection. Following this, a total of 6 and 7 heifers 
were slaughtered at day 3 and day 7 of the estrous cycle, respectively at nearby 
slaughter house. The ovaries were then collected from each experimental animal and 
transported to laboratory in a thermo-flask containing warm phosphate buffer saline 
solution (PBS) at a temperature of 38
o
C. 
 
3.2.3 Follicle isolation and categorization 
 
Immediately up on arrival in the laboratory within 1 hour after collection, the ovaries 
were washed   three times with 0.9% NaCl solution. The ovaries were then rinsed in 
70% alcohol for 30 sec followed by washing in 0.9% NaCl solution three times. Each 
ovary was checked for the presence of cystic ovaries and corpus luteum. The ovaries 
from 3 cows (1 cow at day 3 and 2 cows at day 7 of the estrous cycle) were discarded 
from the experimental group. The ipsilateral or contralateral part of the ovary was noted 
based on the previous corpus luteum and the follicles were then isolated from ipsilateral 
side of ovaries by blunt-dissection using scissors and forceps. The diameter of each 
follicle was measured using a caliper and then classified as subordinate and dominant 
follicles depending on their diameter as recommended by (Ireland et al. 1980) with 
minor modifications. Briefly, at day 3 of the estrous cycle, follicles with follicular 
diameter of ≤ 6 mm (n = 43) were categorized as subordinated follicle (SF) and follicles 
with a diameter of 8-10 mm (n = 9) were considered as dominant follicle (DF). On the 
other hand, at day 7 of the estrous cycle, follicles with a diameter of ≤ 8 mm (n = 58) 
were considered as SF and those with 9-13 mm diameter (n = 3) were categorized as 
DF. 
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3.2.4 Collection of follicular fluid and follicular cells (granulosa cells, theca cells, 
cumulus oocyte complex) 
 
Following classification of follicles as SF and DF at days 3 and 7 of estrous cycle, each 
of the follicles were cut at its top edge by the help of sharp scalpel and the follicular 
contents were released into the 35 mm sterile petri dish. The follicular fluid containing 
granulosa cells remained in the plate after cumulus oocyte complex recovery was 
pooled according to the size of their corresponding follicles in a sterile microcentrifuge 
tube and centrifuged at 300g for 10 min. While follicular fluid was collected as 
supernatant, the granulosa cells were collected as pellet from the bottom of the tube. 
Follicular fluid was snap frozen and stored at -80°C for further use. The granulosa cell 
pellets were then washed twice with DPBS (Gibco, Life Technologies, UK) containing 
0.025% polyvinyl alcohol (PVA) without Ca
2+
 and Mg
2+
 and stored at -80°C for 
downstream experiment. Theca cells were isolated after gently scraping the follicular 
wall with a blind edge of forceps and washed with Ca
2+
 and Mg
2+ 
free DPBS to remove 
any granulosa cell contamination. Then the theca cells (theca interna and theca externa) 
were pealed carefully and scraped off with forceps. After consecutive washings in order 
to remove granulosa cells, the theca cells were transferred into 0.65 ml falcon tube 
containing RNA later (Sigma) and stored at -20
o
C for further use. 
 
3.2.5 Total RNA extraction 
  
Total RNA enriched with small RNA was extracted from granulosa cells, theca cells, 
follicular fluid and cumulous oocyte complexes using the miRNeasy
®
 mini kit (Qiagen 
GmbH, Hilden, Germany), according to the manufacturer’s instructions with minor 
modifications. 
 
3.2.5.1 Total RNA isolation from surrounding follicular cells (granulosa cells and theca 
cells) 
 
The total RNA enriched with miRNAs was extracted from the follicular cells (granulosa 
cells and theca cells) samples using RNeasy mini kit (Qiagen, Hilden, Germany) with 
slight modifications from the manufacturer’s instructions. The cells were disrupted by 
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adding 700 μl QIAzol Lysis Reagent and homogenized by vortexing for 1 min followed 
by incubation at 15-25 
o
C temperature for 5 min. After this 140 μl chloroform was 
added to the homogenate, the tube shacked vigorously for 15 sec and centrifuged for 15 
min at 12000 xg at 4°C in refrigerated universal centrifuge 233MK (Hermle 
Labortechnik, Wehingen, Germany). The upper aqueous phase was transferred carefully 
to a new 2 ml collection tube and 1.5 volumes (525 μl) of 100% ethanol was added and 
mixed thoroughly by pipetting up and down several times. Without any delay after 
mixing, 700 μl of the sample was pipetted onto RNeasy Mini spin column and 
centrifuged at 11000 rpm for 15 sec at room temperature. The flow-through was 
discarded and the previous step was repeated with the left over samples. Following this, 
350 μl of RWT buffer was added to the spin column and centrifuged at 11000 rpm for 
15 sec. Total RNA samples were freed from any Genomic DNA contamination by 
performing on-column DNA digestion using RNase-free DNase (Qiagen GmbH, 
Hilden, Germany).  A total of 80 μl (10 μl DNase + 70 μl buffer RDD) of diluted DNase 
I solution was pipetted directly onto the RNeasy mini spin column membrane and were 
placed on the bench top at 20-30
oC for 15 min. Following incubation, 350 μl RWT 
buffer was added to the spin column and centrifuged for 15 sec at 11000 rpm at room 
temperature. After discarding the flow-through, 500 μl RPE buffer was added to the 
spin column followed by 15 sec centrifugation 11000 rpm. This step was repeated for 
the second time and centrifuged at the same speed for 2 min. The spin column was then 
transferred to a new 2 ml collection tube and centrifuged at 14000 rpm for 1 min to 
eradicate any possible leftover of RPE buffer and residual flow-through remained on the 
spin column. To elute total RNA, the RNeasy spin column was transferred into new 1.5 
ml collection tube to which 30 μl of RNase-free water was added to the centre of the 
RNeasy spin column membrane and centrifuged at speed of 11000 rpm for 1 min at 
room temperature. Isolated total RNA was stored in -80°C until the further step. 
  
3.2.5.2 Total RNA isolation from follicular fluid 
 
Total RNA was isolated from follicular fluid samples using miRNeasy
®
 mini kit 
(Qiagen, Hilden, Germany) according to the protocol adopted for serum or plasma with 
minor modification. Briefly, 5 volume of Qiazol lysis buffer was added to the follicular 
fluid, vortexed for 3-4 min and incubated for 8 min at room temperature. Following 
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incubation, 200 μl of chloroform was added to each sample, vigorously shacked for 1 
min and incubated for 5 min. After incubation the samples were centrifuged at 12000 xg 
for 15 min at 4
o
C.The upper aqueous phase was transferred carefully to a new 2 ml 
collection tube and 1.5 volumes (525 μl) of 100% ethanol was added and mixed 
thoroughly by pipetting up and down several times. Directly after mixing, 700 μl of the 
sample was pipetted onto RNeasy Mini spin column and centrifuged at 11000 rpm for 
30 sec at room temperature. The flow-through was discarded and the previous step was 
repeated with the left over samples. Following this, 700 μl of buffer RPE was added to 
the spin column and centrifuged at 11000 rpm for 1 min at room temperature. After this 
spin column were washed three times by adding 500 μl RPE buffer and centrifuged for 
1 min at 11000 rpm at room temperature. After discarding the flow-through, the spin 
column was then transferred to a new 2 ml collection tube and centrifuged at 14000 rpm 
for 2 min at room temperature. The tube was left over open for 1 min that allowed the 
evaporation of residual ethanol portion from the spin column.  To elute total RNA, the 
RNeasy spin column was transferred into new 1.5 ml collection tube to which 30 μl of 
RNase-free water was added to the centre of the RNeasy spin column membrane and 
centrifuged at speed of 11000 rpm for 1 min at room temperature. Isolated total RNA 
was stored in -80°C until the further step.  
 
3.2.5.3 Purification and isolation of total RNA containing small RNAs from cumulous 
oocyte complexes 
 
Total RNA was purified and isolated from the cumulous oocyte complexes samples by 
using AllPrep DNA/RNA Micro Kit followed by RNeasy mini kit (Qiagen, Hilden, 
Germany) by the manufacturer’s instructions. The cells were disrupted by adding 75 μl 
of buffer RLT plus and homogenized by pipetting and transferred to the top of a 
Qiashredder column placed in a 2 ml collection tube. The sample tube was then rinsed 
with 275 μl of buffer RLT Plus and the entire volume was pipetted over the sample in a 
Qiashredder column and centrifuge for 2 min at 14000 rpm at room temperature. The 
homogenized lysate was transferred to an AllPrep DNA spin column placed in a 2 ml 
collection tube by closing the lid gently, and centrifuged for 30 sec at 10000 rpm at 
room temperature. After these 1.5 volumes (usually 525 μl) of 100% ethanol was added 
to the flow through from the AllPrep DNA spin column, and mixed well by pipetting. 
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700 μl of the sample was transferred to an RNeasy MinElute spin column placed in a 2 
ml collection tube (supplied) by closing the lid gently, and centrifuged for 15 s at 11,000 
rpm) followed by discarding the flow through. Last step was repeated until the whole 
sample passed through the membrane with discarding the flow-through each time. The 
collection tube was used to next step by adding 500 μl Buffer RPE to the RNeasy 
MinElute spin column, closing the lid gently, and centrifuged for 15 sec at 11,000 rpm. 
The flow-through was discarded. Reuse The collection tube was to next step by adding 
500 μl Buffer RPE to the RNeasy MinElute spin column by closing the lid gently, and 
centrifuged for 2 min at 11,000 rpm. The collection tube with the flow-through was 
discarded. After this the RNeasy MinElute spin column was placed in a new 2 ml 
collection tube (supplied) by opened lid of the spin column, and centrifuged at full 
speed for 5 min. The collection tube with the flow-through was discarded. The RNeasy 
MinElute spin column was placed in a new 1.5 ml collection tube by adding 14 μl 
RNase-free water directly to the center of the spin column membrane. The lid was 
closed gently, and centrifuged for 1 min at full speed at room temperature. Isolated total 
RNA was stored in -80°C until the further step.  
 
3.2.5.4 Quantity and quality control of isolated RNA 
 
The quantity and purity of each RNA sample was assessed with spectrophotometer 
NanoDrop ND-800 (Thermo Fisher Scientific, Wilmington, DE, USA). RNA integrity 
was analyzed using the RNA 6000 Nano Kit and Small RNA Kit with the 2100 
Bioanalyzer (Agilent, Palo Alto, CA, USA). All samples were of high quality with the 
absorbance wavelength ratio (A260/A280) of ≥ 1.9 and the RNA Integrity Number of ≥ 
8. RNA samples stored at -80ºC pooled accordingly and send to the company for deep 
sequencing of miRNAs. On average, 100 ng of RNAwas used as starting material for 
small RNA library preparation, miRNA sequencing library construction and sequencing. 
A total of 12 granulosa samples (three biological replicated of granulosa cells from SF 
or DF at day 3 or day 7 of the estrous cycle) were used for miRNA deep sequencing. 
However, the total RNA samples from COCs, follicular fluid and theca cells were used 
for measuring the expression of candidate miRNAs generated from granulosa cells. 
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3.2.5.5 Purity of isolated granulosa cells 
 
Purity of isolated granulosa cells and conceivable contamination of theca cells were 
confirmed by the presence and absence of granulosa cell and theca cell specific markers 
genes namely; follicle-stimulating hormone receptor (FSHR) and Cytochrome P450 
17A1 (CYP17A1), respectively. The program primer3web version 4.0.4 
(http://bioinfo.ut.ee/primer3/) was used to design sequence-specific primers of bovine 
GAPDH, FSHR and CYP17A1 genes (Table 3.1). For this, cDNA (20 μl) was 
synthesized using First Strand cDNA Synthesis Kit (Thermo scientific, MA, USA) 
according to manufacturer´s instruction. Briefly; total RNA samples isolated from 
granulosa cells were diluted to obtain 1 μg of RNA per 20 μl of reaction volume. One μl 
of oligo (dt) 18 primer was added to total RNA samples and were incubated at 65
o
C for 
5 min. 9 μl of master mix (4 μl of 5X reaction buffer, 1 μl RiboLock RNase inhibitor, 2 
μl of 10 mM dNTP mix and 2 μl of M-MuLV Reverse Transcriptase) was added to the 
RNA template and incubated at 37
o
C for 60 min. Finally, reactions were ended by 
heating at 75
o
C for 5 min. Efficiency of cDNA synthesis was confirmed by polymerase 
chain reaction (PCR) amplification of known housekeeping gene (GAPDH) primers. 
PCR was performed using the following cycling conditions: Pre20 incubation at 95
o
C 
for 5 min, 40 cycles of denaturation at 95
o
C for 30 sec, annealing at 55
o
C (FSHR and 
GAPDH) and 57
o
C (CYP17A1) for 30 sec, extension at 72
o
C for 1 min and final 
extension at 72
o
C for 10 min. The PCR product was loaded into 2% agarose gel 
electrophoresis stained with Ethidium bromide (EtBr) and visualized under UV on Gel 
Doc XR+ imaging system (BIO-RAD, München, Germany) to detect the presence or 
absence of specific bands. 
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Table 3.1: Details of primers design for gene markers of follicular cells 
 Gene Sequence (5´-3´) 
Annealing 
temperature 
(
O
C) 
Accession no. 
GAPDH 
For. 
Rev. 
AATGGAGCCATCACCATC 
GTGGTTCACGCCCATCACA 
55 
 
NM_001034034 
 
FSHR 
For. 
Rev. 
GCAGTCGAACTGAGGTTTGT 
AGATATCGGAGGTTGGGAAG 
55 
 
NM_174061 
 
CYP17A1 
For. 
Rev. 
CTACTTGCCCTTTGGAGCAG 
GGAGTCATGAGGTGCTACCC 
57 
NM_174304 
 
For: forward primer Rev: reverse primer 
 
3.2.6 Library preparation and sequencing 
 
The miRNA enriched total RNA samples from granulosa cells from subordinate and 
dominant follicles at day 3 and day 7 of estrous cycle were subjected to construction of 
tagged miRNA sequencing libraries (22 to 30 nt) by a commercial company GATC 
BioTech AG (Konstanz, Germany) according to Illumina Small RNA Sample 
Preparation protocol. Briefly, specific 3´and 5´ RNA adapters were ligated to each end 
of the RNA molecule followed by purification of 1
st
 and 2
nd
 adapter ligation products. 
The 3´ RNA adapter is modified to capture miRNAs and other small RNA species in the 
sample. Single stranded cDNA was synthesized by reverse transcription using RT 
primers. Complementary DNA samples were PCR amplified using specific primers 
(Table 3.2). PCR amplified cDNA constructs were gel purified and band fraction size 
range of 140-160 nucleotides were excised using clean scalpel. Finally, single read 
clusters were generated and sequencing was performed on Illumina HiSeq 2000 in 
single read mode with read length of 50 bases. Base calling, filtering of the data and 
index sorting were performed by the CASAVA Pipeline version 1.8.0. Raw FASTQ 
sequence reads of 50 nucleotides length were obtained. 
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Table 3.2: List of adapters and primers used for library construction and PCR 
amplification  
Adapter/Primer Sequence (5´-3´) 
RNA 5´ adapter GTTCAGAGTTCTACAGTCCGACGATC 
RNA 5´ adapter (RC) GATCGTCGGACTGTAGAACTCGAAC 
RNA 3´ adapter TGGAATTCTCGGGTGCCAAGG 
RNA 3´ adapter (RC)  CCTTGGCACCCGAGAATTCCA 
RNA PCR primer  AATGATACGGCGACCACCGAGATCT
ACACGTTCAGAGTTCTCCAGTCCGA 
RNA PCR primer (RC) TCGGACTGTAGAACTCTGAACGTGT
AGATCTCGGTGGTCGCCGTATCATT 
RNA Reverse transcription  primer GCCTTGGCACCCGAGAATTCCA 
RNA Reverse transcription  primer (RC) TGGAATTCTCGGGTGCCAAGGC 
RC: reverse complement 
 
3.2.7 Sequence Quality control and pre-processing 
 
All Fastq files were subjected to a preliminary sequence quality control procedure using 
FASTQC version 0,10,1 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). 
Based on input reads, FASTQC provide plots for quality control measures such as per 
base GC content, per sequence quality scores, per base sequence quality scores and over 
represented sequences.  The per base sequence quality and per sequence quality scores 
were thoroughly inspected. The 5´adapter, 3´ adapter, RT primers, PCR primers and 
their corresponding reverse complementary sequences, sequence reads with Phred score 
lower than 20 were removed at first. In the second step, sequence reads shorter than 18 
bp after trimming were also removed from all the data sets. These sequences trimmings 
were performed using a combination of Cutadapt (Martin 2012) 
(https://code.google.com/p/cutadapt/) and Seqtk tools (https://github.com/lh3/seqtk). 
  
 The Bos taurus genome release 72 was downloaded from ensemble genome browser 
(ftp://ftp.ensembl.org/pub/release-72/fasta/bos_taurus/dna/) was used as the reference 
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genome build to align the reads after quality control.  The genome was indexed with 
Bowtie 1.3 (Langmead et al. 2009) (http://sourceforge.net/projects/bowtie-
bio/files/bowtie/old/0.11.3/). Moreover, the Fasta file of all matured bovine miRNA, 
precursor bovine miRNAs and mature miRNAs of model species such as human, mouse 
and rat were downloaded from mirBase database (release 20: June 2013)  
(http://mirbase.org/ftp.shtml). The downloaded Fasta files contained 755 bovine mature 
miRNAs, 766 bovine precursor miRNAs, 2042 human mature miRNAs, 1281 mouse 
mature miRNAs and 723 rat mature miRNAs respectively. The results presented here 
are based on miRNA prediction algorithm miRDeep2 and associated workflow. 
The first step of the workflow, “Mapper” maps Fasta formatted input reads to the given 
reference genome index (Friedlander et al. 2012). This read to reference genome 
mapping is used in the miRDeep2 algorithm for the identification of known and novel 
microRNAs. The second step of the workflow, “Quantifier” takes as input Fasta format 
converted reads and sequences of known mature and precursor miRNAs (Friedlander et 
al. 2012). The number of reads mapped to each known mature and precursor miRNAs 
were quantified to generate the miRNA expression data. 
 
The raw FASTQ files and processed CSV files containing expression data have been 
deposited in NCBI's Gene Expression Omnibus and are accessible through GEO series 
accession number GSE56002. 
 
3.2.8 Identification of known and novel miRNAs 
 
Novel miRNAs were predicted from mature, star and loop sequence according to the 
RNAfold algorithm using miRDeep2 (Friedlander et al. 2012, Hofacker 2003). 
RNAfold was used for prediction of RNA secondary structures. In addition, we also 
calculated the estimated probability that the sequence to be true a positive novel miRNA 
candidate. Apart from this, the sequence should not be mapped to the rRNA or tRNA. A 
sequence was considered as a novel miRNA when it was not matched to any of the 
known miRNA in the mirBase. 
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3.2.9 Data normalization and analysis of differential expression of miRNAs 
 
Following detection and identification of miRNAs, the expression level of those 
miRNAs was compared between the granulosa samples of SF and DF to understand 
whether accumulation or degradation of miRNA is associated with follicular selection, 
recruitment and dominance. For this, four comparisons were performed:  
(1) To understand whether accumulation or degradation of miRNAs is associated with 
follicular selection and recruitment in early luteal phase, the expression pattern of 
miRNAs were compared between the granulosa cells of SF and DF at day 3 of the 
estrous cycle.  
(2) To investigate whether the miRNA expression is associated with follicular selection 
and dominance during the early luteal phase, the expression pattern of miRNAs 
was compared between granulosa cells of SF and DF at day 7 of the estrous cycle.  
(3) To understand the temporal miRNAs expression dynamics in DF during the luteal 
phase of the bovine estrous cycle, the miRNA expression pattern of granulosa cells 
in DF samples collected at day 7 was compared to the DF samples collected at day 
3 of the estrous cycle.  
(4) The miRNA expression pattern of the granulosa cells of SF was also compared 
between day 3 and day 7 of the estrous cycle to identify the miRNAs that could be 
changing in SF follicles during the early luteal phase of the estrous cycle. 
 
Differential expression of miRNAs were analyzed using the R statistical software (RDC 
Team 2006) and DESeq2 package (Anders and Huber 2010).  The expression data from 
second step of the workflow (“Quantifier”) was used. To normalize the read count 
differences in each sample, DESeq2 normalization step generated a fictitious sample, 
calculated from the geometric mean of read count of all samples. The read count for 
each gene in each sample is divided by this geometric mean to obtain the normalized 
counts. For each miRNA in each granulosa sample, the observed count is the ratio of 
raw count for each miRNA to the geometric mean across the samples. DESeq2 employs 
a negative binomial distribution based method to identify differentially expressed genes 
or miRNAs. The Benjamini–Hochberg procedure of false discovery rate adjustment 
(Benjamini and Hochberg 1995) was used to correct the p values for multiple testing. At  
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the end of analysis, miRNAs with log2 fold change difference ≥ 1.0, with p value ≤ 0.05 
and false discovery rate (FDR) < 10% were considered as differentially expressed 
miRNAs. The heatmaps and clustering analysis of the differentially expressed miRNAs 
were generated using PermutMatrix (Caraux and Pinloche 2005). 
 
3.2.10 MiRNA target gene prediction and functional annotation (Insilico Analysis) 
 
The functional annotation of differentially expressed miRNAs was analyzed based on 
the functional annotation of their potential target genes. The predicted target genes were 
identified using miRecords http://mirecords.biolead.org/,  (Xiao et al. 2009), an online 
animal miRNA-target interaction tool which integrates 12 miRNA-target prediction 
tools, including DIANA-microT, MicroInspector, miRanda, MirTarget2, miTarget, 
PicTar, PITA, and TargetScan. The target genes which were predicted by at least four 
prediction tools were selected and submitted to DAVID  Functional Annotation 
Bioinformatics Microarray Analysis tool (Da Wei Huang and Lempicki 2008) and the 
potential KEGG, Panther and Reactome pathways significantly enriched by target genes 
of each miRNAs were identified.  
 
3.2.11 Validation of selected differentially expressed miRNAs using qPCR 
 
The expression levels of 12 differentially expressed miRNAs were further validated 
using qPCR. For that, 88 ng miRNA enriched total RNA was reverse transcribed using 
universal cDNA synthesis kit (Exiqon) following the manufactures protocol. Briefly, a 
20 μl reaction mix consisting of total RNA, reaction buffer, enzyme mixes and 
nuclease-free water was incubated at 42°C for 60 min, followed by 5 min incubation at 
95°C. At the end of reaction period, the resulting cDNA was diluted 40x in RNAse free 
water. The qPCR was then performed in 20 µl reaction volume containing cDNA of 
each sample mixed with reverse and forward primer of each miRNA, PCR master mix 
(SYBR Green, thermo stable DNA polymerase) and nuclease-free water in the 
StepOnePlus™ Real-Time PCR Systems (Applied Biosystems, Foster City, CA). The 
real time PCR thermocycler parameter was set to 95°C of denaturation for 10 min 
followed by 40 cycles at 95°C for 15 sec and 60°C for 30 sec. At the end of 40 cycles, 
the melting curve was analyzed at 95°C for 15 s, 60°C for 1 min and the temperature 
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was increased at the rate of 0.3/sec until it reached to 95°C and the reaction was 
incubate at 95°C for 15 sec. At the end of the reaction, the qPCR data with acceptable 
dissociation curve and the amplification plot was used for further quantification 
analysis. The data was analyzed using the delta thresh hold cycle (delta Ct) method. The 
delta Ct values were generated after the expression of each miRNA was normalized 
against the arithmetic mean expression value of U6 and 5S. The within similarities of 
biological replicates and differences between samples of the qPCR data was then 
compared with the data generated by next generation sequencing. 
 
3.2.12 Characterization of the expression of candidate miRNAs in follicular cells (theca 
cells, COCs and follicular fluid) 
 
Following identification of differentially expressed miRNAs between the granulosa 
cells of SF and DFat days 3 and 7 of estrous cycle, we decided to understand whether 
the expression observed in granulosa cell could follow a similar pattern in theca cells, 
follicular fluid and COCs. For this, selected differentially expressed miRNA both at day 
3 and day 7 of the estrous cycle were analyzed in theca cells, follicular fluid and COCs 
(Table 3.3). For this, the miRNA enriched total RNA was isolated from theca cells, 
follicular fluid and COCs of SF and DF whose granulosa cells were used for the next 
generation sequencing was subjected to cDNA synthesis and qPCR analysis. The qPCR 
reaction, the thermo cycler parameters and the data analysis was performed exactly as 
indicated above. 
  
Table 3.3: List of selected differentially expressed miRNAs for their characterization in 
follicular cells (theca cells, COCs and follicular fluid) at day 3 and 7 of estrous cycle 
 
Day3 SF vs DF Day7 SF vs DF Day3&7 DF vs DF 
bta-mir-222 bta-miR-409a bta-mir-155 
bta-miR-21-3p bta-miR-335 bta-miR-221 
bta-mir-21-5p bta-miR-195 bta-mir-222 
bta-mir-155 bta-miR-214 bta-miR-21-3p 
bta-miR-221 bta-mir-21-5p bta-miR-708 
bta-miR-708 bta-miR-21-3p bta-mir-21-5p 
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bta-miR-214 bta-mir-222 bta-miR-365-5p 
bta-miR-335 bta-mir-155 bta-miR-214 
bta-miR-34c bta-miR-708 bta-mir-195 
 bta-miR-221 bta-miR-335 
 bta-miR-2487 bta-mir-409a 
 bta-mir-365-5p  
SF: Subordinate follicle, DF: Dominant follicle 
 
3.2.13 Statistical analysis 
 
Expression data of selected candidate miRNAs in granulosa cells, theca cells, cumulus 
oocyte-complex and follicular fluid derived from SF and DF at day 3 and day 7 of 
estrous cycle was done using comparative  threshold cycle (Ct) method (Livak and 
Schmittgen 2001). Expression data was normalized against the geometric mean of the 
expression of 2 endogenous reference miRNAs; 5s Ribosomal RNA (5s rRNA) and U6  
small non-coding small nuclear RNA (U6 snRNA). Two-tailed student´s t-test was used 
to discover statistical differences in the mean expression value between treatment 
groups (SF vs DF at day 3 of estrous cycle), (SF vs DF at day 7 of estrous cycle), (SF vs 
SF at day 3 and day 7 of estrous cycle), (DF vs DF  at day 3 and day 7 of estrous cycle),  
and statistical significance was defined at p-value ≤ 0.05. GraphPad prism 5 (GraphPad, 
San Diego, CA) was used to plot the relative expression of selected miRNAs. All 
experiments were performed in three biological replicates and relative expression values 
are presented as mean ± SD of normalized Ct values. 
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4 Results 
 
Simmental heifers were estrous synchronized, at day 3 of the estrous cycle, follicles 
with follicular diameter of ≤ 6 mm (number of follicles = 43) were categorized as 
subordinate follicle (SF) and follicles with a diameter of 8-10 mm (number of follicles = 
9) were considered as dominant follicle (DF). On the other hand, at day 7 of the estrous 
cycle, follicles with a diameter of ≤ 8 mm (number of follicles = 58) were considered as 
SF and those with 9-13 mm diameter (number of follicles = 3) were categorized as DF. 
 
4.1 Isolation efficiency from bovine follicles 
 
The purity of granulosa cells isolated from follicles was checked using FSHR as 
granulosa cell specific CYP17A1 as theca cell specific markers. As indiacted in figure 
4.1 below all granulosa cells showed a specific band for FSHR, while negligible amount 
of bands were detected using CYP17A1 gene in the SF and DF group at day 7 of estrous 
cycle. On the other hand in the SF and DF group at day 3 of estrous cycle samples 
showed some bands of CYP17A1 gene in some samples. 
 
Figure 4.1: Granulosa cell-specific marker gene (FSHR) was detected in subordinate 
and dominant follicles at higher level as indicated by strong bands, while theca 
cell-specific marker gene (CYP17A1) had poor band. 
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4.2 Identification of known miRNAs in granulosa cells of subordinate and dominant 
follicles at day 3 and day 7 of the estrous cycle 
 
MiRNAs libraries of 12 (three biological replicates for each sample) granulosa samples 
from SF and DF on day 3
 
and day 7 of post estrous were sequenced using Illumina 
HiSeq 2000 small RNA deep sequencing technology and clusters of sequence reads 
with maximum 50 base-pair (bp) length were obtained. At day 3 of the estrous cycle, the 
raw sequence data within the biological replicates of SF groups ranges from 3.9 to 7.7 
million reads, whereas in DF, the read count ranges from 8.7 to 9.5 million reads. 
Similarly, at day 7 of the estrous cycle, raw sequence data in granulosa cells of SF was 
between 6.7 and 8.1 million reads whereas in DF groups the raw read counts was 
between 7.5 and 9.2 million. However, after filtering adapters, PCR primers, non 
informative sequences and sequences shorter than 18 bp, the mean read counts of SF 
and DF samples at day 3 of the estrous cycle were 1.5 ± 0.32 and 1.9± 0.18 million 
reads, respectively. Similarly, at day 7 of the estrous cycle, the mean read count was 1.9 
± 0.18 and 1.6 ± 0.15 in granulosa samples of SF and DF, respectively.  After quality 
filtering the total number of reads obtained per replicate from SF and DF at day 3 and 
day 7 of estrous cycle ranged from 1,057,154 to 2,116,142 of which 57% to 69% were 
aligned to the reference genome (Table 4.1). 
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Table 4.1: Summary of sequence read alignments to reference genome  
Group 
Biological 
Replicates 
Total number 
of reads 
Unmapped 
reads 
Mapped 
reads 
Percentage of 
unmapped reads 
Percentage 
of mapped 
reads 
Subordinate 
follicles 
day 3 
1 1691367 964766 726601 0.43 0.57 
2 1083734 642467 441267 0.407 0.593 
3 1594922 989857 605065 0.379 0.621 
Dominant 
follicles 
day 3 
1 1973220 1274237 698983 0.354 0.646 
2 2031526 1219346 812180 0.4 0.6 
3 1694104 1149755 544349 0.321 0.679 
Subordinate 
follicles 
day 7 
1 1779229 1120328 658901 0.37 0.63 
2 1786030 1045365 740665 0.415 0.585 
3 2116142 1222335 893807 0.422 0.578 
Dominant 
follicles 
day 7 
1 1701710 1159412 542298 0.319 0.681 
2 1057154 732656 324498 0.307 0.693 
3 1970550 1294502 676048 0.343 0.657 
 
                         
Following this, miRDeep2.pl of mirDeep2 script was used to detect known and novel 
miRNAs. Consequently, miRNAs with at least 1 raw read count in at least 2 of the three 
biological replicates were measured as detected miRNAs. Thus, 43025 and 4400226 
reads of SF and DF, respectively at day 3 of the estrous cycle and 411736 and 358128 
sequence reads of SF and DF, respectively at day 7 of the estrous cycle were matched to 
the known bovine miRNAs available in miRbase. Based on this analysis, the results 
revealed that a total of 291 and 318 known miRNAs were detected in granulosa cells of 
SF and DF, respectively at day 3 of the estrous cycle and 274 miRNAs were commonly 
expressed in both granulosa cell groups. On the other hand, 314 and 316 known 
miRNAs were detected in granulosa cells of SF and DF, respectively at day 7 of the 
estrous cycle of which 279 were detected in both granulosa cell groups. In addition, 
taking all data together, a total of 244 miRNAs were commonly detected in all 
granulosa cells in both follicles sizes at both days of the estrous cycle (Figure 4.2), of 
which 15 miRNAs named bta-miR-10b, bta-miR-26a, bta-miR-99b, bta-miR-27b, let-7 
families (bta-let-7f, bta-let-7a-5p and bta-let-7i), bta-miR-92a, bta-miR-191, bta-miR-
125a,  bta-miR-148a, bta-miR-186,  bta-miR-143, bta-miR-30d and  bta-miR-30a-5p, 
were dominantly abundantly by > 3000 reads (Table 4.2). On the basis of this the results 
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exposed that majority of the detected miRNAs are co-expressed between granulosa cells 
of SF versus SF and DF versus DF at day 3 and day 7 of estrous cycle. 
 
 
 
 
 Figure 4.2: Venn diagram showing the number of known miRNAs detected uniquely or 
commonly in SF and DF granulosa samples at day 3 and day 7 of the estrous 
cycle. SF Day 3 and DF Day 3 indicate the subordinate and dominant follicles, 
respectively at day 3, while SF Day 7 and DF Day 7 indicate the subordinate and 
dominant follicles, respectively at day 7 of the estrous cycle. 
    
Table 4.2: The top most abundant miRNAs with > 3000 read counts in granulosa 
samples of SF or DF at day 3 and/or day 7 of the estrous cycle 
 
miRNAs 
Day 3 SF Day 3 DF Day 7 SF Day 7 DF 
No of reads No of reads No of reads No of reads 
bta-miR-10b 37494 46559 63323 14742 
bta-miR-26a 37300 53636 61103 42278 
bta-miR-99b 18612 31817 15768 7583 
bta-miR-27b 12922 15894 11789 20250 
bta-let-7f 11065 14697 10439 7936 
bta-let-7a-5p 10134 14314 10027 10415 
bta-let-7i 8944 13802 11203 7270 
bta-miR-92a 8853 7929 11115 4348 
bta-miR-191 8073 15492 9996 5147 
bta-miR-125a 7425 10142 8046 4713 
bta-miR-148a 5055 6336 6100 6254 
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bta-miR-186 3795 5778 5052 5272 
bta-miR-143 3737 3802 3906 10194 
bta-miR-30d 3534 5499 4400 2993 
bta-miR-30a-5p 3453 4314 3460 4188 
No of reads describe the average number of read counts aligned to each miRNA 
 
            4.3 Identification of differentially expressed miRNAs between granulosa cells of 
subordinate and dominant follicles at day 3 of estrous cycle 
 
To understand whether miRNAs expression is altered during follicular recruitment and 
selection, during the early luteal phase, we investigated the expression pattern of 
miRNAs at day 3 of the estrous. Therefore, following detection of the known miRNAs, 
their expression difference between the granulosa cells derived from SF and DF was 
analysed using the DESeq2 by comparing the log2 transformed read counts of granulosa 
cells of SF and DF. The expression pattern of 280 miRNAs was found to be altered by ≥ 
1.5 fold changes compared to the granulosa cells of the DF of which 57% were 
activated while the rest 43% were repressed in the SF groups. However, when the 
selection parameters were  limited to log2 fold change ≥ 1.0 (absolute fold change ≥ 2), 
p value < 0.05 and FDR < 10%, only 16 known miRNAs were found to be significantly 
differentially expressed between the granulosa cells of SF and DF groups. Among these, 
the expression level of 14 miRNAs including bta-miR-449a, bta-miR-449c, bta-miR-
212, bta-miR-222, bta-miR-21-3p and bta-miR-155 were increased while the expression 
level of 2 miRNAs (bta-miR-183, bta-miR-34c) was decreased in SF groups. The 
hierarchical clustering, the average expression, the p value and the FDR values of the 
differentially expressed miRNAs are described in figure 4.3.  
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Figure 4.3: The hierarchical clustering of differentially expressed miRNAs between the 
granulosa cells of SF and DF at day 3 of the estrous cycle along with their 
average expression difference (FC=log2 fold change), p value, and false 
discovery rate (FDR). Positive and negative FC values indicate up and 
downregulation of miRNAs, respectively in SF compared to DF granulosa cells. 
The red and green colours designate high and low expression of miRNAs, 
respectively.  
 
                       4.4 Identification of differentially expressed miRNAs between granulosa cells of 
subordinate   and dominant follicles at day 7 of estrous cycle 
 
To uncover whether the degradation or enrichment of miRNAs is associated with 
follicular selection and dominance during the early luteal phase, the expression profiles 
of miRNAs were then compared between granulosa cells of SF and DF at day 7 of the 
estrous cycle using the DESeq2 package. The results revealed that a total of 272 known 
bovine miRNAs exhibited ≥ 1.5 fold change differences between the two granulosa cell 
groups of which 49% of those miRNAs were enriched while the rest 51% of them were 
reduced in the granulosa cells of SF. However, when the miRNAs were filtered based 
on the criteria of log2 fold change ≥ 1.0, p value < 0.05, FDR < 10%, a total of 108 
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known miRNAs were differentially expressed between the granulosa cells of SF and 
DF, of which the expression level of 51 miRNAs were increased while the expression 
level of 57 miRNAs were reduced in the granulosa cell of SF. Among these, bta-miR-
2332, bta-miR-409a, bta-miR-2446, bta-miR-383, bta-miR-2404 and bta-miR-335 were 
not detected in granulosa cells of DF. On the other hand, from 57 downregulated 
miRNAs, bta-miR-184, bta-miR-365-5p, bta-miR-2487 and bta-miR-2389 were not 
absent in granulosa cells of SF. In addition, the expression of 12 miRNA families 
including miR-130 (a, b), bta-miR-181 (a, b, c, d), bta-miR-199 (a-3p, a-5p, b, c), bta-
miR-2285 (k, t), bta-miR-2411(-3p, -5p), bta-miR-2483 (-3p, -5p), bta-miR-29 (a, b), 
bta-miR-339 (a, b), bta-miR-365 (-3p, -5p), bta-miR-455 (-3p, -5p), bta-miR-92, and 
bta-miR-99 (a, -5p, b) were differentially expressed between the granulosa cells of SF 
and DF (Table 4.3). The expression and hierarchical clustering of all differentially 
expressed miRNAs and the top 36 ones are described in figure 4.4A and 4.4B, 
respectively. Moreover, the list of 108 differentially expressed miRNAs with their 
corresponding fold change, p values and FDR is provided in appendix 1. 
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Figure 4.4: Differentially expressed miRNAs between granulosa cells of SF and DF at 
day 7 of the estrous cycle. (A) The expression patterns and hierarchical 
clustering of 108 differentially expressed miRNAs between granulosa cells of SF 
and DF. The numbers 1, 2, 3 under SF and DF indicate the biological replicates. 
(B) The expression patterns and hierarchical clustering of top 36 differentially 
expressed miRNAs along with their average expression difference (FC=log2 fold 
change), p values and false discovery rate (FDR). The red and green colours 
indicate high and low expression, respectively. Positive and negative FC values 
indicate up and downregulation of miRNA, respectively in SF compared to the 
DF granulosa cells. 
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Table 4.3: MiRNA families co-expressed or co-repressed in granulosa cells of SF 
compared to DF at day 7 of the estrous cycle 
 
miRNAs FC p value 
bta-miR-130a 1 0.0001 
bta-miR-130b -2.5 < 0.0001 
bta-miR-181a -2.4 < 0.0001 
bta-miR-181b -2.3 < 0.0001 
bta-miR-181c -1.8 < 0.0001 
bta-miR-181d -1.5 0.074 
bta-miR-199a-3p -2.5 < 0.0001 
bta-miR-199a-5p -2.1 < 0.0001 
bta-miR-199b -2.4 < 0.0001 
bta-miR-199c -2.9 < 0.0001 
bta-miR-2285k 2.6 < 0.0001 
bta-miR-2285t -3.5 0.0085 
bta-miR-2411-3p 2.4 0.0055 
bta-miR-2411-5p -4 0.0112 
bta-miR-2483-3p 3 0.0032 
bta-miR-2483-5p 1.2 0.0212 
bta-miR-29a -1.4 0.0001 
bta-miR-29b -2.2 0.0018 
bta-miR-339a 1.6 < 0.0001 
bta-miR-339b 1.6 < 0.0001 
bta-miR-365-3p -1.9 < 0.0001 
bta-miR-365-5p -19.2 0.0005 
bta-miR-455-3p -3.1 < 0.0001 
bta-miR-455-5p -3.8 0.0002 
bta-miR-92a 1.4 < 0.0001 
bta-miR-92b 2.2 < 0.0001 
bta-miR-99a-5p 1.3 < 0.0001 
bta-miR-99b 1.1 0.002 
 FC=Fold change in log2 scale. Positive FC values indicate upregulation and negative FC values 
indicate downregulation of miRNAs in SF compared to DF. 
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4.5 Commonly differentially expressed miRNAs between the granulosa cells of 
subordinate and dominant follicles at day 3 and day 7 of estrous cycle 
   
Compared to day 3, the number of differentially expressed miRNAs between the 
granulosa cells of SF and DF was higher at day 7 of the estrous cycle (16 vs 108 
miRNAs). However, 9 miRNAs were commonly differentially expressed between 
granulosa cells of SF and DF both at day 3 and 7 of the estrous cycle. Interestingly, 8 
miRNAs namely (bta-miR-199a-5p, bta-miR-214, bta-miR-708, bta-miR-221, bta-miR-
21-5p, bta-miR-155, bta-miR-21-3p and bta-miR-222) were found to be enriched in SF 
at day 3 of the estrous cycle but  at day of 7 the estrous cycle those  miRNAs were 
repressed in SF compared to the DF groups (Table 4.4). 
 
Table 4.4: The list of commonly differentially expressed miRNAs at day 3 and day 7 of 
estrous cycle between granulosa cells of subordinate and dominant follicles 
 
miRNAs Day 3 FC p value Day 7 FC p value 
bta-miR-199a-5p 1.154918723 5.66E-09 -2.05261 5.15E-09 
bta-miR-335 1.183533497 7.48E-08 5.512602 5.64E-31 
bta-miR-214 1.279954695 0.006387 -2.67598 8.52E-11 
bta-miR-708 1.696020455 0.008131 -3.69984 3.68E-13 
bta-miR-221 1.840344086 7.95E-08 -3.7374 3.23E-11 
bta-miR-21-5p 1.918453892 3.4E-32 -2.79013 1.26E-09 
bta-miR-155 2.173146128 3.48E-13 -3.25402 1.44E-11 
bta-miR-21-3p 2.312488135 1.73E-10 -3.01701 4.68E-10 
bta-miR-222 2.729778837 1.29E-08 -3.17048 5.02E-11 
Positive fold change means up regulation and negative fold change means down regulation    
(FC=Log2 fold), P value. 
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4.6 Temporal enrichement or degradation of miRNAs in granulosa cells of DF during 
the early luteal phase of the estrous cycle 
 
We determined the temporal miRNA expression patterns in granulosa cells of DF 
between day 3 and day 7 of the estrous cycle to uncover the miRNAs expression 
dynamics in dominant follicles during the luteal phase of the bovine estrous cycle. Thus, 
after normalization of the read counts, the number of detected miRNAs were quite 
similar in both granulosa cells of DF at day 3 (n= 318) and day 7 of the estrous cycle 
(n=316) of which 262 miRNAs were commonly detected at both time points. The 
scatter plot of all those miRNAs is indicated in figure 4.5 to depict the overall 
expression difference. In addition to this, we also analysed the miRNAs whose 
expression is significantly different in DF between the two time points. Accordingly, a 
total of 131 miRNAs were differentially expressed between day 3 and day 7 of the 
estrous cycle of which 51 and 80 miRNAs were increased at day 3 and at day 7 of the 
estrous cycle, respectively (Figure 4.6). Among miRNAs increased at day 7 of the 
estrous cycle, bta-miR-2389, bta-miR-29d, bta-miR-363, bta-miR-1249, bta-miR-338, 
bta-miR-129-3p, bta-miR-129-5p, bta-miR-129, bta-miR-142-3p, bta-miR-449b, bta-
miR-2285t and bta-miR-346 were not detected at day 3 (Figure 4.6A). On the other 
hand, among the miRNAs that were repressed at day 7 of the estrous cycle bta-miR-
409a, bta-miR-2332 and bta-miR-196a were detected at day 3 but disappeared at day 7 
of the estrous cycle (Figure 4.6A). Others namely, bta-miR-143, bta-miR-99b, bta-miR-
191, bta-miR-16b, bta-miR-99a-5p and bta-miR-30e-5p were expressed by > 500 reads 
counts both at day 3 and day 7 of the estrous cycle. However, the expression pattern of 
these miRNAs was significantly decreased at day 7 compared to day 3 of the estrous 
cycle. The expression pattern of miRNAs expressed both at day 3 and day 7 but 
downregulated at later groups is shown in figure 4.6B and those upregulated are 
indicated in figure 4.6C. Moreover, the expression of 12 miRNA families including bta-
miR-29 (a, b, c, d), bta-miR-449 (a, b, c), bta-miR-181 (a, b, c, d), bta- miR-455 (-3p, -
5p), bta-miR-99 (b, a-5p) and bta-miR-2483 (-5p, -3p) were co-overexpressed or co-
repressed at day 7 compared to day 3 (Table 4.5). The list of all differentially expressed 
miRNAs with their corresponding fold change and p-value in granulosa cells of DF 
during the early luteal phase of the estrous cycle is described in appendix 2. 
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Figure 4.5: Scatter plot showing the read count ratio of 357 miRNAs between day 7 and 
day 3 in the granulosa cells of DF. 
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Figure 4.6: The heatmaps and the hierarchical clustering depicting the expression 
patterns of differentially expressed miRNAs in granulosa cells of DF between 
day 3 and day 7 of the estrous cycle. (A) The expression patterns of miRNAs 
detected only at day 3 (top) or at day 7 (bottom) of the estrous cycle in granulosa 
cells of DF. (B) The expression patterns of miRNAs detected both at day 3 and at 
day 7 of the estrous cycle but significantly increased in the former group. (C) 
The expression patterns of miRNAs expressed both at day 3 and at day 7 of the 
estrous cycle but significantly increased in the later group. The colour scale 
shows the log2 transformed expression values. Zero colour scale indicates 
miRNAs with ≤ 1 average read count. Numbers, 1, 2 and 3 on the heatmaps 
describe the number of biological replicates used in each sample group. Day 3 
and Day 7 indicate the stages of the estrous cycle. 
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Table 4.5:  MiRNA families co-expressed or co-repressed in granulosa cells of DF at 
day 7 compared to day 3 of the estrous cycle 
 
miRNAs         FC P value 
bta-miR-99b -1.7 < 0.0001 
bta-miR-99a-5p -1 < 0.0001 
bta-miR-455-5p 3.2 0.0003 
bta-miR-455-3p 3.1 < 0.0001 
bta-miR-449c 4.1 0.00092 
bta-miR-449b 16.7 0.0007 
bta-miR-449a 4 0.00011 
bta-miR-365-5p 4.5 0.00209 
bta-miR-365-3p 2.7 < 0.0001 
bta-miR-29d 16.4 0.01292 
bta-miR-29c 2.7 0.0166 
bta-miR-29b 2.3 0.00317 
bta-miR-29a 2.4 < 0.0001 
bta-miR-2483-5p -1.6 0.0005 
bta-miR-2483-3p -2.8 0.00188 
bta-miR-2285t 18 0.0002 
bta-miR-2285k -3.3 < 0.0001 
bta-miR-2285f -1.1 0.0093 
bta-miR-199c 3.2 < 0.0001 
bta-miR-199b 2.2 < 0.0001 
bta-miR-199a-5p 2.5 < 0.0001 
bta-miR-199a-3p 3.2 < 0.0001 
bta-miR-181d 2.5 0.00013 
bta-miR-181c 2.6 < 0.0001 
bta-miR-181b 2.9 < 0.0001 
bta-miR-181a 3.3 < 0.0001 
bta-miR-146b 4.1 < 0.0001 
bta-miR-146a 3.2 < 0.0001 
bta-miR-142-5p 4.9 < 0.0001 
bta-miR-142-3p 16.6 0.002 
bta-miR-129-5p 16.6 0.002 
bta-miR-129-3p 17.8 0.002 
 FC=Fold change in log2 scale. Positive FC values indicate upregulation and negative FC   values 
describe downregulation of miRNAs at day 7 compared to day 3. 
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           4.7 Temporal accumulation or degradation of miRNAs in granulosa cells of SF during 
the early luteal phase of the estrous cycle  
 
The temporal miRNA expression difference in the granulosa cells of SF between day 3 
and 7 of the estrous cycle was investigated to uncover the miRNAs expression dynamics 
occurring in subordinate follicles during the early luteal phase of the bovine estrous 
cycle. Results showed that only 5 miRNAs were differentially expressed between the 
two time points. From these, the expression level of 4 miRNAs, namely bta-miR-1271, 
bta-miR-100, bta-miR-424-5p and bta-miR-2285k was downregulated while the 
expression level of only one miRNA, bta-miR-155, was significantly upregulated in 
granulosa cells of SF at day 7 compared to day 3 (Table 4.6). Moreover, 4 of these 5 
miRNAs, namely, bta-miR-1271, bta-miR-424-5p, bta-miR-155 and bta-miR-2285k 
were also differentially expressed in granulosa cells of DF between day 3 and day 7 of 
the estrous cycle. Therefore, 127 miRNAs were uniquely differentially expressed in DF 
while only one miRNA was differentially expressed in SF between day 3 and day 7 of 
the estrous cycle. Thus, the temporal miRNA expression dynamics in the DF was more 
pronounced than the SF groups between the two time points. 
 
Table 4.6: List of differentially expressed miRNAs between granulosa cells of SF 
during the early luteal phase of the estrous cycle 
 
miRNAs  FC pvalue FDR 
bta-miR-1271 1.708093486 1.00E-05 0.001839181 
bta-miR-424-5p 1.058624784 0.000369811 0.025924203 
bta-miR-2285k 1.058150829 0.00053725 0.030412265 
bta-miR-100 1.036116917 4.20E-06 0.001839181 
bta-miR-155 -1.780583915 7.87E-06 0.001839181 
Positive fold change means up regulation and negative fold change means down regulation 
(FC=Log2 fold), P value and false discovery rate (FDR). 
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4.8 Target prediction and functional annotation for differentially expressed miRNAs 
across the estrous cycle  
 
To understand further physiological functions and biological processes of the 
differentially expressed miRNAs between granulosa cells of the subordinate and 
dominant follicles in the follicular development, in silico analysis was performed in 
order to identify the potential target genes. Due to the reason that number of 
experimentally validated miRNA targets is limited, we used miRecords at 
http://mirecords.biolead.org/, which contain animal miRNA potential targets according 
to combinations of the broadly used target prediction programs DIANA, Micro 
Inspector, miRanda, Mir Target2, miTarget, Pictar, PITA, RNA hybrid and miRDB. For 
considering a gene as a potential target of a specific miRNA we set the criteria of at 
least 4 target prediction programs. GO annotation and KEGG, PANTHER and 
REACTOME pathway analysis were performed to identify functional modules 
regulated by these differentially miRNAs in two groups (SF and DF) of follicles at 
different time points (day 3 and day 7) of estrous cycle. 
 
4.8.1 Target prediction, functional annotation and canonical pathways identified for 
differentially expressed miRNAs between granulosa cells of subordinate and dominant 
follicles at day 3 of estrous cycle 
 
Target genes for the 16 differentially expressed miRNAs between granulosa cells of SF 
and DF at day 3 of estrous cycle were predicted in silico. A total of 3319 target genes 
were identified (Fig 4.7). Among these 3053 genes were identified for up regulated 
miRNAs and 607 were identified for down regulated miRNAs between granulosa cells 
of SF and DF. Among them 395 including ACVR2A, ACVR2B, FOXA1, FOXN2, 
FOXO1, FOXP1, SOX6 genes were uniquely present in the downregulated list, while 
2841 genes including ACAD9, ACBD3, ACCN1, ACLY, ACTA1, ACTN1, ACTR2, 
ACTR8, ACVR1B, ACVR1C, HOXA1, WNT1,WNT9A genes  were uniquely 
identified in the upregulated list.  Moreover, 212 genes including ACVR2A, ACVR2B, 
FOXA1, FOXN2, FOXO1, FOXP1, SOX6 genes were commonly identified between 
the two groups. 
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Figure 4.7: Venn diagram showing the targeted genes predicted to be regulated by 
differentially expressed miRNAs at day 3 of estrous cycle between granulosa 
cells of subordinate and dominant follicles.        
                                                                                                            
Other than the differentially expressed miRNAs between granulosa cell of SF and DF 
follicles at day 3 of estrous cycle, also the interest was developed in the signalling 
pathways and biological functions that could be potentially targeted by these 
differentially expressed miRNAs. The biological processes in gene ontology were 
carried on in the analysis by revealing genes targeted by differentially expressed 
miRNAs. Twelve main GO terms were enriched with a p-value ˂ 0.05 (Table 4.7). 
Mostly the genes targeted by DE miRNAs were associated with transcriptional 
categories, regulation of RNA metabolic process, metabolic process, regulation of 
programmed cell death, axonogenesis, biological adhesion, cell-cell adhesion, 
regulation of cell death and cell fate commitment. To uncover, the role of those 
differentially expressed miRNAs, their target genes were predicted using miRecords 
tool and significantly enriched pathway (P ≤ 0.05) by those genes was analysed using 
DAVID Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.gov/). Accordingly, the 
pathway analysis results at day 3 of estrous cycle showed that cadherin signaling, 
apoptosis, ErbB signaling, MAPK signaling, Ras, signaling by BMP, 5HT1 type 
receptor mediated signaling and adipocytokine signaling pathways were enriched by 
genes potentially targeted by miRNAs enriched in granulosa cells of SF, whereas the 
focal adhesion, gap junction, histamine H1 receptor mediated signaling pathway and 
angiotensin II-stimulated signaling through G proteins and beta arrestin were enriched 
by genes potentially targeted by miRNAs enriched in granulosa cells of DF. 
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Interestingly, Wnt signaling pathway, TGF-beta signaling pathway, signaling by NGF, 
oxytocin receptor mediated signalin pathway, notch signaling pathway, axon guidance 
and adherens junction were enriched by genes targeted by miRNAs either enriched or 
repressed in granulosa cells of SF (Table 4.8). Despite of the fact of false-positive 
predictions which could occur every time, we expect that these targets have greater 
chance of being regulated by miRNAs in granulosa cells of SF and DF during the 
follicular development. 
 
Table 4.7: Gene ontology analysis of potential target genes of miRNAs differentially 
expressed between granulosa cells of subordinate and dominant at day 3 of estrous cycle 
  
miRNAs  ID GO ID & Terms List of some genes 
bta-miR-335↑,bta-
miR-21-3p↑,bta-
miR-449a↑,bta-miR-
21-5p↑,bta-miR-
214↑,bta-miR-
221↑,bta-miR-
222↑,bta-miR-199-
5p↑,bta-miR-
212↑,bta-miR-183↓ 
GO:0045449~regulation 
of transcription 
CCNT2, HLF, SNIP1, 
ONECUT2,MEF2A, CNOT8, 
ZNF630, E2F7, E2F3, SLC2A4RG, 
IL16, ZBTB39, ZNF200, TLR4, 
ZNF395, MLL2, L3MBTL4, 
PIM1,CNOT2, CTCF, ZEB2, 
RORB,ENY2, BMI1, MEF2C 
bta-miR-335↑,bta-
miR-449a↑,bta-miR-
1246↑,bta-miR-
221↑,bta-miR-
222↑,bta-miR-21-
5p↑,bta-miR-21-
3p↑,bta-miR-199-
5p↑,bta-miR-
212↑,bta-miR-183↓ 
GO:0006350~transcripti
on 
CCNT2, HLF, ONECUT2, 
MAX,E2F3, SLC2A4RG, ARID4A, 
BACH1, HLF, 
ZNF518B,MORF4L1, BMI1,ZNF83, 
ZEB2, EIF2C2, ELF2, RCBTB1, 
PCGF5, CDCA7,ZNF84, 
HLF,NFE2L1, ZFPM2, ING3, 
NFYC 
bta-miR-21-3p↑,bta-
miR-199-5p↑,bta-
miR-221↑,bta-miR-
GO:0051252~regulation 
of RNA metabolic 
process 
MEF2A, CNOT8, ZNF630, E2F7, 
PASK,ZNF84, HLF, 
ZNF614,CNOT2, ZEB2, 
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449a↑,bta-miR-
222↑,bta-miR-
335↑,bta-miR-212↑ 
RORB,E2F3, SLC2A4RG, 
ARID4A,ZNF83, ZEB2, 
CTCF,HLF, SNIP1, ONECUT2, 
LASS5, NPAS2, RNF141, 
HAND1,HIRA, 
bta-miR-21-3p↑,bta-
miR-199-5p↑,bta-
miR-221↑,bta-miR-
335↑,bta-miR-
449a↑,bta-miR-
222↑,bta-miR-212↑, 
GO:0006355~regulation 
of transcription, DNA-
dependent 
MEF2A, CNOT8, ZNF630,ZNF84, 
HLF, ZNF614, ZNF468, ZNF81, 
ZNF558, CREM,CNOT2, ZEB2, 
RORB,HLF, ONECUT2, SNIP1, 
E2F3, SLC2A4RG,ZNF83, ZEB2, 
CTCF, HIRA, ZEB2, FOXO3 
bta-miR183↓,bta-
miR-335↑,bta-miR-
21-5p↑,bta-miR-21-
3p↑,bta-miR-199-
5p↑,bta-miR-212↑, 
GO:0010604~positive 
regulation of 
macromolecule 
metabolic process 
ENY2, MEF2C, NFYC, FOXO1, 
FKBP1A, SOX6,SATB2, 
ONECUT2, TEAD1, CDC23,CNBP, 
GLIS2,IL6ST, NAA15, GJA1, TBP, 
FOXO3,CAV1, ACVRL1, BTRC, 
ONECUT2,ATXN1, PSMA2, 
MAPK1 
bta-miR-222↑,bta-
miR-21-5p↑,bta-
miR-449a↑,bta-miR-
335↑,bta-miR-21-
3p↑,bta-miR-199-
5p↑,bta-miR-
212↑,bta-miR-183↓ 
GO:0051254~positive 
regulation of RNA 
metabolic process 
MLL, KLF12, NTF3, TEAD1, 
NFYB,KLF6, BMP3, CNBP, NTF3, 
SOX2, SOX5,TBL1XR1, BMP3, 
SATB2, NPAS2, SATB2, 
HAND1,MAF, EPAS1, TBX5, 
EPAS1,EGR1, ENY2, MEF2C, 
BCL10,  FOXO3, 
bta-miR-212↑,bta-
miR-21-5p↑,bta-
miR-214↑,bta-miR-
183↓ 
GO:0043067~regulation 
of programmed cell 
death 
RTN4, PTGS2, ZAK, DEDD, GDF5, 
SOX4, FOXO3,APH1B, TLR4, 
GCLM, TIMP3, ACVR1C,TRAF1, 
YWHAZ, CADM1, ADORA2A, 
AKAP13,MEF2C, ING3, CDK5R1, 
SNCB, PTGS2, FOXO1, NR3C1, 
bta-miR-214↑,bta-
miR-21-3p↑,bta-
GO:0007409~axonogen
esis 
SLITRK1, NRP1, PVRL1, NRXN3, 
DRD2, ROBO2, TNN, UNC5C, 
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miR-449c↑,bta-
miR155↑,bta-miR-
449a↑bta-miR-
34c↓,bta-miR-183↓ 
GAP43, CXCL12, CHL1, PARD3, 
NUMBL, ALCAM, SEMA4F, 
PRKCA, NRP2 
bta-miR-1246↑,bta-
miR-21-3p↑,bta-
miR-221↑ 
GO:0022610~biological 
adhesion 
PCDHA6, PCDHA7, PCDHA8, 
PCDHA9, PCDHA2, FNDC3A, 
THBS2, DLG1, ITGB8, FAT2, 
PCDHA10, CD4 
bta-miR-1246↑,bta-
miR-21-3p↑,bta-
miR-221↑ 
GO:0016337~cell-cell 
adhesion 
PCDHA6, PCDHA7, PCDHA8, 
PCDHA9, PCDHA2, FNDC3A, 
THBS2, DLG1, ITGB8, FAT2, 
PCDHA10, CD4 
bta-miR-21-3p↑,bta-
miR-21-5p↑ 
GO:0010941~regulation 
of cell death 
ALS2, C7, TSPO, DNM1L, 
PTGER3, MSH2, APH1B, RFFL, 
ARHGEF12,MEF2A, LITAF, 
MMD, GJA1, TBP, PPT1, FOXO3, 
SLC11A2 
bta-miR-21-5p↑,bta-
miR-212↑,bta-miR-
183↓ 
GO:0045165~cell fate 
commitment 
SPRY2, SPRY1, NTF3, TBX2, 
SOX2, SOX5,GATA2, SPRY1, 
SALL1, FOXA1,ITGB1 
Note: Top most terms are listed here 
 
 
 
 
 
 
 
 
 
 
Results 
 
75 
Table 4.8: The most enriched pathways of target genes for differentially expressed 
miRNAs between granulosa cells of subordinate and dominant follicles at day 3 of 
estrous cycle 
 
miRNAs ID Term Genes 
mir-214↑,mir-
1246↑,mir-
214↑,mir-
212↑,mir-
449a↑,mir-
222↑,mir-
221↑,mir-183↓ 
Wnt signaling 
pathway 
FZD4, FZD7, ACVR1B, PLCB4, HOXA4, 
SMARCC1, HOXC4, SMARCD1, PPP2CB, 
WNT9A,PCDHA6, PCDHA7, PCDHA8, 
PCDHA9, PCDHA2, PCDHA3, PCDHA4, 
PCDHA5, SENP2, TBL1XR1, PLCB4, 
VANGL1, VANGL2, PPP2CB, WNT9A, 
FZD4, FZD7,EP300, NLK, PPP2R5C, 
PRICKLE2, NFAT5, PPP3CC,  
 
mir-21-5p↑,mir-
199a-5p↑, 
mir-212↑,mir-
214↑,mir-183↓ 
 TGF-beta signaling 
pathway 
SMAD7, BMPR2, SMURF2, ACVR1C, 
BMP8A, PITX2, ACVR2A, BMP3, 
ACVR1B, ACVR2B, ACVRL1, KRAS, 
RAB10, MAPK1, ACVR2B, EP300, FOXA1, 
GDF5, FOXE1, FOXO3, CITED2, FKBP2 
 
mir-222↑,mir-
221↑,mir-21-
3p↑,mir-
214↑,mir-183↓ 
Signalling by NGF CDKN1B, RALA, FRS2, BCL2L11, PIK3R1, 
ITPR2, MAPK1, PDPK1, PRDM4, 
ADORA2A, SQSTM1, PPP2CB,  
MEF2C, RPS6KA3, PPP2CA, PSEN2, 
PPP2CB, NTRK2, RALA, FOXO1, FRS2, 
IRS1 
mir-449a↑,mir-
183↓,mir-34c↓ 
Oxytocin receptor 
mediated signaling 
pathway 
PRKCQ, PLCG1, CACNB1, CACNB3, 
VAMP2, PLCB1, CACNA1C, PRKCA, 
PLCB4, GNB1, CACNB4, GNG4, GNG5 
GNAQ, PRKCI, CACNB3, VAMP3, VAMP2 
mir-449a↑,mir-
34c↓ 
Notch signaling 
pathway 
NOTCH2, DLL1, JAG1,NOTCH1, APH1A, 
DLL1, JAG1, NUMBL 
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mir-199a-
5p↑,mir-449a↑, 
mir-222↑,mir-
214↑,mir-
221↑,mir-
212↑,mir-183↓ 
Axon guidance EPHA7, KRAS, PLXNA2, GSK3B, NTNG1, 
SRGAP2, ABLIM1, MAPK1, NRP1, GNAI2, 
LIMK2, SEMA6D, PLXNA2, ABLIM3, 
SRGAP3, DPYSL5, ARHGEF12,PAK7, 
GNAI3, GNAI2, SEMA6D, EFNB2, PPP3R1, 
SEMA3C, PAK1 
 
mir-212↑,mir-
214↑,mir-34c↓ 
Adherens junction MAPK1, TJP1, EP300, NLK, TCF7L2, 
TCF7L1,PVRL4, FGFR1,ACVR1B, 
SORBS1, PVRL1, TGFBR1, ACTN1, 
SSX2IP,PARD3, WASF1, LEF1, VCL 
mir-221↑ 5HT1 type 
receptor  
mediated signaling 
pathway 
PRKY, SNAP29, GNAI3, GNAI2, GNB3, 
SNAP23 
mir-449c↑ Adipocytokine 
signaling pathway 
IRS4, ACSL1, ACSL4 
mir-222↑,mir-
221↑,mir-212↑ 
Apoptosis BBC3, PPP3R1, APAF1, BMF, KPNA1, 
BCL2L11 
PSMA2, TJP1, PSMD12, DYNLL2, CASP7,  
mir-222↑,mir-
221↑ 
mir-1246↑ 
Cadherin signaling 
pathway 
PCDHA6, PCDHA7, PCDHA8, PCDHA2, 
PCDHA3, PCDH11Y, PCDHA4, PCDH11X, 
PCDHA5, PCDHA1, PCDHAC2, PCDHAC1,  
 
mir-199a-
5p↑,mir-199a-
5p↑,mir-199a-
5p↑ 
ErbB signaling 
pathway 
CDKN1B, KRAS, GSK3B, CBL, 
PIK3CD,PAK7, CDKN1B, ERBB4, PLCG1, 
CBL, MAPK10, PAK1,  
mir-199a-5p↑ MAPK signaling 
pathway 
FGF18, NTF3, MAP3K1, RASGRP1, SOS2, 
IL1B, MAPK10, FGF12, DUSP8, STK3, 
ACVR1C 
mir-199a-5p↑ Ras Pathway RPS6KA6, TIAM1, RPS6KA2, MAP3K1, 
MAP2K3, SOS2, MAP2K4, RHOB 
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mir-199a-5p↑ Signaling by BMP UBE2D3, SMAD7, BMPR2, SKI, SMURF2, 
UBE2D1 
mir-34c↓ Angiotensin II-
stimulated signaling 
through G proteins 
and beta-arrestin 
MAPK1, MAP2K1, GNAQ, PRKCI, GRK6 
mir-34c↓ Focal adhesion MAPK1, MAP2K1, GSK3B, PDGFRA, 
FIGF, COL4A6, VCL 
mir-34c↓ Gap junction MAPK1, MAP2K1, GNAQ, PDGFRA, 
HTR2C 
mir-183↓ Histamine H1 
receptor mediated 
signaling pathway 
PRKCA, PLCB4, GNB1, GNG4, GNG5 
(P value ˂ 0.05) 
            
           4.8.2: Target prediction, functional annotation and canonical pathways identified for 
differentially expressed miRNAs between granulosa cells of subordinate and dominant 
follicles at day 7 of estrous cycle 
             
A total of 19710 target genes were identified by differentially expressed miRNAs 
between granulosa cells of SF and DF at day 7 of estrous cycle (Fig 4.8). Out of total 
5004 genes including the families of ABCA, CASP, CCDC, COX, MAPK, NOTCH and 
WNT genes were uniquely identified for up regulated miRNAs and 2688 genes 
including the family of FOX, HOX, LOC, and ZNF  genes were uniquely predicted for 
down regulated miRNAs between granulosa cells of SF and DF at day 7 of estrous 
cycle. 6009 genes including the family of E2F, EIF2C, FOX, FZD, SOX, and SMARCA 
genes were commonly identified between the two groups. 
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Figure 4.8: Venn diagram showing the targeted genes predicted to be regulated by 
differentially expressed miRNAs at day 7 of estrous cycle between granulosa 
cells of subordinate and dominant follicles. 
 
The gene ontology annotation and pathway analysis were performed to identify 
functional modules of the differentially expressed miRNAs at day 7 of the estrous cycle 
between granulosa cells of SF and DF. The GO annotation enrichment results showed 
that regulation of transcription, regulation of RNA metabolic process, regulation of gene 
expression, cell adhesion, regulation of cell proliferation, cell adhesion, cell motion, cell 
morphogenesis, apoptosis, regulation of cell growth, and ovarian follicle development 
are the main significantly GO terms (Fig 4.9).  
 
The predicted target genes of each miRNAs were uploaded to the DAVID 
Bioinformatics Resources version 6.7 tool and significantly (P ≤ 0.05) enriched 
molecular pathways were identified. The results showed that among 108 miRNAs, the 
targets of 84 miRNAs were found to be involved in metabolic and signaling molecular 
pathways. Metabolic pathways (panthothenate and CoA biosynthesis, O-glycan and N-
glycan biosynthesis, metabolism of vitamins and cofactors, D-glutamine and glutamate 
metabolism, biosynthesis of unsaturated fatty acids), Jak-STAT and cell cycle pathways 
were enriched by genes potentially targeted by miRNAs enriched in granulosa cells of 
SF, whereas the Ras signaling pathway, lipids, lipoproteins, cysteine, methionine and 
carbohydrates metabolic pathways were enriched by genes potentially targeted by 
miRNAs repressed in granulosa cells of SF. Interestingly, axon guidance, Wnt signaling 
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pathway, GnRH signaling pathway, MAPK-signaling, oocyte meiosis, TGF-beta 
signaling pathway and focal adhesion were enriched by genes targeted by miRNAs 
either enriched or repressed in granulosa cells of SF (Figure 4.10, Figure 4.11). The top 
most enriched pathways of target genes for differentially expressed miRNAs between 
granulosa cells of SF and DF at day 7 of estrous cycle are shown in appendix 3. 
 
 
 
Figure 4.9: Partial gene ontology (GO) classification annotated for predicted target 
genes in biological process of miRNAs differentially expressed between 
granulosa cells of SF and DF at day 7 of estrous cycle.  
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Figure 4.10: Significant molecular pathways (P ≤ 0.05) enriched by genes targeted by 
differentially expressed miRNAs between the granulosa cells of SF and DF at 
day 7 of the estrous cycle. Pathways enriched by genes potentially targeted only 
by miRNAs increased in SF are indicated in the left box, pathways enriched by 
genes potentially targeted by both miRNAs repressed and activated in SF are 
shown in the middle box while pathways enriched by genes potentially targeted 
only by miRNAs upregulated in DF but repressed in SF are described in the right 
box.  
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Figure 4.11: The list of differentially expressed miRNAs whose target genes are 
enriched (p ≤ 0.05) in Wnt signaling, GnRH signaling, MAPK, signaling, oocyte 
meiosis, TGF-beta signaling, focal, adhesion, ErbB, gap junction, axon guidance 
and apoptosis. () indicates increased expression while () depicts the reduction 
of miRNA expression in granulosa cells of SF compared to DF groups at day 7 
of the estrous cycle. 
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           4.8.3 Target prediction, functional annotation and canonical pathways identified for 
commonly differentially expressed miRNAs between the granulosa cells of subordinate 
and dominant follicles at day 3 and day 7 of estrous cycle  
 
The software was allowed to predict miRNA target genes, performed the enrichment of 
KEGG, PANTHER and REACTOME pathways from the predicted targets. Insilco 
analysis of the function of the miRNAs via their target genes indicated that these 
miRNAs were found to be involved in 2 or more pathways. For instance, miR-221 and 
mir-222 were found to be involved in Wnt and cadherin signaling pathways by targeting 
protocadherin alpha family of genes (PCDHA1,-2,-3,-4, -5,-6,-7,-8 etc.). In addition, 
miR-221, is also involved in apoptosis and 5HT1 type receptor mediated signaling by 
targeting genes involved in these pathways. Similarly, mir-21-5p was found to be 
involved in TGF-beta signaling pathway, regulation of actin cytoskeleton and MAPK 
signaling pathway and mir-199a-5p was found to be involved in TGF-beta signaling 
pathway, epidermal growth factor receptor (EGFR) signaling, membrane trafficking and 
insulin signaling pathway (Figure 4.12). 
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Figure 4.12: Uniquely and commonly differentially expressed miRNAs between the 
granulosa cells of SF and DF at day 3 and day 7 of the estrous cycle and their 
pathways enriched by their potential target genes. () shows upregulation while 
() indicate downregulation of commonly differentially expressed miRNAs in 
the granulosa cells of SF compared to DF at day 3 or day 7 of the estrous cycle. 
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           4.8.4 Target prediction and functional annotation of differentially expressed miRNAs in 
granulosa cells of dominant follicles between day 3 and day 7 of estrous cycle 
 
The gene ontology annotation and pathway analysis were performed to identify 
functional modules of the differentially expressed miRNAs in granulosa cells of DF 
between day 3 and day 7 of estrous cycle. A total of 19897 target genes were identified 
by differentially expressed miRNAs between granulosa cells of DF at day 3 and 7 of 
estrous cycle. Out of total 3235 genes were uniquely identified for up regulated 
miRNAs and 4296 were uniquely predicted for down regulated miRNAs, while 6183 
genes were commonly identified in granulosa cells of DF between day 3 and day 7 of 
estrous cycle. The pathway analysis results showed  that including transcription, the 
neuroactive ligand-receptor interaction, apoptosis signaling pathway, natural killer cell 
mediated cytotoxicity, Fc gamma R-mediated phagocytosis, tight junction, metabolism 
of carbohydrates, notch signaling pathway, axon guidance mediated by Slit/Robo and 
axon guidance mediated by netrin were enriched by genes targeted by miRNAs elevated 
at day 7, whereas the vitamin D and Phenylalanine metabolism, O-glycan  and N-glycan 
biosynthesis, mRNA metabolic process, cell cycle and biosynthesis of unsaturated fatty 
acids were enriched by genes targeted by miRNAs downregulated at day 7 the estrous 
cycle. On the other hand, Wnt signaling, vascular endothelial growth factor (VEGF) 
signaling, TGF-beta signaling, epidermal growth factor receptor (EGFR) signaling, 
oocyte meiosis, MAPK signaling, GnRH signaling, focal adhesion, axon guidance, 
angiogenesis, calcium signaling and ubiquitin mediated proteolysis were enriched by 
genes potentially targeted by both down and upregulated miRNAs (Figure 4.13). The 
top most enriched pathways of target genes for differentially expressed miRNAs in 
granulosa cells of dominant follicles between day 3 and day 7 of estrous cycle are 
described in appendix 4. 
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Figure 4.13: Graphical illustration of DF follicles and molecular pathways enriched by 
genes targeted by differentially expressed miRNAs between day 3 and day 7 of 
the estrous in granulosa cells of DF. Pathways significantly (P ≤ 0.05) enriched 
by genes potentially targeted only by miRNAs enriched at day 3 are indicated in 
the left box. Pathways enriched by genes potentially targeted by  miRNAs 
increased  at  day 3 and  day 7 of the estrous cycle are listed in the middle box 
and pathways enriched by genes potentially targeted only by miRNAs  increased 
at day 7 of the estrous cycle are described in the right box. DF, dominant follicle, 
Day 3 and Day 7 indicate the stages of the estrous cycle post estrus. 
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 4.8.5 Target prediction and functional annotation of differentially expressed miRNAs 
in granulosa cells of subordinate follicles between day 3 and day 7 of estrous cycle 
 
The gene ontology annotation and pathway analysis were performed to identify 
functional modules of the differentially expressed miRNAs in granulosa cells of SF 
between day 3 and day 7 of estrous cycle. A total of 3326 target genes were identified 
by differentially expressed miRNAs in granulosa cells of SF at day 3 and 7 of estrous 
cycle. Out of total 478 genes were uniquely identified for up regulated miRNAs and 
2713 were uniquely predicted for down regulated miRNAs in granulosa cells of SF 
between day 3 and day 7 of estrous cycle. Moreover, 135 genes were commonly 
identified in granulosa cells of SF between day 3 and day 7 of estrous cycle. Similarly, 
the pathway analysis revealed top pathways that were enriched in differentially 
expressed miRNAs. MAPK signaling pathway, Wnt signaling pathway, signalling by 
NGF, cadherin signaling pathway, integrin signalling pathway, focal adhesion,  axon 
guidance, GnRH signaling pathway, apoptosis, oxytocin receptor mediated signaling 
pathway, insulin signaling pathway and progesterone-mediated oocyte maturation 
ranked among the most enriched pathways targeted by both up regulated and down 
regulated miRNAs (Table 4.9). 
  
Table 4.9: The most enriched pathways of target genes for differentially expressed 
miRNAs between granulosa cells of subordinate follicles at day 3 and day 7 of estrous 
cycle 
 
miRNAs Id Term Genes 
count 
Genes 
mir-1271↓,mir-424-
5p↓ 
MAPK 
signaling 
pathway 
62 MAP2K7, RASA1, PRKCA, 
MAP2K1, NF1, MAPK11, 
CACNA2D2, MAP4K4, 
RPS6KA3, MAP3K14, CACNA1C, 
PLA2G5, DUSP6, FGFR1, 
MAP2K1, GNA12, PPM1A, 
PTPRR 
mir-1271↓,mir-424- Wnt signaling 59 RAC1, NFAT5, FRAT2, NFATC4, 
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5p↓,mir-155↑ pathway CHP, FBXW11, PLCB2, WNT8B, 
FZD4, WNT2B, FZD6,PRICKLE2, 
SFRP4, LRP6, TBL1X, TBL1XR1, 
DVL3, WNT3A, BTRC, SMAD3  
mir-1271↓,mir-424-
5p↓ 
Signalling by 
NGF 
52 TRIB3, FOXO1, FOXO3, 
FOXO4,ATF1, PRKAR2B, 
LINGO1, KRAS, CASP9, 
MAPKAP1,CASP2, FRS2, 
PIK3R1, PPP2R1A, MAP2K1, 
PRKCI, MAPK11,  
mir-1271↓,mir-155↑ Cadherin 
signaling 
pathway 
51 PCDHA6, PCDHA7, PCDHA8, 
PCDHA9, PCDHAC2, PCDHGA2, 
PCDHAC1, CDH22, PCDHA10, 
PCDHA11, PCDHA12, PCDH17,  
PCDHGB4, WNT2B, FZD6, FYN,  
mir-1271↓ Integrin 
signalling 
pathway 
41 ARFGAP1, ENAH, CAV1, GRB2, 
COL3A1, MAP3K3, RAC2, 
ITGB8, ITGAV, RAC1, RHOB, 
COL6A1, SHC1, MAP2K7, 
PIK3R1, MAP2K1,MAPK11, 
NAV3, COL4A6, ITGA6,  
mir-1271↓ Focal adhesion 31 CAV1, XIAP, GRB2, COL3A1, 
DOCK1, PAK2, RAC2, ITGB8, 
ITGAV, RAC1, , COL4A4, 
PRKCA, COL4A2, VAV3, 
MAP2K1, MYLK2, ITGA2, 
COL4A6, CCND1, ITGA6,  
mir-1271↓ Axon guidance 25 ABLIM1, ABLIM2, GNAI3, 
EFNA1, EFNA3, PPP3R1, KRAS, 
PAK2, RAC2, RAC1, NFAT5, 
NTN4, DPYSL5, ARHGEF12, 
NTN1, SEMA6A, SEMA6B,  
mir-1271↓ GnRH 20 ADCY7, MAP2K1, ADCY6, 
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signaling 
pathway 
MAPK11, MMP2, ITPR2, PLCB4, 
MAP3K4, KRAS,  
mir-1271↓  Apoptosis 16 TRAF2, XIAP,PPP3R1, ENDOD1, 
ATM, CASP9, RIPK1, PRKAR1A, 
CHP, MAP3K14,  
mir-1271↓ Oxytocin 
receptor 
mediated 
signaling 
pathway 
14 PRKCA, PRKCI, CACNB1, 
CACNB2, CACNB4, GNG12, 
PRKCE, PLCB4, PLCD3, GNB4, 
VAMP3, CACNA1C, PLCB2, 
GNG7 
mir-424-5p↓ Insulin 
signaling 
pathway 
14 MAP2K1, PRKAB2, PHKA1, 
PDE3B, MKNK1, IRS1, 
PRKAR2A, TSC1, SOS2,  
mir-424-5p↓ Progesterone-
mediated 
oocyte 
maturation 
10 RPS6KA6, RPS6KA3, GNAI3, 
MAP2K1, ADCY5, PDE3B, 
CDC23, AKT3, CDC25A,  
() shows upregulation while () indicate downregulation of differentially expressed miRNAs 
in the granulosa cells of subordinate follicles at day 3 and day 7 of estrous cycle, (P value ˂ 
0.05). 
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            4.9 Novel miRNAs detected in granulosa cells of subordinate and dominant follicles at 
days 3 and 7 of estrous cycle 
 
            In addition to known miRNAs, novel miRNAs were identified from the sequenced data. 
For this, miRDeep2 novel miRNAs prediction tool was used and a sequence was 
considered as novel miRNA when it was not aligned to known miRNA in mirBase 
database. Once the sequence is confirmed as novel miRNA, it was considered as a 
detected when the average read counts in at least two of the biological replicates within 
the same sample group was ≥ 10 read counts. Based on this analysis, a total of 21 
candidate novel miRNAs with base pair length of 17-22 were identified and detected in 
granulosa cells of SF or DF at day 3 or day 7 of the estrous cycle. Out of 21 candidate 
novel miRNAs, 13 candidates were found to be localized in the intergenic region while 
8 of them were found in to be located the intronic part of CEP20,VCPIP1, EIFF31, 
ERRCC3, GNB1L, TEX14 or RPL12 genes (Table 4.10). 
 
Table 4.10: Novel candidate miRNAs detected in granulosa cells of SF or/and DF at day 
3 or/and day 7 of the estrous cycle 
The numbers under SF and DF columns indicate the average read counts for each novel 
candidate miRNAs, Ch = chromosome number           
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            4.10 Validation of deep sequencing data for their expression pattern between the 
granulosa cells of subordinate and dominant follicles at day 3 and day 7 of estrous cycle 
by using qRT-PCR 
 
Although the results obtained by sequencing are believed to be more realistic than other 
methods, we opted to measure the expression level of selected candidate miRNAs using 
the qPCR by assuming that if the results obtained by the higher sensitive method are 
validated by relatively lower sensitive technique, the results obtained could be more 
reliable. Accordingly, the results of the qPCR data showed a similar trend of miRNA 
expression patterns as that of the deep sequencing result. Differences and similarities 
within and between biological replicates of the qPCR data along with the deep 
sequencing data is described in figure 4.14. 
 
 
Figure 4.14: The heatmap showing the qPCR data along with the deep sequencing data 
for randomly selected differentially expressed miRNAs. (A) The expression 
pattern of candidate miRNAs in granulosa cells of SF and DF at day 3 of the 
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estrous cycle. (B) The expression pattern of candidate miRNAs in granulosa 
cells of SF and DF at day 7 of the estrous cycle. (C) The expression pattern of 
candidate miRNAs in granulosa cells of DF at day 3 and day 7 of the estrous 
cycle. The red and green colours indicate high and low expression, respectively. 
NGS and qPCR indicate the results obtained from next generation deep 
sequencing and quantitative real time qPCR, respectively. Numbers, 1, 2 and 3 
on the heatmaps indicate the number of biological replicates used in each sample 
group.                                      
 
           4.11 Expression of differentially expressed miRNAs in companion follicular cells 
(granulosa cells, theca cells, COCs and follicular fluid) of subordinate and dominant 
follicles at day 3 of estrous cycle 
 
The relative abundance of selected candidate miRNAs was determined in theca cells, 
cumulus-oocyte-complex and follicular fluid derived from corresponding SF and DF 
from which the granulosa cells were isolated. Results showed that the (bta-miR-21-3p 
and bta-miR-155) was higher in granulosa cells (GC), theca cells (TC), cumulus oocyte 
complex (COC) and follicular fluid (FF) of the SF compared with the DF counterparts 
(Figure 4.3). Similarly, bta-miR-214, bta-miR-221 and bta-miR21-5p were higher in 
follicular fluid, granulosa cells and theca cells while it was downregulated in cumulus-
oocyte-complex of the SF compared to the DF. Moreover, bta-miR-708 and bta-miR-
222 was higher in granulosa cells and theca cells while lower in   the follicular fluid and 
COCs of SF compared to the dominant follicles. Among these bta-miR-34c was lower 
in all follicular cells except theca cells where as bta-miR-335 was higher in granulosa 
cells while lower in theca and COCs of the subordinate group at day 3 of estrous cycle 
(Figure 4.15). 
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Figure 4.15: Expression pattern of miRNAs in different follicular cells at day 3 of 
estrous cycle (A) bta-miR-21-3p and bta-miR-155 (B) bta-miR-214, bta-miR-
221 and bta-miR21-5p (C) bta-miR-708 and bta-miR-222 (D) bta-miR-34c and 
bta-miR-335   in companion follicular cells of both subordinate and dominant 
follicles using qPCR. The mean expression value of target miRNA was 
normalized against U6 snRNA and 5s rRNAs as an endogenous control. Relative 
expression values were calculated using ΔΔCT method. 
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           4.12 Expression of differentially expressed miRNAs in granulosa and theca cells of 
subordinate and dominant follicles at day 7 of estrous cycle 
 
The relative abundance of selected candidate miRNAs was determined in granulosa 
cells and theca cells from subordinate and dominant follicles. Results showed that ten 
selected miRNAs (bta-miR-409a, bta-miR-195, bta-miR-214, bta-miR-21-5p, bta-miR-
21-3p, bta-miR-222, bta-miR-155, bta-miR-708, bta-miR-221 and bta-miR-365-5p) 
were higher in granulosa and theca cells of SF group with the counter part of DF (Figure 
4.16). While bta-miR-335 was enriched in granulosa cells and lower in theca of the SF 
compared to the DF. Moreover, bta-miR-2487 was lower in granulosa cells and higher 
in theca cells of SF compared to the DF at day 7 of estrous cycle.  
 
 
Figure 4.16: Expression pattern of miRNAS in granulosa and theca cells at day 7 of 
estrous (*P<0.05)  
   
 
Results 
 
94 
4.13 Expression of differentially expressed miRNAs in granulosa cells, theca cells and 
follicular fluid of dominant follicles between day 3 and day 7 of estrous cycle 
 
The relative abundance of selected candidate miRNAs was determined in granulosa 
cells, theca cells and follicular fluid from DF at two different time points of estrous 
cycle. Results showed that nine selected miRNAs (bta-miR-155, bta-miR-221, bta-miR-
222, bta-miR-21-3p, bta-miR-708, bta-miR-21-5p, bta-miR-365-5p and bta miR-214) 
were higher in granulosa cells, theca cells and follicular fluid of DF at day 3 of estrous 
cycle with the counter part of day 7 of estrous cycle (Figure 4.17). While, bta-miR-195 
and bta miR-335 was enriched in theca cells and lower in granulosa cells and follicular 
fluid. Moreover, bta-miR-409a was lower in granulosa cells and theca cells and 
enriched in follicular fluid.  
 
 
 
Figure 4.17: Expression pattern of selected miRNAS in different follicular cells of 
dominant follicles between day 3 and day 7 of estrous cycle (* P<0.05, ** p<0.02). 
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5 Discussion 
 
During follicular development, miRNAs are obligatory to accomplish vital roles in the 
course of folliculogenesis. Follicles are the most commanding units of the ovary. 
Advancement of follicles within the ovary is a dynamic process which follows 
throughout the estrus cycle and comprises recruitment of follicles into the growing pool, 
physiological selection of an ovulatory follicle, and ovulation or regression. Though the 
ultimate fate for utmost of the follicles is atresia, which occurs at any stage but the 
dominant follicle survives and become the part of healthy pool of antral follicles, 
continually developing and eventually ovulation took place. These sequential 
recruitment, selection and growth of the follicles, atresia, ovulation and luteolysis, are 
reoccurring on a cyclical basis within the ovary and resulting in the development of a 
number of ovulatory follicles (Hunter et al. 2004). The capability of an ovulation of a 
selected dominant follicle from the cohort of same sized follicles is an acute transition 
in follicular development and the mechanisms underlying this are not well understood. 
Cattle deliver a very useful animal model for studies on follicular recruitment, selection, 
dominance, atresia and ovulation. Two or three consecutive waves of follicular 
development occur during the bovine estrous cycle, each generating a dominant follicle 
capable of ovulating if luteal regression occurs, whereas its sister subordinate follicles 
upland in growth and then degenerate (Fortune et al. 2001). The granulosa cells play a 
very important role during folliculogenesis. The expansion of oocyte and emerging into 
mature form is accompanied by the proliferation and differentiation of the surrounding 
granulosa cells during folliculogenesis (Eppig 1985). Therefore, it may be potential to 
envisage that the subordinate and dominant follicles have exclusive molecular signals 
that may alter contrarily the bidirectional crosstalk between the oocytes and the 
granulosa cells (Oktem and Urman 2010, Vanderhyden and Macdonald 1998). 
 
Generating miRNA expression profiles in granulosa cells obtained from bovine 
subordinate and dominant follicles at defined developmental stages of estrous cycle 
using the Illumina deep sequencing approach is a prerequisite for a better understanding 
of their physiological involvement in relation to follicle recruitment, selection and 
maturation in the monovular bovine ovary and miRNA-mRNA interactions involved in 
follicular development. So, the major goal of this study was to understand the complete 
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miRNA transcriptome in the context of follicular development. The Illumina deep 
sequencing platform is effective for miRNA detection and is broadly used to produce 
small RNA profiles in numerous organisms. Deep sequencing of the small RNA 
fragment within cells produces a remarkably enormous quantity of data in the form of 
read counts, from which not only the expression levels of microRNAs are determined 
but the discovery of novel miRNAs also took place (Creighton et al. 2009). In the 
present study we investigated enrichment and degradation of miRNAs in granulosa cells 
of subordinate and dominant follicles during the early luteal phase of the bovine estrous 
cycle. For this, we have generated miRNA sequencing data from 12 granulosa samples 
derived from subordinate and dominant follicles both at day 3 and day 7 of the estrous 
cycle using high throughput sequencing technology. Meanwhile the sequencing data 
were generated from three biological replicates of each sample, we believe that the 
analysis has been robust and the findings could be repeatable. Furthermore, a definite 
miRNA was considered to be detected when it was expressed at least in two of the three 
biological replicates of each sample. Therefore, from our data, we detected numerous 
miRNAs in granulosa cells of subordinate and dominant follicles. Remarkably, 244 
miRNAs were commonly detected in all samples irrespective of the follicle stage and 
days of the estrous cycle (Figure 4.2). For example, bta-miR-10b, bta-miR-26a, bta-
miR-99b, bta-miR-27b, let-7 families (bta-let-7f, bta-let-7a-5p and bta-let-7i), bta-miR-
92a, bta-miR-191, bta-miR-125a, bta-miR-143, bta-miR-30d and  bta-miR-30a-5p were 
among the top 15 abundantly expressed miRNAs in both of the follicular groups and at 
each time point of the estrous cycle (Table 4.2). Certainly, the function of these 
miRNAs during folliculogenesis is still narrow, but the let-7 family members are 
thought to be involved in cell proliferation by targeting multiple genes (Johnson et al. 
2007). Also, the let-7 miRNA family expressed abundantly in ovary and oocyte of 
bovine in several studies by cloning and deep sequencing techniques (Huang et al. 2011, 
Miles et al. 2012, Tesfaye et al. 2009, Tripurani et al. 2010), as well as in murine 
ovaries and testis (Reid et al. 2008).  Similarly, miR-10b is stated to be involved in cell 
proliferation and growth by targeting the TGF-beta signaling pathway (Han et al. 2014). 
On the other hand bta-miR-143 is reported in the mouse ovary whose expression is 
insignificant in primordial follicles, but became readily detectable in the granulosa cells 
of primary, secondary and antral follicles. Thus by defining that the expression of bta-
mir-143 is under the negative control of FSH which suggests that FSH regulates 
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folliculogenesis by a nowel pathway of miRNAs (Yao et al. 2009). Also, bta-miR-143 is 
highly expressed in the bovine testis and ovary and targets genes which participate in 
pathways associated with reproduction (Huang et al. 2011). Furthermore, miR-148a, 
miR-26a and miR-30d expression pattern has been documented in mouse and bovine 
gonads (Hossain et al. 2009, Mishima et al. 2008, Tripurani et al. 2010) . Moreover, 
miR-26a is stated to have anti-apoptotic effects in many cancers (Garzon et al. 2006, Lu 
et al. 2005, Saito and Jones 2006, Zhang et al. 2011). Similarly, mir-99b being a 
positive modulator of the TGF-β pathway regulates cell proliferation and also perform 
key roles in cancer development and progression, as well as in embryonic growth 
(Turcatel et al. 2012). The abundantly expressed miRNAs in SF and DF at different 
time points of estrous indicating their potential role in the follicular growth in the 
bovine and they may have important roles in female reproductive physiology. 
Therefore, the expression of these miRNAs in all cases could indicate their 
housekeeping cellular roles (Tripurani et al. 2010) during follicular recruitment, 
selection, dominance or follicular atresia. 
  
5.1 At day 3 of the estrous cycle, the granulosa cells of subordinate follicle (SF) 
exhibited triggering of miRNAs equated to dominant follicles (DF) 
  
Analyzing the spatiotemporal expression patterns of miRNAs would provide valuable 
information for their physiological functions (Wang et al. 2007). Differential expression 
of definite miRNAs at a certain stage and size in the somatic cells of bovine estrous 
cycle may deliver valued perception into their impending role in the development of a 
follicle for recruitment, selection, dominance, atresia and ovulation. Even though, 244 
miRNAs were commonly detected in all sample groups, it does not necessary entail that 
they were likewise expressed. Therefore, to distinguish significant differences in the 
expression of miRNAs during the early luteal stage of the bovine estrous cycle, a 
differential miRNA expression analysis was directed between the granulosa cells of SF 
and DF at day 3 of the estrous cycle. On this day of the cycle, 14 out of 16 differentially 
expressed miRNAs were triggered in granulosa cells of SF compared to DF equivalents 
(Figure 4.3). Certainly, it is questionable to fully apprehend why the majority of the 
differentially expressed miRNAs were triggered in SF compared to DF. However, 
similar studies in gene expression at day 3.5 of estrous cycle showed that 11 of the 16 
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genes measured by qPCR were found to be activated in granulosa cells of SF compared 
to DF (Evans et al. 2004). In fact, the activation of miRNAs in granulosa cells of SF at 
day 3 of the estrous cycle could partly be linked to the repression of several genes 
associated with masking of the estrogen and progesterone production in granulosa cells. 
On this regard, (Evans and Fortune 1997) reported that at day 3 of the follicular wave, 
the granulosa cells of SF secreted lower estradiol levels and exhibited reduced level of 
FSH receptor expression compared to the granulosa cells of the DF. Thus, the reduction 
of estradiol and follicle stimulating hormone receptor (FSH) gene expression may also 
be associated with downregulation of several arrays of genes potentially targeted by 
activated miRNAs. With the connection of this, the current study specified a 2.3 to 16 
fold change increase in the expression of 14 miRNAs in SF group. Among these, miR-
449a and mir-449c were activated by 16 and 10.6 folds, respectively while miR-221 and 
miR-222 were increased by 3.5 and 6.5 folds, respectively. Similarly, the miR-21 family 
(bta-miR-21-3p and bta-miR-5p) are enriched in granulosa cells of subordinate follicle 
with 5 and 3.8-fold, respectively compared to the dominant follicle. Despite of these 
upregulated, two miRNAs (miR-183, miR-34c) were found to be downregulated. 
Although the role of these miRNAs in folliculogenesis needs to be expounded, the 
higher expression of miR-449a can be associated with growth arrests and apoptosis 
(Bou Kheir et al. 2011, Noonan et al. 2009, Noonan et al. 2010). Similarly, 
overexpression of miR-221/222 is suggested to affect the growth potential of cells by 
inducing a G1 to S shift in the cell cycle (Galardi et al. 2007). Moreover, an increased 
level of miR-222 could affect the cell motility by influencing the AKT signalling 
pathway (Wong et al. 2010) and its involvement in human endometrial cell 
differentiation has been described (Qian et al. 2009). On the other side, miR-183 which 
was down regulated in the SF group is believed to have an anti-apoptotic role and it can 
induce cell survival (Galardi et al. 2007, Zhang et al. 2010). This may propose while the 
triggering of miRNAs could be linked with cell arrest, its suppression might be related 
with cell proliferation and survival in SF groups. Gene ontology annotation and pathway 
analyses are capable to acquire an enhanced understanding from the cellular 
components, molecular functions and biological processes of target genes (Ji et al. 
2012). The analysis of GO and KEGG, PANTHER and REACTOME analysis revealed 
that the theoretical target genes appear to be involved in a wide variety of biological 
processes. Ranging from genes encoding transcription factors involved in transcription, 
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regulation to genes involved in metabolism, genes regulating cell-cell adhesion, genes 
involved in programmed cell death, genes regulating biological adhesion and genes 
encoding cell fate commitment (Table 4.7). Apart from this, genes targeted by those 
miRNAs were found to be involved in main canonical pathways including Wnt 
signaling, TGF beta signaling, notch signaling, MAPK signaling, axon guidance, 
apoptosis, cadherin signaling and gap junction (Table 4.8). These results directed that 
these miRNAs might be involved in physiology of follicular development, and function 
in granulosa cell proliferation, apoptosis, and differentiation. Even though a bulky 
number of target gene candidates were predicted using bioinformatics tools, validation 
of the relationship between miRNAs and mRNA transcripts need further more 
biological experimental confirmations to exhibit downregulation of those pathways 
which are essential for follicular development in the granulosa cells of subordinate 
follicles. 
 
5.2 The granulosa cells in subordinate follicle revealed a noticeable miRNA expression 
dysregulation at day 7 of the estrous cycle  
 
Selection of a dominant follicle and productive hormonal influence of follicular wave 
growth is reliant on the understanding of the gonadotrophin provisions of independent 
wave follicles. The mechanism by which definite number of dominant follicles in 
mammals is designated from a morphologically alike cohort of follicles, while the 
remaining follicles of the cohort regress is not fully understood. SF and DF progress in 
the same endocrine environment, but it is probable that the selection process involves 
the differential expression of factors that mediate the actions of FSH and IGF-I (Ryan et 
al. 2007). After selection, the dominant follicle increased in  diameter, higher follicular 
fluid concentrations of estradiol, insulin-like growth factor-binding protein (IGFBP) 
protease activity and free IGF, and lower IGFBP-4 concentrations (Fortune et al. 2004, 
Mihm et al. 2000). This phenomenon is synchronized by upregulation and 
downregulation of numerous arrays of genes which may have role in folliculogenesis. 
Thus observing into miRNAs associated with posttranscriptional regulation of genes in 
subordinate and dominant follicle during this period will improve the knowledge of 
molecular mechanism of folliculogenesis. In line to this, the current results discovered 
differences in the miRNA expression between the granulosa of SF and DF to be obvious 
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at day 7 than day 3 of the estrous cycle  (Table 4.8, Figures 4.3, 4.12), intending that SF 
and DF could be molecularly distinct as the luteal phase of the estrous cycle progresses. 
This can be also explained by the fact that unlike to day 7, follicles may not reach the 
size of dominant at day 3 of the estrous cycle to exhibit remarkable difference between 
the two follicle sizes (subordinate and dominant) at that day of the estrous cycle. It is 
revealed that the greatest shifts in miRNA expression occur at dominance just after 
selection of dominant follicles. Interestingly, at day 7 of the estrous cycles, 108  
differentially miRNAs are identified in granulosa cells of SF and DF follicles, out of 
which 51 miRNAs including bta-miR-2332, bta-miR-409a, bta-miR-2446, bta-miR-383, 
bta-miR-130a and bta-miR-148b were up regulated in the granulosa cells of SF while 57 
miRNAs including bta-miR-184, bta-miR-365-5p, bta-miR-2487, bta-miR-143, bta-
miR-185 and bta-miR-29  were found down regulated in the granulosa cells of 
subordinate follicles (Figure 4.4). Interestingly, at day 7 of the estrous cycles, 12 
miRNA families were co-activated or co-repressed in SF compared to DF groups (Table 
4.3). For example miR-199 family members namely, miR-199a-3p, miR-199a-5p, -miR-
199b and miR-199c were repressed in granulosa cells of SF by a same regulation 
direction (FC=4-7.5) indicating that these miRNAs belonging to the same family could 
have a similar role during folliculogenesis. Among the miR-199 family members, higher 
expression of miR-199a-3p was found be associated with cell proliferation by imposing 
G1 cell cycle arrest (Fornari et al. 2010, Wang et al. 2012a). Similarly, miR-199a-5p 
along with miR-30d and miR-181a is believed to induce apoptosis by targeting the 
GRP78 gene (Su et al. 2013). On the other hand, increased expression of miR-199a 
significantly inhibited the ability of TGF-beta cell growth arrest and apoptosis in vitro 
(Zhang et al. 2012) suggesting the potential involvement of miR-199 family members in 
cellular development. Similar to miR-199 families, the miR-181 family members 
namely, miR-181a,-miR-181b, miR-181c, miR-181d were also downregulated in 
granulosa cells of SF. Previous study showed that miR-181a and miR-181b were found 
to be overexpressed in more aggressive breast cancers cells suggesting their anti-
apoptotic role (Bisso et al. 2013) and miR-181a can influence cellular proliferation by 
targeting activin receptor IIA (Actr2a) (Zhang et al. 2013). In the current study, the 
bioinformatic analysis showed that Actr2a gene was found to be potentially targeted by 
all these miR-181 family members. Reduced level of miR-181a expression was found to 
result in reduced glucose deprivation induced apoptosis, mitochondrial dysfunction, and 
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loss of mitochondrial membrane potential in astrocyte cells (Ouyang et al. 2012) and 
implicated as a predictive biomarker for breast cancer metastasis and patient survival 
(Taylor et al. 2013). The other family member of miR-181, namely, miR-181b is also 
associated with cell proliferation and inhibited cell apoptosis in cervical cancer cells 
(Yang et al. 2014). Thus, alteration in the expression of miR-181 family may result in 
dysregulation of programmed cell death and cell proliferation in granulosa cells of the 
subordinate follicles. In a study it is reported that miR-195 was found to be repressed in 
colorectal cancer tissues compared to matched normal mucosa. This miR-195 is 
believed to target Bcl-2 and hence apply its pro-apoptotic function when physiologically 
regulated (Liu et al. 2010b). In addition, miR-202 was verified to be connected with 
reproductive hormone secretion (Bannister et al. 2011, Sirotkin et al. 2009). Similarly, a 
huge number of studies have shown that miR-143 (miR-143-3p) might be involved in 
mammalian reproductive activities (Hossain et al. 2009, Huang et al. 2011, Landgraf et 
al. 2007, Li et al. 2011, Mishima et al. 2008). A study reported that miR-21 was 
significantly up-regulated in murine granulosa cells prior and 4 h after the human 
chorionic gonadotropin (hCG)/LH surge and that it plays a role in stopping apoptosis in 
periovulatory granulosa cells as they passage to luteal cells. Further more, in-vivo 
experiments demonstrated that there was significant reduction in ovulation rate of 
miR21-LNA inhibitor treated ovaries compared to the controls. These results propose 
that miRNA 21 plays an important role in post transcriptionally regulating transcripts 
that are involved in preventing apoptosis in LH-induced terminally differentiating 
granulosa cells (Carletti et al. 2010, Fiedler et al. 2008). Other studies have revealed that 
miR-21 was repressed by estradiol in MCF7 cancer cells (Maillot et al. 2009, 
Wickramasinghe et al. 2009). In the present study, the miR-21 family (bta-miR-21-3p 
and bta-miR-21-5p) are enriched in granulosa cells of dominant follicle with 8 and 6.9-
fold, respectively compared to the subordinate follicle, suggesting that miR-21 family 
plays an important role in development of folliculogenesis. Similarly in the current 
study, bta-miR-23a was regressed in the granulosa cells of SF with the counterpart DF. 
The bioinformatics analysis showed that pro-apoptotic gene casp-7 and antiapoptotic 
gene XIAP was found to be potentially targeted by bta-miR-23a. These findings suggest 
that mir-23a may play a role in the regulation of granulosa cell apoptosis. The mir-23a 
has been shown to play vital roles in numerous processes during normal and pathologic 
states and is firmly related to the cell cycle, proliferation, differentiation, apoptosis, 
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hematopoiesis, and cardiac hypertrophy (Chhabra et al. 2010, Huang et al. 2008). 
Studies have demonstrated that the mir-23a functions as a growth-promoting and 
antiapoptotic factor targeting the Smad pathway in hepatocellular carcinoma cells 
(Huang et al. 2008). On the other hand, a study proved that the mir-23a could induce 
caspase-dependent and caspase-independent apoptosis in human embryonic kidney cells 
(Chhabra et al. 2010). The pro-apoptotic and antiapoptotic nature of the mir-23a 
suggests that this may play diverse roles under different physiological and pathological 
conditions. It is of keen interest to recognize the function of mir-23a in granulosa cells 
and follicular atresia. 
  
In order to further explore the function of the differentially expressed miRNAs at day 7 
of the estrous cycle between granulosa cells of SF and DF, GO analysis and pathway 
annotation were used to evaluate their target gene pools. The gene ontology annotation 
and pathway analysis were performed to identify functional modules of the 
differentially expressed miRNAs at day 7 of the estrous cycle between granulosa cells 
of SF and DF. The results of GO term analysis from predicted miRNA target genes 
showed further significant biological processes classifications. In this study GO  
annotation enrichment results illustrates that these miRNAs are mostly related to the 
regulation of transcription, regulation of RNA metabolic process, regulation of 
transcription, DNA-dependent, regulation of cell proliferation, cell adhesion, 
posttranscriptional regulation of gene expression, regulation of apoptosis and apoptosis 
(Fig 4.9). The KEGG, PANTHER and REACTOME analysis showed that survival 
pathway (TGF-beta), significantly proliferative (ErbB, MAPK, Wnt, cell cycle) and 
apoptotic (apoptosis) signaling pathways, were utmost abundant among the significantly 
enriched ones (Table 4.11), which was in agreement with the GO analysis. Further 
investigation, based on the computational predictions revealed that cyclin D3 (CCND3) 
was defined as a potential target of bta-miR-13a, bta-miR-15b, bta-miR-195, bta-miR-
497, bta-miR-592 and bta-miR-409a, which are downregulated in DF group, and that 
may induce cell cycle arrest in the granulosa cells of DF. This statement is in agreement 
with a study where its mentioned that CCND3 is expressed in nearly all proliferating 
cells and could promote the cell cycle (Lin et al. 2001). One of the study reported that 
miR-16 family could induce cell cycle arrest by targeting CCND3, CCNE1 and cyclin-
dependent kinase (Cdk)-6 (Liu et al. 2008). The cell cycle is controlled by a family of 
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the CDKs and their stimulating partners (cyclins). The G1/S phase transition is 
controlled mainly by D-type cyclins (D1, D2 or D3) in complex with CDK4/CDK6 and 
E-type cyclins (E1 or E2) in complex with CDK2. These complexes collaborate in 
phosphorylating and avoiding Rb binding to E2F, thus triggering E2F-mediated 
transcription and driving cells from G1 into S phase (Grillo et al. 2006). CCND3 is 
communicated widely, signifying that it has numerous diverse cell functions. CCND3 
had been specified to be involved in the advancement of cell growth by a number of 
research groups (Faast et al. 2004, Lin et al. 2001, Liu et al. 2008, Lu et al. 2011, Wang 
et al. 2011). Another study revealed that the downregulated miR-138 can regulate 
CCND3 and function as a tumor suppressor in hepatocellular carcinoma (HCC), thus by 
showing a useful therapeutic agent for miRNA-based HCC therapy (Wang et al. 2012b). 
On the basis of these current findings lead to postulate that these miRNAs are involved 
in the degenatration process of SF by targeting the CCND3 gene which is involved in 
cell cycle. Moreover, the functional identity recognized by diverse computational 
methods proposed that miRNAs may have regulatory effects on proliferation and 
apoptosis of granulosa cells by affecting the signaling pathways as mentioned above. 
Similarly, previous study on the gene expression analysis of small ( ≤ 5 mm) and large ( 
> 12 mm) follicles indicated altered expression of genes involving in TGF beta 
signaling, axonal guidance and protein trafficking (Hatzirodos et al. 2014b). Moreover, 
the gene expression pattern of granulosa cells from small healthy (3.1 ± 0.2 mm 
diameter) and atretic (4.2 ± 0.5 mm) bovine follicles also indicated the TGF-beta 
signaling and apoptosis pathways to be affected in atretic follicles (Hatzirodos et al. 
2014a). Indeed, the role of TGF-beta in the bidirectional crosstalk between the 
granulosa cells and the oocyte has been reviewed (Knight and Glister 2003, Knight and 
Glister 2006). In addition to the common pathways enriched by genes targeted by 
miRNAs increased in SF or DF, there were also unique molecular pathways enriched by 
genes targeted by miRNAs only enriched in the granulosa cell of DF (Figure 4.10). For 
instance, the miRNA-gene interaction and pathway analysis showed that the target 
genes of by miR-142-5p, namely, ENAH, ROBO1, Rho GTPases (RHOA, RHOQ), 
NEO1 were found to be involved in axon guidance mediated by Slit/Robo. Among 
these, ROBO1 is one of the four Roundabout (Robo) which is believed to be interacting 
with the Slits (Huminiecki et al. 2002) and the Slit/Robo signaling can also be 
interacting with Rho GTPase activating proteins (Wong et al. 2001). The guidance 
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mediated by Slit/Robo is believed to involve in tissue growth, development, and 
remodeling (Dickinson and Duncan 2010). In addition, the Slit/Robo signaling induces 
cell adhesion, cell proliferation and survival (Dickinson and Duncan 2010). Given the 
gene expression and/or translation repression role of miRNAs, increased level of miR-
142-5p in granulosa cells of DF may suggest downregulation of axon guidance by 
Slit/Robo pathway. Reducing the Slit/Robo activity may increase cell migration and 
reduce apoptosis activity (Dickinson et al. 2008). Indeed, the anti-apoptosis role of miR-
142-5p has been also described by (Saito et al. 2012). This may suggest that miR-142-
5p could be an important candidate for granulosa cell survival by targeting genes 
involving in guidance by Slit/Robo. On the other hand, the gene targeted by miRNAs 
enriched only in SF groups were found to be involved in O-glaycan biosynthesis, N-
glycan biosynthesis, the metabolism pathways (D-glutamine and D-glutamate, vitamins 
and cofactors, phenyl alanine, biosynthesis of unsaturated fatty acids). The N-glycan 
generated by N acetylglucosaminyltransferase is encoded by mannosyl (alpha-1, 3) 
glycoprotein beta-1, 2-N acetylglucosaminyltransferase (Mgat1) (Shi et al. 2004). Our 
miRNA- target-gene analysis indicated 12 genes including Mgat1and Mgat2 to be the 
targets of miR-592 and miR-30e-5p, which were upregulated in granulosa cells of SF 
group. Previous studies,  (Shi et al. 2004, Williams and Stanley 2009) have shown that 
targeted deletion of oocyte-specific Mgat1 gene to be associated with reduced cumulus 
cell number around the oocytes and reduction in ovulation rates. This may suggest 
aberrant expression of N-glycans could lead to abnormal folliculogenesis. In addition, 
lack of complex N- and O-glycans in oocytes may have a negative consequence on 
further embryonic development (Grasa et al. 2012). Therefore, increased level of 
miRNAs targeting genes involving in the N- and O-glycan biosynthesis in granulosa 
cells of SF groups may indicate a negative effect on follicle development in those 
follicular stages during the early luteal phase of the estrous cycle. 
 
5.3 The temporal miRNA expression dynamics is bulging in granulosa cells of dominant 
follicle with the counterpart subordinate follicle at day 3 and day 7 of the estrous cycle 
 
After identification of the differential expressed miRNAs between SF and DF, next 
attempt took place to recognize the temporal dynamic miRNA enrichment and 
degradation in granulosa cells within SF vs SF and DF vs DF at day 3 and day 7 of 
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estrous cycle.  Results have displayed that the temporal miRNA expression profile 
changes between day 3 and day 7 of the estrous was appreciable in DF groups by which 
the expression profile of 131 miRNAs was found to be altered between day 3 and 7 of 
the estrous cycle. Conversely, in SF groups, only 5 miRNAs were differentially 
regulated between these two time points. This may conclude that follicles (subordinate 
and dominant) present during the early luteal phase act like nonovulatory follicles 
present during the follicular phase and become atretic. This idea of regression and 
follicular atresia could be associated to the influence of progesterone (Taylor and 
Rajamahendran 1991), and the decline in FSH commencement after day 2 of the estrous 
cycle which brings differential alterations in FSH dependent growth factors and 
hormones within the cohort of preselected follicles, which simultaneously inducing 
growth and boosting estradiol producing capacity of the DF and atresia of subordinate 
follicles (Mihm et al. 1997). The granulosa cells of DF displayed noticeable miRNA 
transcriptional activity variation as compared to SF in the current results (Figure 4.6). 
This may propose the presence of dynamic molecular shift in the follicles that could 
progress in size and to be entitled for dominance. The biological reason for this could be 
the element that bovine follicles are not adequate to attain the dominant stage at day 3 
unlike to day 7 when the follicle can reach dominance stage even though they are not 
ovulated. Furthermore, as the estrous cycle progresses from day 3 to day 7, the follicles 
increase in size, the production of estradiol also elevates. The upsurge in estradiol 
concentrations in performance with inhibin are the main endocrine signals that suppress 
FSH concentrations from the anterior pituitary gland via negative feedback reducing 
FSH to basal concentrations (Ginther 2000, Ginther et al. 2000b, Sunderland et al. 
1994). However, the increment of estradiol secretion usually does not occur more than 3 
or 4 days and thus due to high levels of progesterone, the DF becomes atretic and 
estradiol production drops on day 6 of the estrous cycle (Mihm et al. 2002). Centered on 
this perception, the considerations were made to feature into the miRNAs whether their 
shift is associated with estradiol production. In fact, during folliculogenesis, 
steroidogenesis is one of crucial process that happened in the granulosa cells. For this, 
dehydroepiandrosterone (DHEA) is produced from pregnenolone, androstenedione from 
progesterone by cytochrome p450 enzyme called CYP17A1 occurs in theca cells. On 
the other hand, the conversion of androstenedione into estrone and conversion of 
testosterone into estradiol occurs in granulosa cells by aromatase gene (Craig et al. 
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2011). Agreeing to (Xu et al. 2011), aromatase gene (CYP19A1) is a validated target of 
miR-378. However, this miRNA was found to be increase in granulosa cells of DF at 
day 7 compared to day 3 of the estrous cycle suggesting a decrease in the level of 
aromatase genes expression. Similarly, the miRNAs which were found to be associated 
with inhibitory effect on estradiol production (Sirotkin et al., 2009) namely, miR-96b, 
miR-146, miR-28, miR-29a, miR-184, miR-32, miR-34a, miR-129, miR-132, miR-
133a, and miR-150 were found to be increased at day 7 of the estrous cycle. Others, 
miR-24, miR-122, miR-145, miR-182, miR-143 and miR-150 which increased 
progesterone level in human granulosa cells after they were over expressed (Sirotkin et 
al. 2009) were found to be increased at day 7 of the estrous cycle. Other miRNAs which 
were dysregulated in DF between day 7 and day 3 of the estrous cycle namely miR-21, 
miR-132, miR-191 and miR-99b were also exhibited temporally expression alteration in 
mural granulosa cells collected from mice treated with eCG for 46 h followed by 
injection of hCG  (Fiedler et al. 2008). This may suggesting some miRNAs whose 
expression was suppressed or enriched in granulosa cells of DF between day 3 and 7 of 
the estrous may involve in steroidogenesis or they may have some role in acquisition of 
follicular maturation. Recruitment and selection, the processes that give rise to the DF, 
and dominance, the physiological state of the mature DF, are important areas of basic 
research. Results of these basic studies on early luteal phase of follicular development 
need further validation to solve the problems in farm animal reproduction.  
 
In conclusion, this thesis reported comprehensive understandings into the miRNA 
enrichment and degradation in the subordinate and dominant follicle during the luteal 
phase of the estrous cycle using high-throughput miRNA sequencing data generated 
from granulosa cells obtained from subordinate and dominant follicles at day 3 and 7 of 
the estrous cycle. In addition to novel miRNAs, the study identified large set of 
miRNAs which are found to be differentially expressed in granulosa cells of SF and DF 
and suggested to play a diverse role in various physiological processes associated with 
the two follicle types during the course of folliculogenesis. Further detail functional 
analysis of miRNAs is required to precisely determine the regulatory role of those 
noncoding small RNAs in bovine follicular development.  
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6 Summary 
 
Follicular development is the outcome of multifarious hormonal and biochemical 
interactions that could be triggered or deactivated within the follicular environment in a 
spatiotemporal fashion. Mammalian ovaries consist of follicles as elementary functional 
units, and each follicle comprises of an oocyte enclosed by one or multiple layers of 
somatic granulosa cells and theca cells. The layer and number of granulosa cells may 
differ reliant on the size and phase of follicular development. It has been reported that, 
bidirectional crosstalk between the gonadal cell (oocyte) and the somatic cell type 
(granulosa and theca) affects the hormonal production and as well as the expression of 
genes associated with follicular development. The significance and involvement of 
miRNAs in the ovarian function, and follicular development has been described by 
several authors, but their existence, richness and sequential expression in the 
subordinate and dominant follicles during the bovine luteal phase of the estrous cycle 
needs to be revealed. In the recent years, next generation sequencing (NGS) 
technologies has enormously boosted the profiling of miRNA expression levels as well 
as identification of novel miRNA genes. So far, the involvement of miRNAs in specific 
ovarian somatic cell type was not investigated using high-throughput miRNA profile 
analysis. Therefore, this study was aimed to investigate the availability and abundance 
of miRNAs in bovine granulosa cells derived from subordinate and dominant follicles 
during early luteal phase of estrous cycle in the process of bovine follicular 
development. In addition, we predicted the potential targets of the differential expressed 
miRNAs in either of the cell type or at each time points and their potential involvement 
in biological pathways. In this study, 13 Simmental heifers were synchronized using 
optimized protocol and heifers were slaughterd at day 3 and day 7 of estrous cycle to 
collect ovarian samples. 
  
At day 3 of the estrous cycle, follicles with follicular diameter of ≤ 6 mm (n = 43) were 
categorized as subordinate follicle (SF) while follicles with a diameter of 8-10 mm (n = 
9) were considered as dominant follicle (DF). On the other hand, at day 7 of the estrous 
cycle, follicles with a diameter of ≤ 8 mm (n = 58) were considered as SF and those 
with 9-13 mm diameter (n = 3) were categorized as DF. The purity of granulosa cells 
was confirmed using cell-specific gene markers and showed that the contamination of 
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theca to granulosa cells was minimum. The subordinate and dominant follicles with the 
corresponding granulosa, theca, COCs and follicular fluid were then retrieved from the 
ovaries of each animal. The granulosa cells were subjected to miRNA-enriched total 
RNA isolation using the miRNeasy
®
 mini kit (Qiagen GmbH, Hilden, Germany). The 
RNA integrity and quality was determined using Agilent 2100 Bioanalyzer (Agilent 
Technologies Inc, CA, USA) and Nanodrop 8000 Spectrophotometer (Thermo Fisher 
Scientific Inc, DE, USA), respectively. Total RNAs from all groups were subjected to 
construction of tagged miRNA sequencing libraries (22 to 30 nt) according to Illumina 
Small RNA Sample Preparation protocol by GATC BioTech AG (Konstanz, Germany). 
The raw data from the deep sequencing was further analyzed and processed using 
miRDeep software package www.mdc-berlin.de/rajewsky/miRDeep. The miRNAs were 
considered to be differentially expressed when their fold change difference is ≥ 2, p-
value ≤ 0.05 and false discovery rate is ≤ 0.1. 
 
The detection analysis revealed that, at day 3 of the estrous cycle 291 and 318 miRNAs 
were detected in granulosa cells of SF and DF, respectively. Similar analysis showed 
that, at day 7, a total of 314 and 316 miRNAs were detected in granulosa cells derived 
from SF and DF, respectively. A total of 244 detected miRNAs were common to all 
follicle groups. Moreover, candidate miRNAs were validated for their expression in 
independent granulosa, theca, COCs and follicular fluid samples isolated from the two 
follicular catagories in both day 3 and day 7 of the estrous cycle.  
 
We used state of the art NGS technology to explore the expression pattern of miRNAs 
in the granulosa cells of SF and DF at day 3 and day 7 of the estrous cycle. Accordingly, 
we found 16 miRNAs including bta-miR-449a, bta-miR-449c, bta-miR-212, bta-miR-
21-3p, bta-miR-183 and bta-mir-34c were differentially expressed in granuolosa cell of 
subordinated follicle groups. Similarly, at day 7 of the estrous cycle, a total of 108 
miRNAs including bta-mir-409a, bta-miR-2446, and bta-mir-383 were altered in their 
expression in granulosa cells of SF compared to DF. Interestingly, 9 miRNAs including 
bta-miR-21-3p, bta-miR-708, and bta-miR-335 were differentially expressed at both day 
3 and 7 of the estrous cycle. Among these, bta-miR-335 showed similar expression 
pattern at day 3 and day 7 while other 8 miRNAs showed opposite pattern of 
expression. Expression analysis within the groups (day 3 SF vs day 7 SF and day 3 DF 
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vs day 7 DF) revealed that, 5 miRNAs including bta-miR-100 and bta-miR-155 to be 
differentially expressed at day 3 SF vs. day 7 SF group. On the other hand, a total of 131 
miRNAs including bta-miR-409a, bta-miR-196a, bta-miR-505, bta-miR-16b, bta-miR-
99a-5p, bta-miR-32, bta-miR-132, bta-miR-129 and bta-miR-346 to be differentially 
expressed at day 3 DF vs day 7 DF group. 
 
To further understand physiological functions and biological processes of the 
differentially expressed miRNAs between granulosa cells of the subordinate and 
dominant follicles in the follicular development, in silico analysis of the candidate 
miRNAs was performed in order to identify the potential target genes. The gene 
ontological analysis indicated that the majority of the differentially expressed miRNAs 
in granulosa cells of subordinate and dominant follicles at day 3 and day 7 of the estrous 
cycle were found to be involved in regulation of programmed cell death and regulation 
of cell proliferation. Furthermore, the pathway analysis results at day 3 of estrous cycle 
showed that cadherin signaling, apoptosis, ErbB signaling, MAPK signaling, Ras, 
signaling by BMP, 5HT1 type receptor mediated signaling and adipocytokine signaling 
pathways were enriched by genes potentially targeted by miRNAs enriched in granulosa 
cells of SF, whereas the focal adhesion, gap junction, histamine H1 receptor mediated 
signaling pathway and angiotensin II-stimulated signaling through G proteins and beta 
arrestin were enriched by genes potentially targeted by miRNAs enriched in granulosa 
cells of DF. Interestingly, Wnt signaling pathway, TGF-beta signaling pathway, 
signaling by NGF, oxytocin receptor mediated signalin pathway, notch signaling 
pathway, axon guidance and adherens junction were enriched by genes targeted by 
miRNAs either enriched or repressed in granulosa cells of SF. Similar analysis for day 7 
of estrous cycle  showed that metabolic pathways (panthothenate and CoA biosynthesis, 
O-glycan and N-glycan biosynthesis, metabolism of vitamins and cofactors, D-
glutamine and glutamate metabolism, biosynthesis of unsaturated fatty acids), Jak-STAT 
and cell cycle pathways were enriched by genes potentially targeted by miRNAs 
enriched in granulosa cells of SF, whereas the Ras signaling pathway, lipids, 
lipoproteins, cysteine, methionine and carbohydrates metabolic pathways were enriched 
by genes potentially targeted by miRNAs enriched in granulosa cells of DF. 
Interestingly, axon guidance, Wnt signaling pathway, GnRH signaling pathway, 
MAPK-signaling, oocyte meiosis, TGF-beta signaling pathway and focal adhesion were 
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enriched by genes targeted by miRNAs either enriched or repressed in granulosa cells of 
SF. Although, miRNA expression profile shows very little similarity between groups, 
interestingly in silico predicted biological pathways were similar between groups. In 
addition to known miRNAs, novel miRNAs were identified from the sequenced data by 
using miRDeep2 novel miRNAs prediction tool. A total of 21 candidate novel miRNAs 
with base pair length of 17-22 nucleotides were identified and detected in granulosa 
cells of SF or DF at day 3 or day 7 of the estrous cycle. 
  
In the present study, we provided detailed insights into the miRNA enrichment and 
degradation during the luteal phase of the estrous cycle using high-throughput miRNA 
sequencing data generated from granulosa cells obtained from subordinate and 
dominant follicles at day 3 and 7 of the estrous cycle. This study highlights the miRNA 
expression patterns of granulosa cells in subordinate and dominant follicles that could 
be allied with follicular recruitment, selection and dominance during the early luteal 
phase of the bovine estrous cycle. The functional identity by different bioinformatics 
methods suggested  that the differentially expressed miRNAs at specific time points and 
groups may have regulatory effects on proliferation and apoptosis of granulosa cells by 
affecting the signaling patways. Together these observations exposed the importance of 
miRNAs in the regulation of follicular development during the bovine estrous cycle. 
However, further functional study based on this data is required to fully understand the 
role of each of the differentially expressed miRNAs during folliculogenesis. 
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7 Zusammenfassung 
 
Die follikuläre Entwicklung ist das Ergebnis von vielfältigen hormonellen und 
biochemischen Interaktionen, die innerhalb der follikulären Umwelt in einer spatio-
temporalen Form ausgelöst oder deaktiviert werden können. Die Eierstöcke von 
Säugetieren bestehen aus Follikel als elementare Funktionseinheiten und jeder Follikel 
besteht aus einer Eizelle die durch eine oder mehrere Schichten von somatischen 
Granulosa- und Thekazellen eingeschlossen wird. Die Schicht und Anzahl der 
Granulosazellen können abhängig von der Größe und der Phase der Follikelreifung sein. 
Es wurde berichtet, dass sich eine bidirektionale Kommunikation zwischen der 
Keimdrüsenzelle (Eizelle) und den somatischen Zelltyp (Granulosa-und Theka) auf die 
Hormonproduktion und somit auf die Expression von Genen, die mit der follikulären 
Entwicklung verbunden sind, auswirkt. Es wurde bereits von mehreren Autoren die 
Bedeutung und die Beteiligung von miRNAs an der Funktion des Eierstocks und der 
Follikelreifung beschrieben. Jedoch ihre Existenz, ihre Fülle Reichhaltigkeit und die 
sequentielle Expression in den untergeordneten und dominanten Follikel während der 
bovinen Lutealphase des Östruszyklus muss noch aufgeklärt werden. In den letzten 
Jahren haben die Next Generation Sequencing (NGS)-Technologien zu einem enormen 
Anstieg in der Erstellung von miRNA-Expressionsprofilen sowie zur Identifizierung 
neuer miRNA-Gene beigetragen. Bisher wurde die Beteiligung von miRNAs in 
bestimmten Eierstockzelltyp mittels Hochdurchsatz-miRNA-Profil-Analyse nicht 
untersucht. Daher war das Ziel dieser Studie die Untersuchung nach dem Vorkommen 
und der Fülle von miRNAs in bovinen Granulosazellen von untergeordneten und 
dominanten Follikel während der frühen Lutealphase des Östruszyklus beim Prozess der 
bovinen Follikelreifung. Weiterhin prognostizierten wir, die potenziellen Ziele der 
differenziell exprimierten miRNAs entweder in den Zelltypen oder an jedem Zeitpunkte 
und deren möglichen Beteiligung an biologischen Signalwegen. In dieser Studie wurden 
13 Simmental Färsen nach optimiertem Protokoll synchronisiert und dann am Tag 3 und 
Tag 7 der Östruszyklus geschlachtet um Eierstockproben zu sammeln. 
 
Am Tag 3 des Östruszyklus wurden Follikel mit einem follikulärem Durchmesser ≤ 6 
mm (n = 43) als untergeordnete Follikel (SF) und Follikel mit einem Durchmesser von 
8-10 mm (n = 9) als dominante Follikel (DF) eingeteilt. Auf der anderen Seite wurden 
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Follikel am Tag 7 des Zyklus mit einem Durchmesser von ≤ 8 mm (n = 58) als SF und 
solche mit einem Durchmesser von 9-13 mm (n = 3) als DF unterteilt. Die Reinheit der 
Granulosazellen wurde mit einem zellspezifischen Marker-Gen bestätigt und somit 
konnte gezeigt werden, dass Kontaminationen der Theka- und Granulosazellen minimal 
waren. Die untergeordneten und dominanten Follikel mit ihren entsprechenden 
Granulosa- und Thekazellen, dem COC und ihrer Follikelflüssigkeit wurden dann aus 
den Eierstöcken von jedem Tier isoliert. Von den Granulosazellen wurden miRNA-
angereicherte Gesamt-RNA mittels des miRNeasy® Mini Kit (Qiagen GmbH, Hilden, 
Deutschland) isoliert. Die RNA-Integrität und Qualität wurde jeweils mit dem Agilent 
Bioanalyzer 2100 (Agilent Technologies Inc, CA, USA) und dem Nanodrop 8000 
Spektralphotometer (Thermo Fisher Scientific Inc, DE, USA), bestimmt. Die Gesamt-
RNA aller Proben wurde für die Konstruktion einer markierten miRNA-Sequenzierung 
Bibliotheken (22 bis 30 nt) eingesetzt. Dieses erfolgte nach dem Illumina Small RNA 
Sample Preparation Protokoll der Firma GATC BioTech AG (Konstanz, Deutschland). 
Die Rohdaten aus der Tiefensequenzierung (Deep Sequenzierung) wurde mit dem 
miRDeep Software-Paket www.mdc-berlin.de/rajewsky/miRDeep weiter analysiert und 
verarbeitet. Die miRNAs galt als differentiell exprimiert bei einer fold change ≥ 2, 
einem p-Wert ≤ 0,05 und bei einer false discovery rate ≤ 0,1. 
 
Durch die Analyse konnten, für die Granolusazellen am Tag 3 des Östruszyklus 291 
miRNAs in SF und 318 miRNAs in DF erfasst werden. Während für in Granulosazellen 
von Tag 7, insgesamt 314 miRNAs in SF und 316 in DF abgeleitet werden konnten. 
Insgesamt stimmten 244 miRNAs in alle Follikel-Gruppen überein. Zur Validierung 
wurde die Expression von Kandidaten miRNAs in unabhängigen Granulosa- und 
Thekazellen, COC und Follikelflüssigkeit von beiden follikulären Unterkategorien 
sowohl am Tag 3 als auch am Tag 7 des Zyklus untersucht. 
 
Zur Untersuchung der Expressionsmuster von miRNAs in den Granulosazellen von SF 
und DF am Tag 3 und Tag 7 des Östruszyklus wurde die Technik NGS verwendet. 
Dementsprechend fanden wir 16 miRNAs einschließlich bta-miR-449a, bta-miR-449c, 
bta-miR-212, miR-bta-21-3p, bta-miR-183 und miR-bta-34c unterschiedlich exprimiert 
in Granuolosazelle von untergeordneten Follikeln. Am Tag 7 des Östruszyklus konnten 
insgesamt 108 miRNAs einschließlich bta-mir-409a, miR-bta-2446, und bta-mir-383 
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mit einer unterschiedlichen Expression in Granulosazellen von SF gegenüber DF 
beobachtet werden. Interessanterweise überschnitten sich neun miRNAs einschließlich 
bta-miR-21-3p, bta-miR-708 und miR-bta-335 sowohl bei Tag 3 und 7 des 
Östruszyklus. Davon zeigte bta-miR-335 ein ähnliches Expressionsmuster an Tag 3 und 
Tag 7, während die anderen acht miRNAs ein gegenläufiges Expressionsmuster 
aufwiesen. Expressionsanalyse innerhalb der Gruppen (Tag 3 SF vs SF Tag 7 und Tag 3 
DF vs Tag 7 DF) ergab, dass fünf miRNAs einschließlich bta-miR-100 und miR-bta-
155 unterschiedlich am Tag 3 SF vs Tag 7 SF exprimiert waren. Auf der anderen Seite, 
zeigten insgesamt 131 miRNAs einschließlich bta-miR-409a, bta-miR-196a, bta-miR-
505, miR-bta-16b, bta-miR-99a-5p, bta-miR-32, bta -miR-132, miR-bta-129 und miR-
bta-346 ein unterschiedliches Expressionsprofil am Tag 3 DF vs Tag 7 DF. 
 
Um weitere physiologischen Funktionen und biologische Prozesse der unterschiedlich 
exprimierten miRNAs zwischen Granulosazellen der untergeordneten und der 
dominanten Follikel in der follikulären Entwicklung zu verstehen, wurde eine in silico 
Analyse von Kandidaten miRNAs durchgeführt, mit dem Ziel potentielle Ziel-Gene zu 
identifizieren. Die Analyse der Genontologie ergab, dass die Mehrheit der 
unterschiedlich exprimierten miRNAs in Granulosazellen von untergeordneten und 
dominanten Follikel die am Tag 3 und 7 des Östruszyklus ermittelt wurden, in der 
Regulierung des programmierten Zelltods und der Regulierung der Zellproliferation 
involviert sind. Zudem zeigten die Ergebnisse der Signalweg-Analyse, dass am Tag 3 
des Östruszyklus die folgenden Signalwege: Cadherin, Apoptose, ErbB, MAPK, Ras, 
Signalisierung durch BMP, 5HT1 Typ rezeptorvermittelte Signalisierung und 
Adipocytokines; bei potentiellen miRNA Ziel-Genen in Granulosazellen der SF 
vorkamen. Wobei fokal Adhesion, Gab Junction, Histamin H1 rezeptorvermittelter 
Signalweg und Angiotensin II –stimulierter Signalweg durch G Proteine und beta 
Arrestin in potentiellen miRNA Ziel-Genen in Granulosazellen der DF ermittelt wurden. 
Interessanterweise traten folgende Signalwege: Wnt, TGF-beta, NGF, Oxytocin 
rezeptorvermittelter Signalweg, Notch, Axon Guidance und Adherens Junction bei 
miRNA Ziel-Genen die entweder in Granulosazellen der SF hoch oder runter reguliert 
waren auf. Ähnliche Analysen zeigten eine höherer aktivität von potentielle miRNA 
Ziel-Gene von hoch regulierten miRNA von Granulosazellen der SF an Tag 7 des 
Östruszyklus in folgende metabolische Signalwegen (Pantothenate und CoA 
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Biosynthese, O- Glykan und N- Glykan Biosynthese, Vitamin und Cofaktor 
Metabolismus, D-Glutamin und Glutamat Metabolismus, Biosynthese der ungesättigten 
Fettsäure), Jak-STAT und Zellzyklus Signalweg. Wohingegen die Signalwege Ras, 
Lipide, Lipoproteine, Cystein, Methionin Signalwege und der metabolischer 
Kohlenhydrat Signalweg durch potentielle miRNA Ziel-Genen in Granulosazellen von 
DF identifiziert wurden. Axon Guidance, Wnt Signalweg, GnRH Signalweg, MAPK, 
Meiose der Eizellen, TGF-beta Signalweg und focal Adhesion kamen interessanterweise 
in der Gruppe der miRNA Ziel-Gene die entweder in Granulosazellen von SF hoch oder 
runter reguliert waren, vor. Obwohl das Expressionsprofil der miRNAs gar keine 
Ähnlichkeit zwischen den beiden Gruppen zeigte, waren die in silico vorhergesagten 
biologischen Signalwege interessanterweise zwischen beiden Gruppen ähnlich. 
Zusätzlich zu den bekannten miRNAs wurden neue miRNAs mit Hilfe des neuen 
miRNA Prognosetool miRDeep2 identifiziert. Insgesamt wurden 21 neue Kandidaten-
miRNAs mit einer Basenlänge von 17-22 Nukleotide in Granulosazellen der SF oder 
DF am Tag 3 oder am Tag 7 des Östruszyklus ermittelt. 
In der vorliegenden Studie, geben wir einen detaillierten Einblick in die miRNA 
Anreicherung und ihren Abbau während der Lutealphase des Östruszyklus. High-
throughput miRNA Sequenzierungs-Daten wurden aus Granulosazellen, die aus 
untergeordneten und dominanten Follikeln am Tag 3 und 7 des Östruszyklus gewonnen 
wurden, generiert. Diese Studie hebt miRNA Expressionsmuster von Granulosazellen 
aus untergeordneten und dominanten Follikeln hervor, die in Verbindung mit der 
follikulären Rekrutierung, Selektion und Dominanz während der frühen Lutealphase des 
bovinen Östruszyklus stehen. Die nach unterschiedlichen bioinformatischen Methoden 
ermittelte funktionelle aktivität zeigte, dass unterschiedlich exprimierte miRNAs zu 
bestimmten Zeitpunkten und Gruppen einen möglichen regulatorischen Effekt auf die 
Proliferation und Apoptose der Granulosazellen haben und dies durch die Beeinflussung 
von Signalwegen erzielen können. Zusammenfassend lässt sich sagen, dass die miRNAs 
in der Regulierung der follikulären Entwicklung während des bovinen Östruszyklus von 
Bedeutung sind. Dennoch sind weitere funktionelle Studien basierend auf diesen Daten 
notwendig, um vollständig die Rolle jeder unterschiedlich exprimierten miRNA 
während der Follikulogenese zu verstehen. 
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9 Appendices 
 
Appendix 1: List of differentially expressed miRNas between granulosa cells of              
subordinate and dominant follicles at day 7 of estrous cycle 
 
miRNAs ID FC Pvalue FDR 
bta-miR-184 -23.5 1.67E-32 9.50E-30 
bta-miR-365-5p -19.2 0.00052605 0.003434445 
bta-miR-2487 -18.3 0.013818341 0.059460738 
bta-miR-2389 -18.1 0.022832071 0.08890562 
bta-miR-483 -4.8 0.023635121 0.08890562 
bta-miR-1249 -4.2 0.004415618 0.023009824 
bta-miR-2411-5p -4.0 0.011258 0.050350742 
bta-miR-455-5p -3.7 0.000212775 0.001469912 
bta-miR-221 -3.7 3.23E-11 7.06E-10 
bta-miR-708 -3.7 3.68E-13 1.49E-11 
bta-miR-150 -3.6 0.002300316 0.012809605 
bta-miR-34a -3.6 4.04E-06 3.95E-05 
bta-miR-346 -3.5 0.00165579 0.009796758 
bta-miR-2285t -3.5 0.008572809 0.039912751 
bta-miR-142-5p -3.3 0.003537107 0.018776418 
bta-miR-155 -3.3 1.44E-11 3.55E-10 
bta-miR-193b -3.2 6.85E-12 1.77E-10 
bta-miR-222 -3.2 5.02E-11 1.06E-09 
bta-miR-455-3p -3.1 7.52E-09 1.07E-07 
bta-miR-23a -3.1 1.23E-12 3.49E-11 
bta-miR-21-3p -3.0 4.68E-10 8.31E-09 
bta-miR-21-5p -2.8 1.26E-09 2.17E-08 
bta-miR-214 -2.7 8.52E-11 1.73E-09 
bta-miR-218 -2.6 0.02329968 0.08890562 
bta-miR-149-5p -2.6 6.98E-09 1.02E-07 
bta-miR-199a-3p -2.5 1.23E-17 7.12E-16 
bta-miR-199c -2.5 1.23E-17 7.12E-16 
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bta-miR-130b -2.5 1.33E-10 2.52E-09 
bta-miR-146b -2.5 4.63E-06 4.41E-05 
bta-miR-326 -2.5 0.008756066 0.040116175 
bta-miR-27a-3p -2.4 5.15E-13 1.75E-11 
bta-miR-181a -2.4 5.21E-13 1.75E-11 
bta-miR-199b -2.4 2.66E-07 3.08E-06 
bta-miR-22-5p -2.3 0.00071126 0.004488844 
bta-miR-181b -2.3 1.09E-12 3.25E-11 
bta-miR-29b -2.2 0.001886234 0.010822031 
bta-miR-2425-5p -2.1 0.007301522 0.035446706 
bta-miR-199a-5p -2.1 5.15E-09 8.01E-08 
bta-miR-365-3p -1.9 8.71E-06 7.61E-05 
bta-miR-204 -1.9 6.05E-08 7.16E-07 
bta-miR-24-3p -1.9 2.44E-11 5.56E-10 
bta-miR-146a -1.9 0.000904744 0.005647193 
bta-miR-2284aa -1.8 0.007573989 0.035553933 
bta-miR-3613 -1.8 0.008757757 0.040116175 
bta-miR-181c -1.8 8.56E-06 7.61E-05 
bta-miR-28 -1.7 1.96E-05 0.000166227 
bta-miR-451 -1.7 2.31E-05 0.000193158 
bta-miR-23b-3p -1.7 4.66E-06 4.41E-05 
bta-miR-107 -1.5 0.00047124 0.003112378 
bta-miR-181d -1.5 0.019423357 0.078244443 
bta-miR-486 -1.5 0.000100564 0.000771896 
bta-miR-29a -1.4 0.000147472 0.001073901 
bta-miR-22-3p -1.4 1.38E-06 1.43E-05 
bta-miR-152 -1.4 0.001609023 0.009620264 
bta-miR-874 -1.4 4.62E-05 0.000359681 
bta-miR-185 -1.3 0.01497738 0.063963549 
bta-miR-143 -1.3 0.000547562 0.003534266 
bta-miR-2478 1.0 0.023055342 0.08890562 
bta-miR-130a 1.0 0.000197757 0.001386741 
bta-miR-148b 1.0 0.002868312 0.015665398 
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bta-miR-99b 1.1 0.002212934 0.012445016 
bta-miR-16b 1.1 0.000158475 0.001125176 
bta-miR-25 1.2 0.000138582 0.001035721 
bta-miR-296 1.2 0.001738087 0.010177665 
bta-miR-450b 1.2 0.006227416 0.030758019 
bta-miR-2483-5p 1.2 0.021267183 0.084473845 
bta-miR-99a-5p 1.3 1.18E-06 1.24E-05 
bta-miR-128 1.3 4.27E-05 0.000341989 
bta-miR-92a 1.4 6.24E-06 5.72E-05 
bta-miR-423-3p 1.4 9.92E-07 1.06E-05 
bta-miR-30c 1.4 4.28E-08 5.17E-07 
bta-miR-769 1.4 0.000214793 0.001469912 
bta-miR-15b 1.5 2.94E-05 0.000242189 
bta-miR-6119-3p 1.5 0.026437804 0.0987939 
bta-miR-1271 1.5 0.000260344 0.00176042 
bta-miR-30e-5p 1.6 3.81E-09 6.35E-08 
bta-miR-339a 1.6 1.24E-08 1.63E-07 
bta-miR-339b 1.6 1.24E-08 1.63E-07 
bta-miR-484 1.6 5.51E-06 5.13E-05 
bta-miR-195 1.7 3.33E-06 3.38E-05 
bta-miR-202 1.8 3.97E-06 3.95E-05 
bta-miR-574 1.9 1.79E-08 2.31E-07 
bta-miR-31 1.9 3.42E-07 3.89E-06 
bta-miR-1296 1.9 0.000153302 0.00110222 
bta-miR-592 2.0 0.009652084 0.043859069 
bta-miR-497 2.0 6.54E-09 9.78E-08 
bta-miR-505 2.0 0.000103734 0.000785609 
bta-miR-2885 2.0 0.023405773 0.08890562 
bta-miR-10b 2.1 5.15E-15 2.44E-13 
bta-miR-744 2.1 3.50E-05 0.000284397 
bta-miR-2285k 2.2 7.08E-07 7.85E-06 
bta-miR-92b 2.2 4.55E-10 8.31E-09 
bta-miR-2411-3p 2.4 0.005568101 0.027742821 
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Positive fold change means up-regulated in granulosa cells of subordinate follicles and 
negative fold change means down-regulated in granulosa cells of subordinate follicles 
compared to granulosa cells of dominant follicles at day 7 of estrous cycle (FC=Log2 
fold), P value and false discovery rate (FDR). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
bta-miR-1343-3p 2.8 8.83E-13 2.79E-11 
bta-miR-2483-3p 3.0 0.003270191 0.017690178 
bta-miR-452 3.3 0.000276098 0.001844984 
bta-miR-3431 3.6 9.62E-11 1.88E-09 
bta-miR-224 3.6 3.69E-14 1.61E-12 
bta-miR-2344 3.6 0.001219755 0.00753066 
bta-miR-190b 3.9 4.48E-05 0.000353812 
bta-miR-6526 4.2 6.02E-18 6.84E-16 
bta-miR-2284t-3p 4.4 0.001429003 0.008727672 
bta-miR-335 5.5 5.64E-31 1.60E-28 
bta-miR-2404 16.3 0.023504345 0.08890562 
bta-miR-383 16.3 0.020668992 0.082675967 
bta-miR-2446 16.4 0.013369487 0.057968464 
bta-miR-409a 16.5 0.004178814 0.021977468 
bta-miR-2332 17.9 0.000142205 0.001048992 
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Appendix 2: List of differentially expressed miRNas between granulosa cells of 
dominant follicles at day 3 and day 7 of estrous cycle 
 
miRNAs ID FC pvalue FDR 
bta-miR-409a -18.8 0.00949551 0.03446748 
bta-miR-2332 -18.6 0.00306952 0.01234431 
bta-miR-196a -18.4 0.01287771 0.04458695 
bta-miR-6526 -5.0 4.66E-12 5.42E-11 
bta-miR-2284t-3p -4.9 3.02E-05 0.00017418 
bta-miR-335 -4.2 2.26E-26 6.01E-25 
bta-miR-3431 -3.7 3.78E-16 6.61E-15 
bta-miR-592 -3.6 1.30E-10 1.37E-09 
bta-miR-190b -3.5 0.00030501 0.00155003 
bta-miR-2346 -3.5 0.02084214 0.06734541 
bta-miR-224 -3.5 4.94E-20 9.86E-19 
bta-miR-2285k -3.3 6.67E-17 1.28E-15 
bta-miR-452 -3.3 5.86E-05 0.00033081 
bta-miR-1343-3p -3.2 1.24E-22 2.88E-21 
bta-miR-1271 -3.0 1.25E-08 1.03E-07 
bta-miR-2483-3p -2.8 0.00188144 0.00821658 
bta-miR-744 -2.5 9.51E-10 8.71E-09 
bta-miR-92b -2.5 1.08E-21 2.25E-20 
bta-miR-202 -2.3 3.50E-09 3.16E-08 
bta-miR-1296 -2.2 9.18E-07 6.58E-06 
bta-miR-2285c -2.2 0.0324179 0.09503858 
bta-miR-497 -2.1 6.91E-15 1.04E-13 
bta-miR-574 -2.0 2.07E-12 2.63E-11 
bta-miR-505 -2.0 1.06E-05 6.87E-05 
bta-miR-450b -1.9 5.31E-09 4.49E-08 
bta-miR-31 -1.7 2.98E-08 2.35E-07 
bta-miR-15b -1.7 4.48E-11 4.81E-10 
bta-miR-99b -1.7 2.32E-08 1.88E-07 
bta-miR-195 -1.6 6.32E-07 4.65E-06 
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bta-miR-873 -1.6 0.00217441 0.00900367 
bta-miR-2483-5p -1.6 0.00058752 0.00280704 
bta-miR-30e-5p -1.6 3.43E-16 6.19E-15 
bta-miR-148b -1.5 8.41E-08 6.53E-07 
bta-miR-769 -1.4 3.70E-09 3.28E-08 
bta-miR-339b -1.4 2.91E-10 2.86E-09 
bta-miR-339a -1.4 2.91E-10 2.86E-09 
bta-miR-484 -1.3 3.87E-06 2.67E-05 
bta-miR-374a -1.3 7.46E-06 4.90E-05 
bta-miR-194 -1.3 0.01693635 0.05635369 
bta-miR-16b -1.2 4.51E-09 3.94E-08 
bta-miR-128 -1.2 1.32E-05 8.45E-05 
bta-miR-10b -1.2 7.06E-07 5.12E-06 
bta-miR-1260b -1.2 0.01945164 0.06321784 
bta-miR-652 -1.1 1.48E-05 8.73E-05 
bta-miR-191 -1.1 2.72E-10 2.82E-09 
bta-miR-423-3p -1.1 4.57E-07 3.40E-06 
bta-miR-30c -1.1 3.78E-10 3.52E-09 
bta-miR-2478 -1.1 0.00113459 0.00515636 
bta-miR-2285f -1.1 0.00930551 0.03399855 
bta-miR-99a-5p -1.0 4.98E-09 4.28E-08 
bta-miR-424-5p -1.0 0.00504665 0.01919102 
bta-miR-126-3p 1.0 0.0016148 0.00710766 
bta-miR-185 1.2 0.01212062 0.04234643 
bta-miR-874 1.2 6.42E-05 0.00035863 
bta-miR-32 1.3 0.00274919 0.01113621 
bta-miR-378 1.3 1.35E-05 8.54E-05 
bta-miR-3432 1.3 0.00634198 0.02379308 
bta-miR-2425-5p 1.4 0.02321531 0.07249919 
bta-miR-345-3p 1.4 0.00574124 0.02168483 
bta-miR-2419-5p 1.4 0.01114134 0.03941777 
bta-miR-145 1.6 3.64E-10 3.45E-09 
bta-miR-183 1.6 1.38E-05 8.54E-05 
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bta-miR-182 1.7 5.47E-06 3.68E-05 
bta-miR-204 1.8 1.37E-07 1.05E-06 
bta-miR-28 1.8 4.05E-14 5.80E-13 
bta-miR-143 1.9 9.34E-07 6.61E-06 
bta-miR-107 1.9 1.88E-05 0.00010925 
bta-miR-22-5p 2.0 0.00422252 0.01627853 
bta-miR-199b 2.2 2.52E-08 2.01E-07 
bta-miR-23b-3p 2.2 1.02E-12 1.32E-11 
bta-miR-29b 2.3 0.00317481 0.01258666 
bta-miR-24-3p 2.4 4.58E-31 1.42E-29 
bta-miR-24-3p 2.4 5.37E-31 1.58E-29 
bta-miR-29a 2.4 4.10E-22 9.16E-21 
bta-miR-34a 2.5 0.00058036 0.00279671 
bta-miR-6524 2.5 0.02220839 0.06979809 
bta-miR-181d 2.5 0.00013114 0.00068513 
bta-miR-199a-5p 2.5 2.48E-15 3.86E-14 
bta-miR-181c 2.6 3.52E-14 5.18E-13 
bta-miR-132 2.7 4.34E-07 3.28E-06 
bta-miR-365-3p 2.7 2.97E-10 2.86E-09 
bta-miR-29c 2.7 0.01668064 0.05583519 
bta-miR-760-3p 2.8 1.99E-06 1.39E-05 
bta-miR-181b 2.9 4.29E-23 1.04E-21 
bta-miR-455-3p 3.1 2.66E-11 2.92E-10 
bta-miR-455-5p 3.2 0.00037138 0.00185361 
bta-miR-146a 3.2 5.53E-09 4.62E-08 
bta-miR-199a-3p 3.2 1.91E-49 9.68E-48 
bta-miR-199c 3.2 1.42E-49 8.80E-48 
bta-miR-149-5p 3.3 9.47E-14 1.32E-12 
bta-miR-181a 3.3 2.33E-40 8.88E-39 
bta-miR-27a-3p 3.3 1.50E-47 6.98E-46 
bta-miR-6121-3p 3.4 0.01906656 0.06232871 
bta-miR-130b 3.4 2.16E-26 6.01E-25 
bta-miR-2284aa-1 3.4 1.43E-05 8.54E-05 
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bta-miR-2411-5p 3.5 0.01538145 0.05242823 
bta-miR-223 3.5 0.00369432 0.01454312 
bta-miR-96 3.6 0.00050302 0.00248839 
bta-miR-338 3.6 0.02986021 0.09273253 
bta-miR-330 3.6 0.03219727 0.09503858 
bta-miR-214 3.8 7.48E-16 1.23E-14 
bta-miR-133a 3.8 0.00129052 0.00577121 
bta-miR-449a 4.0 0.00011613 0.00061241 
bta-miR-449c 4.1 0.00092818 0.00425287 
bta-miR-146b 4.1 2.73E-12 3.39E-11 
bta-miR-483 4.2 0.00140628 0.00623899 
bta-miR-23a 4.3 8.27E-25 2.10E-23 
bta-miR-365-5p 4.5 0.00209543 0.00900367 
bta-miR-2904 4.5 0.00085463 0.00394824 
bta-miR-150 4.8 5.48E-05 0.00031252 
bta-miR-142-5p 4.9 1.05E-11 1.18E-10 
bta-miR-193b 5.0 1.05E-45 4.50E-44 
bta-miR-326 5.5 1.44E-05 8.54E-05 
bta-miR-21-5p 5.6 8.88E-82 4.96E-79 
bta-miR-708 6.2 1.74E-58 2.43E-56 
bta-miR-21-3p 6.6 2.68E-72 5.00E-70 
bta-miR-222 6.9 9.81E-38 3.23E-36 
bta-miR-221 7.0 3.54E-52 3.96E-50 
bta-miR-155 7.2 4.74E-74 1.32E-71 
bta-miR-184 9.0 3.78E-40 1.32E-38 
bta-miR-363 16.3 0.03147695 0.09498658 
bta-miR-29d 16.4 0.01292144 0.04458695 
bta-miR-2389 16.5 0.01345579 0.04614592 
bta-miR-142-3p 16.6 0.00260502 0.01062923 
bta-miR-129-5p 16.6 0.00216743 0.00900367 
bta-miR-129 16.6 0.00216743 0.00900367 
bta-miR-449b 16.7 0.00077646 0.00367832 
bta-miR-129-3p 17.8 0.00206603 0.00895281 
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bta-miR-1249 17.8 0.00015707 0.00081299 
bta-miR-2285t 18.0 0.00023659 0.00121332 
bta-miR-346 18.0 5.95E-06 3.96E-05 
Positive fold change means up-regulated in granulosa cells of subordinate follicles and 
negative fold change means down-regulated in granulosa cells of subordinate follicles 
compared to granulosa cells of dominant follicles at day 7 of estrous cycle (FC=Log2 
fold), P value and false discovery rate (FDR). 
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Appendix 3: Top most enriched pathways of target genes for differentially expressed 
miRNAs between granulosa cells of subordinate and dominant follicles at day 7 
of estrous cycle 
 
miRNAs ID Term                                     Genes 
mir-214↓,mir-181b↓,mir-27a-
3p↓,mir-346↓,mir-181a↓,mir-
130a↑,mir-10b↑,mir-452↑,mir-
204↓,mir-2332↑,mir-326↓,mir-
148b,mir-146b↓,mir-155↓,mir-
15b↑,mir-16b↑,mir-152↓,mir-
222↓,mir-195↑,mir-1249↓,mir-
497↑,mir-221↓,mir-2446↑,mir-
1271↑,mir-505↑,mir-185↓ 
Wnt signaling 
pathway 
FZD4, FZD7, 
WNT9A,WNT11,CSNK1G3,WN
T16,FZD3, 
WNT1,WNT2B,WNT5A,WNT6, 
WNT10B,WNT7A,FZD10 
mir-185↓,mir-181d↓,mir-
1296↑, 
mir-24-3p↓,mir-21-5p↓,mir-
204↓,mir-150↓,mir-128↑,mir-
181b↓,mir-199b↓,mir-
2404↑,mir-326↓,mir-
193b↓,mir-199c↓,mir-
15b↑,mir-16b↑,mir-1271↑,mir-
142-5p↓,mir-181c↓,mir-
195↑,mir-181a↓,mir-27a-
3p↓,mir-452↑,mir-484↑, 
mir-365-3p↓,mir-1249↓,mir-
2446↑ 
MAPK 
signaling 
pathway 
MAPK14,MAP2K1,MAPK1,MA
P3K8,MAP4K2, 
MAPKAPK3,MKNK1,MAPKAP
K2, 
MAP3K3,MAP3K2,MAP2K7,M
APK13,MAPK8IP2, 
MAPK8IP3,MAPK8IP1,MAP3K
11, 
MAP3K1,MAPK10,MAP2K4,M
AP3K4, 
 
mir-199a-5p↓,mir-218↓,mir-
130a↑,mir-193b↓,mir-452↑, 
mir-202↑,mir-130b↓,mir-
146a↓, 
mir-34a↓,mir-1296↑,mir-
181b↓, 
 Axon 
guidance 
EPHA7,SEMA6A,PAK6,EPHA4,
FGFR1,NRAS, 
GNAI2, SEMA4F, EFNB1, MET, 
SEMA4C, 
NRP1,PAK7,RPS6KA5,NRP1,M
ET,ST8SIA4, 
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mir-148b↑,mir-497↑,mir-27a-
3p↓,mir-142-5p↓,mir-
181c↓,mir-218↓,mir-204↓,mir-
181a↓,mir-152↓,mir-326↓,mir-
484↑,mir-15b↑,mir-16b↑,mir-
29b↓,mir-148b↑,mir-195↑,mir-
339b↑,mir-152↓,mir-222↓,mir-
214↓,mir-1271↑,mir-221↓,mir-
29a↓,mir-1249↓,mir-
199c↓,mir-185↓,mir-
1249↓,mir-128↑,mir-31↑,mir-
2446↑,mir-30c↑,mir-29a↓,mir-
29b↓ 
SEMA6A,ROCK1, 
ROBO1,ROBO2, ARHGEF12 
MAPK1,COL4A4, COL4A3, 
COL4A2, COL4A1, COL3A1, 
COL2A1, COL5A2, COL5A1, 
COL4A5, COL9A1, COL6A3, 
COL1A2, COL1A1, SPTAN1 
COL4A4, COL4A3, COL4A2, 
COL4A1, COL3A1, COL2A1, 
COL5A2, COL5A1, COL4A5, 
COL9A1, COL6A3, COL1A2, 
COL1A1, SPTAN1 
mir-199b↓,mir-1271↑,mir-
92b↑, 
mir-148b↑,mir-107↓,mir-92a↑, 
mir-486↓,mir-2404↑,mir-152↓, 
mir-497↑,mir-150↓,mir-199c↓, 
mir-25↑,mir-484↑,mir-195↑, 
mir-185↓,mir-1249↓,mir-15b↑, 
mir-16b↑,mir-2446↑,mir-29b↓, 
mir-29a↓ 
 Focal 
adhesion 
PDGFRA, ITGA3, MAPK10, 
THBS1, FN1, 
ITGA6, ITGA5, ITGAV, 
COL1A2, PPP1R12A, RAP1B, 
COL11A1, PTEN, 
COL5A1,IGF1R, PDPK1, IGF1, 
ITGA4, 
PTEN,MAP2K1,MAP2K1,RAPG
EF1, PIK3R1, AKT3, MYLK 
mir-222↓,mir-221↓,mir-365-
3p↓,mir-92a↑,mir-31↑,mir-21-
3p↓,mir-148b↑,mir-218↓,mir-
181b↓,mir-185↓,mir-
181d↓,mir-181c↓,mir-
214↓,mir-181a↓,mir-128↑,mir-
195↑,mir-15b↑,mir-16b↑,mir-
204↓,mir-497↑,mir-2446↑,mir-
1271↑,mir-1249↓ 
Signalling by 
NGF 
CDKN1B, RALA, FRS2, 
BCL2L11, PIK3R1, ITPR2, 
CDKN1B, PLCG1, ADAM17, 
RALA, BCL2L11, PIK3R1, 
ITPR2,SOS1, ADCY6, RIT1, 
RICTOR, FRS2, 
AKT3,ADCY3,PPP2R1B,MEF2
A,RTN4, 
RICTOR, PRKCE, PRKCD, 
PIK3R1, ITPR2 
IRS2,PRKAR2A,CALM1,MAPK
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1, PDPK1, PRDM4, ADORA2A, 
SQSTM1, PPP2CB, YWHAB, 
FOXO4, IKBKB, ITPR3, 
PTEN,CL2L11,PPP2R1A,MAP2
K1, 
APH1A,SH3GL2,FOXO1, 
NFKB1, FOXO3 
mir-155↓,mir-21-5p↓,mir-
181a↓, 
mir-1249↓,mir-128↑,mir-
130b↓, 
mir-15b↑,mir-16b↑,mir-181b↓, 
mir-3431↑,mir-199a-5p↓,mir-
181c↓,mir-195↑,mir-346↓, 
mir-346↓,mir-214↓,mir-130a↑, 
mir-199c↓,mir-148b↑,mir-
152↓, 
mir-2446↑ 
TGF-beta 
signaling 
pathway 
SP1,GDF6,SMAD2,RPS6KB1,S
MAD1,ACVR1C, 
SMAD7,BMPR2,SMURF2,ACV
R1C,BMP8A, 
PPP2R1B,ACVR2A,INHBB,SM
AD7, SMAD5, SMAD3, 
SMURF2, SMURF1, BMPR1A, 
BMP8A,TGIF1,ZEB2,BMPR1B, 
TGFBR1, CREBBP, BMPR2, 
RPS6KB1, DCN 
ACVR2A,INHBB,LTBP1, 
BMP7, BMP6 
mir-15b↑,mir-16b↑,mir-2487↓, 
mir-497↑,mir-195↑,mir-128↑, 
mir-193b↓,mir-185↓,mir-27a-
3p↓,mir-1271↑,mir-484↑, 
mir-181c↓,mir-2404↑,mir-
181d↓,mir-181a↓,mir-181b↓, 
mir-1249↓, 
GnRH 
signaling 
pathway 
MAP3K4, MAP2K1, MAP3K3, 
MAP2K3, MAP2K4, PRKACA, 
ITPR1, CALM1,CDC42, 
PLD1,MAP3K4,MAP3K2,MAPK
3,CDC42,EGFR,KRAS,CAMK2
D, CALM3, GNRHR,SOS1, 
MAP2K4, HBEGF, PRKX, 
PRKCB,MAPK11, MMP14, 
MMP2, 
MAPK1, PRKCD, 
CALM1,ADCY1, PLD1 
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mir-339b↑,mir-199a-5p↓,mir-
2404↑,mir-769↑,mir-30c↑, 
mir-128↑,mir-222↓,mir-181d↓, 
mir-181b↓,mir-181c↓,mir-
181a↓,mir-221↓,mir-150↓, 
mir-1249↓,mir-2446↑ 
ErbB signaling 
pathway 
PAK6, ERBB4, SOS1, 
ABL2,CDKN1B, KRAS, GSK3B, 
CBL, PIK3CD,MAP2K1, GRB2, 
MAP2K4, CRK, 
CAMK2A,CBLB, KRAS, EREG, 
PAK4, CAMK2D, PIK3R3, 
AKT3,PAK7, CDKN1B, ERBB4, 
PLCG1, CBL, MAPK10, PAK1, 
PIK3R1,PRKCA, EREG, 
CAMK2G, CBL, MAP2K4, 
ELK1, PAK1, AKT3, SHC4 
mir-592↑,mir-326↓,mir-452↑, 
mir-193b↓,mir-181d↓,mir-
181a↓,mir-15b↑,mir-16b↑, 
mir-2404↑,mir-181b↓,mir-
195↑, 
mir-181c↓,mir-497↑,mir-185↓ 
Oocyte 
meiosis 
MAPK1, RPS6KA3, ADCY1, 
ADCY2, RPS6KA1, IGF1, 
SMC1A, CAMK2A, PRKX, 
ITPR2,PRKACG, IGF1R, 
PPP2R5B, PPP3CB,RPS6KA3, 
ANAPC4, YWHAB, PPP2R5E, 
SKP1, CPEB1, YWHAE, PRKX 
YWHAZ, ADCY9, PPP2R5C, 
PRKACB, CALM1 
CCNB1, MAPK1, RPS6KA3, 
ADCY1, YWHAG, MAP2K1, 
ADCY9, CAMK2G, CAMK2D, 
PPP3R1 
mir-30c↑,mir-15b↑,mir-16b↑, 
mir-195↑,mir-146b↓,mir-185↓, 
mir-484↑,mir-1249↓ 
VEGF 
signaling 
pathway 
KRAS, 
PLCG1,PLA2G12A,PIK3CD,NF
AT5, PPP3CB, 
PPP3R1,PPP3CA,PIK3R2,CDC4
2, 
MAP2K1,VEGFA,PPP3CB,NFA
TC3,AKT3,PXN, PIK3R1, 
KDR,PRKCA,SPHK2,PIK3CD, 
MAPKAPK3,CHP2,PLA2G2F 
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mir-199c↓, 
mir-365-3p↓,mir-22-3p↓, 
mir-195↑,mir-143↓,mir-25↑, 
mir-2446↑,mir-218↓ 
Gap junction TJP1, ADRB1, GNAI3, 
CSNK1D, MAP3K2, 
PLCB4, SOS1, ADCY6, 
PDGFRA, PRKG1, 
GRM5, NRAS, GNAI3, 
GUCY1B3, PRKCB 
PRKCA, ADCY3, 
ADRB1,ADCY3, GRM1, GRM5, 
MAPK1, ADRB1, KRAS, 
MAP3K2, SOS1, PDGFRA, 
GUCY1B3, EGF, 
HTR2A,GNAI2, ADCY9, GNAI1 
mir-1271↑,mir-181c↓,mir-365-
3p↓,mir-181b↓,mir-181b↓, 
mir-222↓,mir-221↓ 
Apoptosis TRAF2,XIAP,DFFA,PPP3R1,EN
DOD1,ATM, 
PRKAR2B,TNFRSF1A,TNFRSF
10B,CASP9,RIPK1, 
PRKAR1A,CHP,MAP3K14,IKB
KB,PIK3R1, 
CASP10 
mir-181b↓,mir-744↑,mir-
2446↑, 
mir-181d↓,mir-214↓,mir-592↑, 
mir-497↑,mir-30c↑,mir-365-
3p↓, 
mir-346↓ 
Aldosterone-
regulated 
sodium 
reabsorption 
MAPK1,ATP1B1,IRS2,KRAS,A
TP1B2, PIK3R3 
IGF2,KCNJ1,IGF1,PDPK1,SGK1
,MAPK3,ATP1B4, INSR, 
PIK3R1 
mir-484↑ Cytokine-
cytokine 
receptor 
interaction 
CCL3, IL22RA1, PDGFA, CSF1, 
IL28RA, IL21R, CNTFR, 
CXCL12, ACVR1B, TNFRSF1A, 
TNFRSF1B, PLEKHO2, IL18R1, 
IL2RB, TGFBR1, FLT4, EDA2R, 
EDAR, IL6R, CD40, TNFSF9, 
CCL18, KDR, IFNAR1 
mir-2446↑ Jak-STAT GRB2, STAT5A, STAM2, 
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signaling 
pathway 
STAT5B, IL15, SPRY4, SPRY3, 
ZFP91, SPRY2, SPRY1, SOS1, 
IFNG, STAM, SPRED1, PIK3R1, 
IL6, IL2RA, IL7, CREBBP 
mir-1296↑ Cell adhesion 
molecules 
(CAMs) 
CLDN18, CD8A, CADM1, 
CDH1, CLDN11, PDCD1, SDC3, 
NRCAM, PVRL1, ICOS, PVRL2, 
CNTNAP2, CD6, HLA-DOA, 
HLA-DOB, ICAM1 
mir-30c↑,mir-30e-5p↑ Cell Cycle, 
Mitotic 
PPP2R1B, XPO1, E2F3, TAOK1, 
DBF4, CCNE2, 
RANBP2, CCNA1, PSMD7, 
STAG2, TFDP1 
mir-1271↑ Angiotensin II-
stimulated 
signaling 
through G 
proteins and 
beta-arrestin 
PRKCA, MAP2K1, PRKCI, 
ADRBK2, GNG12, PRKCE, 
ITPR2, GRK6, RHOB, GRK4, 
PLCB2, GRK1, GNG7 
mir-1249↓,mir-181c↓, 
mir-181a↓,mir-21-3p↓ 
Ras Pathway HRAS, GRAP, GRB2, SRF, 
MAPK1, RPS6KA2, ETS1, 
GSK3A, JUN, MAPK14, 
MAPK3, MAP2K7, 
MAPK1, PAK7, RPS6KA3, 
PLD1, KRAS, MAP2K1, 
RPS6KA6, TIAM1, RPS6KA2, 
MAP3K1, MAP2K3 
mir-218↓ Leukocyte 
transendothelia
l migration 
RASSF5, ARHGAP5, VAV3, 
PLCG1, GNAI2, GNAI1, 
ACTN1, RAPGEF4, PXN, 
PIK3R1 
mir-185↓ Integration of 
energy 
PRKAR2A, ADCY2, GCK, 
CHKB, PPP2R5D, PRKAB2, 
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metabolism ADCY6, PRKAB1, GNG12, 
GNB3 
mir-130b↓ Lysosome CTSK, LIPA, GNPTAB, TPP1, 
AP1G1, PSAP, CLTC 
mir-143↓ Metabolism of 
carbohydrates 
GOT1, HK2, GYG2, PGK1, 
CALM1, PC 
() shows upregulation while () indicate downregulation of differentially expressed 
miRNAs in the granulosa cells of SF compared to DF at day 7 of the estrous cycle, (P 
value ˂ 0.05). 
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Appendix 4: The most enriched pathways of target genes for differentially expressed 
miRNAs between granulosa cells of dominant follicles at day 3 and day 7 of estrous 
cycle. 
 
miRNAs,ID Term Genes 
bta-miR-1271↓,bta-miR-15b↓,bta-miR-
16b↓,bta-miR-195↓,bta-miR-185↑,bta-
miR-326↑,bta-miR-133a↑,bta-miR-
497↓,bta-miR-181a↑,bta-miR-181b↑,bta-
miR-1249↑,bta-miR-221↑,bta-miR-
330↑,bta-miR-155↑,bta-miR-214↑,bta-
miR-222↑,bta-miR-183↑,bta-miR-
2332↓,bta-miR-497↓,bta-miR-145↑, 
bta-miR-424-5p↓,bta-miR-204↑,bta-miR-
182↑,bta-miR-96↑,bta-miR-129-5p↑,bta-
miR-148b↓,bta-miR-27a-3p↑,bta-miR-
449a↑,bta-miR-129↑,bta-miR-452↓,bta-
miR-132↑,bta-miR-194↓,bta-miR-345-
3p↑,bta-miR-2904↑,bta-miR-2285c↓,bta-
miR-10b↓,bta-miR-346↑,bta-miR-146b↑ 
Wnt signaling 
pathway 
WNT7B,WNT5A, 
WNT4,WNT1, 
WNT9A,WNT8B, 
WNT7A,WNT6, 
WNT5A,WNT4, 
WNT3A,WNT2B, 
WNT2,WNT16, 
WNT11,WNT10B, 
WNT1,WIF1 
bta-miR-1271↓,bta-miR-1296↓,bta-miR-
484↓,bta-miR-1249↑,bta-miR-96↑,bta-
miR-181a↑,bta-miR-181c↑,bta-miR-
182↑, 
bta-miR-15b↓,bta-miR-16b↓,bta-miR-
195↓,bta-miR-181b↑,bta-miR-330↑,bta-
miR-424-5p↓,bta-miR-181d↑,bta-miR-
27a-3p↑,bta-miR-199c↑,bta-miR-
204↑,bta-miR-145↑,bta-miR-128↓,bta-
miR-452↓,bta-miR-129↑,bta-miR-142-
5p↑,bta-miR-326↑,bta-miR-338↑,bta-
miR-185↑,bta-miR-150↑,bta-miR-21-
5p↑,bta-miR-365-3p↑,bta-miR-24-
MAPK 
signaling 
pathway 
MAP3K5,MAP2K7, 
FGF3,AKT3,AKT2 
,PRKCA,TAOK1, 
CACNG4,CACNG2, 
FLNB,CACNA1S, 
CACNA2D2,MAPK1,  
MAPK14,MAPK3, 
MAPK8IP3,MAP3K12 
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3p↑,bta-miR-193b↑,bta-miR-873↓,bta-
miR-199b↑ 
bta-miR-1271↓,bta-miR-30c↓,bta-miR-
1249↑,bta-miR-96↑,bta-miR-145↑,bta-
miR-182↑,bta-miR-330↑,bta-miR-
31↓,bta-miR-181a↑,bta-miR-181c↑,bta-
miR-29b↑,bta-miR-15b↓,bta-miR-
16b↓,bta-miR-195↓,bta-miR-181b↑,bta-
miR-199c↑,bta-miR-29a↑,bta-miR-
29b↑,bta-miR-29c↑,bta-miR-497↓,bta-
miR-185↑,bta-miR-204↑,bta-miR-
214↑,bta-miR-132↑,bta-miR-1296↓,bta-
miR-484↓,bta-miR-130b↑,bta-miR-
148b↓,bta-miR-326↑,bta-miR-34a↑,bta-
miR-449a↑,bta-miR-129↑,bta-miR-142-
5p↑,bta-miR-221↑,bta-miR-183↑,bta-
miR-128↓,bta-miR-222↑,bta-miR-
330↑,bta-miR-146a↑,bta-miR-199a-
5p↑,bta-miR-27a-3p↑,bta-miR-96↑,bta-
miR-338↑,bta-miR-148b↓,bta-miR-
202↓,bta-miR-339b↓,bta-miR-193b↑,bta-
miR-52↓,bta-miR-196a↓ 
Axon guidance PAK7, GNAI3, GNAI2, 
SEMA6D, EFNB2, 
PPP3R1, SEMA3C, 
PAK1, EPHA4, EFNB3, 
SEMA4C, SEMA4B, 
NFATC4, COL4A4, 
COL4A3, COL4A2, 
COL4A1, COL3A1, 
COL2A1, COL5A2, 
COL5A1, COL4A5, 
COL9A1, COL6A3, 
COL1A2, COL1A1,  
bta-miR-1271↓,bta-miR-1249↑,bta-miR-
96↑,bta-miR-182↑,bta-miR-15b↓,bta-
miR-16b↓,bta-miR-195↓,bta-miR-
497↓,bta-miR-181a↑,bta-miR-181c↑,bta-
miR-181b↑,bta-miR-181d↑,bta-miR-
330↑,bta-miR-204↑,bta-miR-128↓,bta-
miR-31↓,bta-miR-424-p↓,bta-miR-
214↑,bta-miR-129↑,bta-miR-129-
5p↑,bta-miR-185↑,bta-miR-32↑,bta-miR-
148b↓,bta-miR-183↑,bta-miR-133a↑,bta-
miR-142-3p↑,bta-miR-21-3p↑,bta-miR-
Signalling by 
NGF 
SOS1, ADCY6, RIT1, 
RICTOR, FRS2, AKT3, 
MEF2C, MEF2A, 
ADCYAP1R1, CREB1, 
FOXO1, FOXO3, 
MAPK1, PDE1B, 
ADCY9, RALA, RAP1A, 
PIK3R1, CALM1, 
MAP2K5 
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345-3p↑,bta-miR-221↑,bta-miR-
222↑,bta-miR-365-3p↑ 
bta-miR-484↓,bta-miR-29c↑,bta-miR-
1271↓,bta-miR-29a↑,bta-miR-29b↑,bta-
miR-1249↑,bta-miR-96↑,bta-miR-
15b↓,bta-miR-16b↓,bta-miR-195↓,bta-
miR-182↑,bta-miR-330↑,bta-miR-
497↓,bta-miR-199c↑,bta-miR-185↑,bta-
miR-107↑,bta-miR-148b↓,bta-miR-
150↑,bta-miR-145↑,bta-miR-92b↓,bta-
miR-363↑,bta-miR-196a↓,bta-miR-
199b↑ 
Focal adhesion HRAS, XIAP, GRB2, 
PXN, SRC, ITGB7, 
COMP, THBS1, PIK3R3, 
SHC2, RAPGEF1, AKT3, 
AKT2, COL4A4  
bta-miR-484↓,bta-miR-1249↑,bta-miR-
15b↓,bta-miR-16b↓,bta-miR-195↓,bta-
miR-497↓,bta-miR-181a↑,bta-miR-
181c↑,bta-miR-424-5p↓,bta-miR-
181b↑,bta-miR-96↑,bta-miR-592↓,bta-
miR-181d↑,bta-miR-182↑,bta-miR-
330↑,bta-miR-214↑,bta-miR-128↓,bta-
miR-150↑,bta-miR-199a-5p↑,bta-miR-
193b↑,bta-miR-3431↓,bta-miR-769↓ 
Insulin 
signaling 
pathway 
MAP2K1, GRB2, FLOT2, 
FOXO1, IRS1, KRAS, 
CRKL, PRKAR1A, 
MAPK9, SHC1, 
PRKACB, PIK3R1, SHC4 
bta-miR-1249↑,bta-miR-182↑,bta-miR-
96↑,bta-miR-330↑,bta-miR-145↑,bta-
miR-181c↑,bta-miR-199c↑,bta-miR-
145↑,bta-miR-132↑,bta-miR-148b↓,bta-
miR-195↓,bta-miR-181a↑,bta-miR-
181b↑,bta-miR-15b↓,bta-miR-16b↓,bta-
miR-214↑,bta-miR-130b↑,bta-miR-199a-
5p↑,bta-miR-128↓,bta-miR-155↑,bta-
miR-21-5p↑,bta-miR-183↑,bta-miR-
374a↓,bta-miR-346↑,bta-miR-345-
3p↑,bta-miR-363↑,bta-miR-3431↓ 
TGF-beta 
signaling 
pathway 
ACVR2A, MAPK1, 
ACVR2B, E2F5, 
RPS6KB1, DCN, 
SMAD7, MRAS, FOXK2, 
FOXO1, FOXO3, 
SMAD1, FOXO4, 
FOXN3 
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bta-miR-1271↓,bta-miR-484↓,bta-miR-
1249↑,bta-miR-96↑,bta-miR-181a↑,bta-
miR-181b↑,bta-miR-181c↑,bta-miR-
182↑,bta-miR-181d↑,bta-miR-195↓,bta-
miR-27a-3p↑,bta-miR-330↑,bta-miR-
15b↓,bta-miR-16b↓,bta-miR-497↓,bta-
miR-128↓,bta-miR-185↑,bta-miR-
129↑,bta-miR-193b↑ 
GnRH 
signaling 
pathway 
ADCY1, PLD1, 
MAP2K1, CAMK2G, 
MAP2K4, MMP14, 
MAPK1, KRAS, ADCY9, 
MAP3K3,  
bta-miR-1296↓,bta-miR-1249↑,bta-miR-
182↑,bta-miR-497↓,bta-miR-107↑,bta-
miR-185↑,bta-miR-34a↑,bta-miR-
449a↑,bta-miR-221↑,bta-miR-129↑,bta-
miR-365-3p↑,bta-miR-223↑,bta-miR-
10b↓ 
Angiogenesis WNT5A, PTPRJ, ETS1, 
SOS1, FZD3, WNT5B, 
FGFR3, APC2, PDGFB, 
GRAP 
bta-miR-484↓,bta-miR-1249↑,bta-miR-
592↓,bta-miR-181a↑,bta-miR-30c↓,bta-
miR-96↑,bta-miR-182↑,bta-miR-
330↑,bta-miR-181d↑,bta-miR-204↑,bta-
miR-129-5p↑,bta-miR-326↑,bta-miR-
143↑,bta-miR-142-3p↑,bta-miR-196a↓ 
Calcium 
signaling 
pathway 
ADCY1, PTGER3, 
SLC25A4, CAMK2G, 
PPP3R1, GRM5, 
ATP2B1, EDNRA 
bta-miR-181c↑,bta-miR-330↑,bta-miR-
497↓,bta-miR-181a↑,bta-miR-181b↑,bta-
miR-15b↓,bta-miR-16b↓,bta-miR-195↓, 
bta-miR-181d↑,bta-miR-185↑,bta-miR-
182↑,bta-miR-96↑,bta-miR-592↓,bta-
miR-129↑,bta-miR-145↑,bta-miR-
452↓,bta-miR-326↑,bta-miR-193b↑ 
Oocyte 
meiosis 
ADCY1, MAP2K1, 
CAMK2G, PPP3R1, 
PPP1CB, PPP2R1A, 
MAP2K1, BTRC, CDC23, 
ITPR1 
bta-miR-1249↑,bta-miR-195↓,bta-miR-
27a-3p↑,bta-miR-96↑,bta-miR-29a↑,bta-
miR-330↑,bta-miR-15b↓,bta-miR-
16b↓,bta-miR-181a↑,bta-miR-181d↑,bta-
miR-29b↑,bta-miR-129↑,bta-miR-129-
5p↑,bta-miR-31↓,bta-miR-497↓,bta-miR-
Signaling by 
EGFR 
MAPK1, HRAS, AP2A2, 
GRB2, MAPK3, CDC42, 
AP2A1, PAG1, SH3GL2, 
UBE2D3, SMAD7, 
BMPR2 
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221↑,bta-miR-145↑,bta-miR-133a↑,bta-
miR-452↓,bta-miR-199a-5p↑,bta-miR-
142-3p↑,bta-miR-374a↓ 
bta-miR-30c↓,bta-miR-30e-5p↓,bta-miR-
23b-3p↑,bta-miR-424-5p↓,bta-miR-
128↓,bta-miR-21-3p,bta-miR-224↓,bta-
miR-194↓,bta-miR-146a↑,bta-miR-
338↑,bta-miR-365-5p↑, 
Ubiquitin 
mediated 
proteolysis 
PRKCA, SPHK2, 
PIK3CD, MAPKAPK3, 
SOCS3, SOCS1,  
bta-miR-484↓,bta-miR-1249↑,bta-miR-
15b↓,bta-miR-16b↓,bta-miR-195↓,bta-
miR-30c↓,bta-miR-29c↑,bta-miR-
330↑,bta-miR-185↑,bta-miR-146b↑, 
VEGF 
signaling 
pathway 
PRKCA, MAPK1, HRAS, 
FLT1, ETS1, CDC42, 
VEGFA, 
bta-miR-1296↓,bta-miR-1249↑,bta-miR-
96↑,bta-miR-128↓,bta-miR-183↑,bta-
miR-769↓ 
Insulin/IGF 
pathway-
protein kinase 
B signaling 
cascade 
IGF1R, FOXQ1, FOXK2, 
FOXF2, FOXO1, IRS2, 
FOXJ2, FOXK1, 
PIK3C2B, RALGAPA2, 
FOXJ1  
bta-miR-182↑,bta-miR-96↑,bta-miR-
195↓,bta-miR-199c↑,bta-miR-143↑,bta-
miR-365-3p↑,bta-miR-374a↓, 
Gap junction KRAS, PDGFRA, 
MAPK7, HTR2C,  
bta-miR-15b↓,bta-miR-16b↓,bta-miR-
195↓,bta-miR-199c↑,bta-miR-21-
5p↑,bta-miR-181a↑,bta-miR-32↑,bta-
miR-497↓,bta-miR-27a-3p↑,bta-miR-
330↑,bta-miR-374a↓, 
Signaling by 
BMP 
SMAD9, SMAD5, 
SMAD4, SMAD1, 
ACVR2A, ACVR2B 
bta-miR-27a-3p↑ Neuroactive 
ligand-receptor 
interaction 
PTGER3, ADORA2B, 
PTGER4, CYSLTR2, 
GRIK3, GLRA2, GRIA3, 
GRIA4  
bta-miR-1249↑,bta-miR-181a↑,bta-miR-
181c↑,bta-miR-21-3p↑ 
Ras Pathway HRAS, MAP2K7, AKT3, 
AKT2 
bta-miR-181b↑ Apoptosis MAP2K4, PRKCE, 
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signaling 
pathway 
PRKCD, CASP10, 
HSPA5, FAS, AKT3 
bta-miR-96↑ Natural killer 
cell mediated 
cytotoxicity 
MAP2K1, GRB2, 
PPP3R1, SH2D1A, 
KRAS, PLCG1, FYN 
bta-miR-1249↑ Fc gamma R-
mediated 
phagocytosis 
PRKCA, MAPK1, GAB2, 
LIMK1, WASF2, MAPK3 
bta-miR-133a↑, bta-miR-185↑ Integration of 
energy 
metabolism 
DLST, STX1A, TPI1, 
PFKFB3, PPP2CA, 
PPP2R5D, ADCY6  
bta-miR-185↑, bta-miR-146a↑ Tight junction CDC42, TJP1, EPB41L1, 
ZAK 
bta-miR-96↑, bta-miR-182↑ Fc gamma R-
mediated 
phagocytosis 
PLD1, CRKL, PLCG1, 
MAP2K1, WASF2, CFL1, 
RAC1, PAK1,  
bta-miR-130b↑ Lysosome CTSK, LIPA, GNPTAB, 
TPP1,  
bta-miR-129-5p↑, bta-miR-149-5p↑, bta-
miR-365-5p↑ 
Processing of 
Capped Intron-
Containing 
Pre-mRNA 
SFRS6, HNRNPA3, 
HNRNPK, SRRM1, 
SMC1A, HNRNPA1, 
PRPF4, SLBP 
bta-miR-107↑, bta-miR-146a↑, bta-miR-
142-3p↑ 
Fc gamma R-
mediated 
phagocytosis 
PTPRC, CRKL, VAV3, 
CFL1, RAF1, PRKCE, 
AKT3, PIK3R1,  
bta-miR-183↑ Transcription SSRP1, RNMT, POLR1C, 
POLR2D,  
bta-miR-182↑ Axon guidance 
mediated by 
netrin 
ABLIM1, PLCG1, RAC1, 
NTN4, NTNG1, UNC5D,  
bta-miR-143↑ Metabolism of 
carbohydrates 
GOT1, HK2, GYG2, 
PGK1, CALM1, PC 
bta-miR-34a↑, bta-miR-449a↑ Notch NOTCH2, NOTCH1, 
Appendix                                                                                                                        172 
 
 
 
signaling 
pathway 
DLL1, JAG1, NUMBL 
bta-miR-183↑ Histamine H1 
receptor 
mediated 
signaling 
pathway 
PRKCA, PLCB4, GNB1, 
GNG4, GNG5 
bta-miR-142-5p↑ Axon guidance 
mediated by 
Slit/Robo 
ENAH, ROBO1, RHOA, 
RHOQ, NEO1 
bta-miR-130b↑ Xanthine and 
guanine 
salvage 
pathway 
GDA, HPRT1, PGM2L1 
bta-miR-146b↑ Natural killer 
cell mediated 
cytotoxicity 
KRAS, NFAT5, PPP3R2 
bta-miR-130b↑ Metabolism of 
nitric oxide 
WASL, CALM2, DNM2 
bta-miR-24-3p↑ Pyridoxal 
phosphate 
salvage 
pathway 
PDXK, PNPO 
bta-miR-1296↓, bta-miR-202↓ Cell adhesion 
molecules 
(CAMs) 
CLDN18, CD8A, 
CADM1, CDH1, 
CLDN11, PDCD1,  
bta-miR-30c↓, bta-miR-30e-5p↓ Cell Cycle, 
Mitotic 
PPP2R1B, XPO1, E2F3, 
TAOK1, DBF4,  
bta-miR-1271↓ Angiotensin II-
stimulated 
signaling 
through G 
proteins and 
PRKCA, MAP2K1, 
PRKCI, ADRBK2, 
GNG12, PRKCE, ITPR2, 
GRK6, RHOB, GRK4, 
PLCB2, GRK1, GNG7 
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beta-arrestin 
bta-miR-1296↓ Vitamin D 
metabolism 
and pathway 
CYP27C1, CYP27B1, 
RARG, FDX1, CYP2D6, 
PML,  
bta-miR-30e-5p↓, bta-miR-592↓ N-Glycan 
biosynthesis 
MGAT2, TUSC3, 
MAN1A2, ALG10B,  
bta-miR-202↓ 5HT3 type 
receptor 
mediated 
signaling 
pathway 
HTR3E, VAMP3, 
SLC18A1, SNAP23, 
KCNK3, HTR3D 
bta-miR-30e-5p↓ O-Glycan 
biosynthesis 
GALNT3, GALNT2, 
GALNT1, GALNT7, 
GALNT4 
bta-miR-202↓ Phenylalanine 
metabolism 
NAT6, MAOA, TAT, 
ALDH3B1 
() shows upregulation while () indicate downregulation of differentially expressed 
miRNAs in the granulosa cells of DF at day 3 and day 7 of the estrous cycle, (P value ˂ 
0.05). 
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